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Experimental animal models and observational studies suggest that maternal obesity in 
pregnancy influences the development of obesity in early infancy. As the trajectory of later 
adiposity is thought to be determined in early life; an understanding of potential 
contributing factors and associative mechanisms are essential to inform targeted 
interventions.  
 
The analyses reported in this thesis have sought to address these associations in mothers 
and their offspring from the UK Pregnancies Better Eating and Physical Activity Trial 
(UPBEAT), a randomised controlled trial of a behavioural intervention (diet and physical 
activity) in obese pregnant women. As the trial, did not show a reduction in the primary 
outcomes; incidence of gestational diabetes and delivery of a large for gestational age 
neonate, the dataset was treated as a cohort.  
 
Modifiable maternal risk factors including early pregnancy measures of maternal adiposity, 
were linearly associated with neonatal adiposity. An independent association with maternal 
birthweight and neonatal adiposity was also identified. Mode of early infant feeding 
(breast, formula and mixed feeding) and measures of general appetite influenced measures 
of infant growth and body composition at 6 months in offspring born to obese women from 
the UPBEAT cohort; providing evidence of a potential target for intervention within a 
sensitive window of opportunity.  
 
To address mechanistic pathways underpinning the associations between in-utero 
exposures and offspring adiposity, assessment of the cord blood metabolic profile was 
undertaken including measurement of candidate biomarkers and metabolome. A novel 
relationship between cord lysophosphatidylcholine with neonatal and infant anthropometry 




Maternal fasting glucose in late second trimester was also found to partially mediate the 
effect of maternal parity and early pregnancy adiposity with neonatal adiposity.  
 
The UPBEAT intervention was associated with a reduction in a measure of offspring 
central adiposity, which was mediated through changes in antenatal diet and gestational 
weight gain instigated by the intervention. This provides evidence, within a randomised 








Chapter 1 Introduction 
 
1.1  Childhood obesity 
1.1.1 Epidemiology 
Globally, 41 million children under the age of 5 years are currently estimated to be 
overweight or obese (Ng et al., 2014; Poston et al., 2016) (Figure 1.1). In a report from 
2015 it was suggested that in the UK, 24.4% of children aged between two and five years 
are overweight (defined as >85th centile weight for length z-scores) (de Onis et al., 2010; 
van Jaarsveld and Gulliford, 2015). There is now evidence to suggest that many of these 
obese children were born large for gestational age (LGA) or macrosomic (birthweight 
>4kg) (Cunningham et al., 2014). A population study, undertaken in the United States of 
America (USA ) in children (n=21,260) aged 0-14 years, found that 36% of childhood 
obesity from 5 to 14 years occurred in macrosomic neonates (Cunningham et al., 2014). 
This study also demonstrated that obesity tracked through childhood, with an incidence at 
14 years of age, 4 times higher amongst overweight children at 5 years of age 
(Cunningham et al., 2014); suggesting that obesity in adolescence is associated with 
birthweight and subsequently childhood obesity. 
 





Figure 1.1: Age standardised global prevalence of obesity defined by the International Obesity Task Force Criteria for male and females aged between 2-19 years of 
age.  
 Age standardized prevalence rates were calculated using the standard population distribution based on the average country distribution by age determined by World Population Prospects 2012 
Revision. Source: Ng et al. Global, Regional and National Prevalence of Overweight and Obesity in Children and Adults 1980-2013: A Systematic Analysis. Lancet 2014;384:766-781 (Ng et al., 
2014). 
 




1.2 Health consequences of childhood obesity 
The consequences of childhood obesity can be classified into immediate adverse health 
(childhood consequences) and those that persist throughout the life course (adulthood 
consequences). 
 
1.2.1 Childhood consequences 
Childhood obesity is associated with a wide range of immediate psychological and 
psychosocial ill health including depression, anxiety and low self-esteem (Reeves et al., 
2008). Population level analysis, from Booth et al, found that children who are obese at 11 
years of age had significantly reduced academic attainment at 16 years of age in 
comparison to non-obese children (Booth et al., 2014). If this relationship between 
childhood obesity and academic attainment were found to be causal, this may impact upon 
later employment and subsequent socioeconomic status (Johansson and Sundquist, 1999). 
Paediatric obesity is associated with concurrent prevalence of fatty liver disease, asthma 
and allergy (Dietz, 1998; Ebbeling et al., 2002). Health care costs, are also higher amongst 
overweight and obese children, due to an increased frequency of utilisation of healthcare 
services, hospitalisations and prescribed medications in comparison to those children of 
normal weight and of corresponding age (Hayes et al., 2016).  
 
1.2.2 Adulthood consequences 
Overweight and obese children are more likely to have risk factors increasing their 
susceptibility to later disease as adults. Childhood obesity increases not only susceptibility 
to later obesity but also insulin resistance and cardiovascular disease throughout the life 
course (Lawlor, 2013). Within an Israeli population study including 2,298,130 adolescents 
(followed up for 42,297,007 person-years) aged between 16 and 19 years, obesity during 




risk of mid-life cardiovascular mortality, in particular from coronary artery disease (17.7% 
associated cardiovascular mortality (95% CI 14.9% to 20.7%), following adjustment for 
age, birth year, sex, education, socioeconomic origin and country of origin (Twig et al., 
2016) (Figure 1.2). A dose-response relationship is evident between the length of time an 
individual is obese and subsequent risk of adult onset cardiovascular disease and all-cause 
mortality (Aune et al., 2016). 
 
Figure 1.2: Body mass index during adolescence and subsequent risk of cardiovascular 
mortality.  
2,298,130 participants followed-up for 44 years according to the percentile of BMI during adolescence 
(measured at 16-19 years). Grey shading indicates 95% confidence intervals and all models were adjusted for 
sex, age at examination, birth year, education, socioeconomic status, country of origin and height. Within this 
study, there were 2,918 deaths from cardiovascular causes including coronary artery disease, stroke and 
sudden death of unknown cause. Source: Twig et al. Body Mass Index in 2.3 Million Adolescents and 







1.3 Causes of childhood obesity 
The increasing prevalence of obesity is thought to be due to an energy imbalance secondary 
to energy intake exceeding energy expenditure. Obesity is a complex, multifactorial trait, 
composed of interlinked genetic and environmental components (Aguilera et al., 2013). 
The global increase in obesity over the last two generations from 15% to 33.9% globally, 
suggests that although genetic variants may play a contributing role, an increasing 
emphasis should now be placed on the potential role of environmental factors.  
 
1.3.1 Genetic factors associated with childhood obesity 
Within the adult population, twin studies have demonstrated that concordance for fat mass 
is higher in monozygotic twins in comparison to dizygotic twins suggesting a genetic 
component for the development of adiposity (Silventoinen et al., 2009). Genome wide 
association studies (GWAS) within adult populations (n=249,796), have demonstrated 32 
confirmed loci, explaining 1.45% of inter-individual variation in BMI, where the Fat Mass 
and Obesity (FTO) gene accounted for the largest proportion of variance (0.34%) 
(Speliotes et al., 2010; Fall and Ingelsson, 2014). Using stimulation studies, Speliotes et al 
determined that for each additional risk allele, there was an associative increase in BMI by 
0.17 kg/m2 (Speliotes et al., 2010).  
 
Evidence for a potential genetic contribution in the development of childhood obesity, has 
arisen from well conducted twin and sibling studies, which have suggested that 40-70% of 
the inter-variation associated with obesity may be of a genetic origin (Maes et al., 1997). A 
landmark study, conducted by Whitaker et al, found that the development of mid-childhood 
obesity at 10-14 years of age was associated with a 4-5 fold increased risk if both parents 
were obese, in comparison to those with normal weight parents (Whitaker  et al., 1997). 
Furthermore, within a twin population study including 2,508 male twin sets, clustering of 




31.6% monozygotic pairs and 6.3% dizygotic pairs (Carmelli et al., 1994), providing 
consistent evidence of a genetic involvement in the development of adulthood 
cardiometabolic disease (Aguilera et al., 2013).  
 
GWAS studies, have recently provided robust evidence for the role of variant genes in the 
development of childhood obesity. The Avon Longitudinal Study of Parents and Children 
(ALSPAC) identified associations with genetic variants within the FTO gene, the 
Melanocortin 4 receptor (MC4R) gene and transmembrane protein genes as assessed in 
cord leucocytes, with mid-childhood body mass index (BMI) at 11 years of age (Sovio et 
al., 2011). The study further identified a relationship with a rs9939609 variant which was 
associated with an accelerated adiposity rebound in early childhood but also increased BMI 
by 0.1 kg/m2 per allele from birth to 13 years of age (Sovio et al., 2011). Development of 
an ‘obesity allele risk-score’ with inclusion of these causative genetic variants, den Hoed et 
al demonstrated that offspring (n=7,146) with a raised obesity risk score were heavier and 
longer at 6 weeks of age, findings of which were replicated in the Severe Childhood Onset 
and Obesity project (n=1038) (den Hoed et al., 2010). A meta-analysis of 2.7 million single 
nucleotide polymorphisms (SNPs), from 14 included studies, consisting of 8,318 normal 
weight (<50th percentile of BMI) and 5,530 obese children (95th percentile of BMI) 
confirmed previous findings of a role of FTO, transmembrane protein gene (TMEM18), 
Pro-opiomelanocortin (POMC), Melanocortin 4 receptor (MC4R) and others, as well as a 
novel role for HOXB5 (implicated in regulating gut function) and OLFM4 (involved in cell 







Figure 1.3: Manhattan plot of the genome wide association meta-analysis of childhood obesity. 
Each locus was found to achieve genome wide significance (p< 5x10-8). Novel loci identified in this study are 
indicated in red text. Source: Bradfield JP et al. A genome-wide association meta-analysis identified new 
childhood obesity loci. Nature Genetic 2012; 44:526-531 (Bradfield et al., 2012) 
 
These findings collectively suggest that as few as 5% of cases of childhood obesity are 
directly caused by a defective gene due to the observed small effect estimates (Bouchard, 
2009). The development of childhood obesity is thought to result from an acquired 
predisposition favouring obesogenic behaviours within a high-risk obesity environment 
(Bouchard, 2009). Studies investigating the role of genetic factors in the development of 
childhood obesity have provided mechanistic insight between the interaction of 
environmental risk factors and genetic susceptibility to obesity related traits (Frayling et 
al., 2007). However, these relationships are potentially confounded by environmental 
factors shared amongst family members. Insight into the interactions between key genetic 
and causative environmental factors, may provide additional targets for intervention within 






1.3.2 Childhood lifestyle behaviours 
 
1.3.2.1 Diet  
Observational and randomised controlled studies (RCTs), have demonstrated that formula 
feeding promotes rapid early postnatal growth, associated with the development of later 
childhood obesity, in comparison with exclusive breastfeeding (Kramer, 1981; Ong et al., 
2006). However, the effect sizes are small and are discussed in detail in Section 1.3.12: 
Postnatal feeding.   
 
A high saturated fat diet, increased consumption of sugar-sweetened beverages and caloric 
intake have been consistently associated with the development of childhood obesity. As 
food preferences are determined in early childhood, it is suggested that poor diet may 
increase susceptibility to later life obesity. However, assessment of secular trends in dietary 
composition over the last twenty-five years using data from the Nationwide Food 
Consumption Survey have identified a constant calorie intake, placing an increasing 
emphasis nutrient composition (Evert et al., 2014) 
 
A relationship between increased consumption of sugar-sweetened beverages and increased 
weight gain in children has been consistently demonstrated, as recently observed in a 
systematic review (Malik et al., 2013). In a more recent study, a post-hoc analysis of a 
blinded RCT replacing sugar-sweetened with sugar free beverages over an 18 month period 
in children  7-10 years of age, consumption of sugar-sweetened beverages was associated 
with a significant increase in weight particularly in those children overweight and obese at 
baseline (Katan et al., 2016). In another recent report, intakes of sugar-sweetened 
beverages were found to be highest in overweight and obese children in a cross-sectional 
study of 1075 children aged 8-11 years,  with an increase in consumption of 330ml/day 




2016). The prominence of ‘fast-food’ within children’s diet has quadrupled, as observed in 
a USA population study in 6212 children aged between 4-19 years (Bowman et al., 2004). 
Indeed increased availability and access to processed food is thought to play a significant 
role in the increasing incidence of obesity (Ebbeling et al., 2002), highlighting the need to 
modify dietary composition in children to reduce the incidence of obesity.   
 
1.3.2.2 Physical activity 
Physical inactivity defined as increased sedentary behaviour, is associated with increased 
risk of childhood obesity (Tremblay and Willms, 2003; LeBlanc et al., 2015). Physical 
inactivity has been shown to be linearly associated with an increase in screen/ television 
viewing time in a study including 5,844 children (mean age 10.4 years) (LeBlanc et al., 
2015), and which has been shown to be associated with an increase in energy and total 
dietary fat intake (Dietz and Gortmaker, 1985; Hill and Peters, 1998). A population study 
in the USA (n=284, 675), found that 79% of children watched television >1hr daily. The 
time spent watching television was linearly associated with BMI in adolescents and 
children, exhibiting a dose response relationship (Greaves et al., 2011). The relationship 
was demonstrated as causal, in an RCT assessing the provision of educational aids focused 
on reducing television and video game use in 192 school children (mean age 8.9 years) 
(Robinson, 1999). Children randomised to the intervention arm had a reduction in BMI 
(adjusted relative difference -0.45 kg/m2 (95% CI -0.73 to -0.17), triceps skinfold 
thicknesses (SFT) (-1.47mm (95% CI -2.41 to -0.54)) and waist circumference (-2.30cm 
(95% CI -3.27 to -1.33)), suggesting a potential causal relationship between physical 
activity and childhood obesity (Robinson, 1999).  
 
While there is little doubt that a high fat, western style diet combined with a reduction in 
physical activity are strong contributors (Robinson, 1999; Moreno and Rodríguez, 2007); 




childhood obesity, a concept integral to the Developmental Origins Health and Disease 
Hypothesis (DoHaD).  
 
1.3.3  The DoHaD hypothesis (developmental programming) 
Observational data and animal studies, have highlighted associations between alterations in 
the in-utero environment and increased susceptibility to obesity and adverse 
cardiometabolic profiles in adulthood. A combination of antenatal and postnatal factors 
have been implicated in the development of infant and childhood obesity including, in the 
first instance, maternal undernutrition (Barker et al., 1989; Whitaker  et al., 1997; 
Hattersley and Tooke, 1999) and more recently maternal obesity, excessive gestational 
weight gain (GWG), gestational diabetes (GDM) and early life feeding and growth 
trajectories (Nelson et al., 2010). This has led to numerous studies exploring these 
associations and potential contributory mechanisms, with the ultimate objective being the 
development of interventions in early in life to reduce the risk of offspring obesity.  
 
Studies in experimental animals were amongst the first to propose that the in utero 
environment including maternal size and nutrition could be play a role in future 
development. The classic Shire horse/Shetland pony breeding experiments of McCance and 
Widdowson (McCance and Widdowson, 1974), for example demonstrated the role of 
intrauterine restraint on future growth trajectory. Work by Dubos et al in 1966 identified a 
consistent trend between the earlier maturation of children attributable to environmental 
influences in early life. His animal models focused primarily on early postnatal life as a 
critical window for environmental exposures to influence development. Within a 
genetically identical mice model, Dubos et al demonstrated that growth trajectories in early 
life are determined at birth (Dubos et al, 1966). These experimental animal studies showed 
proof of principle of the developmental programming hypothesis but predated the 




by Barker et al (Barker, 2002; Almond and Currie, 2011)The Barker hypothesis originated 
from studies within historical population cohorts assessing the influence of in-utero 
exposure to maternal undernutrition. Low birthweight was found to be associated with 
inadequate nutrition in-utero ‘programming’ the fetuses’ susceptibility to future 
cardiovascular and metabolic disease (Barker, 2002). Whilst a reduction in birthweight is 
evident at birth, it is apparent that more subtle effects within the in-utero environment may 
have latent effects on the offspring phenotype. A series of observational studies derived 
from the Dutch “Hunger Winter” determined the underlying effects of in-utero 
programming including the observation that famine exposure in-utero was associated with 
a two-fold increase in the incidence of obesity at 18 years of age in offspring without a 
change in birthweight (Ravelli et al., 1976; Murray et al., 2015). Intrauterine insults from 
normal development during the critical phases of growth and development have been 
associated with permanent functional and structural changes in certain organs including 
liver and kidney and cellular function within adipocytes, myocytes, nephrons, neurons and 
pancreatic beta cells (Vickers et al., 2000; Bagby, 2007). 
 
Barker and Hales subsequently formulated the ‘Thrifty Phenotype’ hypothesis, to account 
for the observed correlations between birthweight and development of type 2 diabetes 
(Hales and Barker, 2001). It was hypothesised that fetuses experiencing poor maternal 
nutrition in-utero are prone to permanent modifications in glucose metabolism, 
consequently associated with an increased risk of cardiometabolic disease. It was proposed 
that fetuses exposed to poor maternal nutrition undergo plasticity adaptive responses which 
conserve energy to protect fetal survival (Desai et al., 2015). However, when offspring are 
faced with an affluent postnatal environment, this adaptive response may increase the 
velocity of early-life growth, which will lead to loss of cellular function in already 
compromised tissues including the pancreas and heighten insulin resistance (Figure 1.4) 








Figure 1.4: Proposed role of in-utero programming contributing to the increased prevalence of 
obesity and metabolic syndrome. 
Source: Desai M et al. Epigenomics, Gestational Programming and Risk of Metabolic Syndrome. International 
Journal of Obesity 2015;39:633-41 (Desai et al., 2015). 
 
Robust evidence from observational and birth cohort studies have identified that the 
trajectory for later obesity may be established by the age of 3-5 years (Stuart and Panico, 
2016). The inference being that intervening prior to pre-school may provide one approach 
to curb the increasing incidence of childhood obesity. Observational and experimental 
animal studies suggest that the offspring’s response to obesogenic environmental exposures 
within the postnatal period, specifically feeding practices, may be determined by 
intrauterine exposures and early postnatal development (Bateson et al., 2004; Parlee and 
MacDougald, 2014). The upward crossing of growth centiles in early life, specifically rapid 




has been shown to be associated with increased risk of later obesity and an adverse 
cardiometabolic risk profile in adolescence and early adulthood (Ong and Loos, 2006; Fall 
et al., 2008; Taveras et al., 2009; Perng et al., 2016; Voerman et al., 2017). Others have 
shown that accelerated weight gain and growth in the first 6 months of life is associated 
with a 3.4 increased risk of overweight at 7 years of age (Stuart and Panico, 2016). A rapid 
increase in weight for length z-scores has also been associated with raised hypertension and 
adiposity in adolescents (Taveras et al., 2009; Perng et al., 2016). Furthermore, 4 discrete 
BMI trajectories have been identified from birth to 3.5 years of age, characterised as low, 
intermediate or high accelerating growth traits, evident at 6 months of age, which 
demonstrated a linear graded effect on the risk of overweight and obesity at 9 years of age 
(Giles et al., 2015).  
 
1.3.4 In-utero determinants of offspring adiposity 
In light of the increasing obesity epidemic, the fundamentals of the Developmental 
Programming hypothesis have been adapted to include exposure to maternal over-nutrition 
in-utero and subsequent offspring health. The concept that maternal “overnutrition” could 
lead to excess fetal growth and adiposity was derived from the knowledge that maternal 
hyperglycaemia stimulates fetal hyperinsulinemia, a major driver of fetal adiposity, as 
described by the Pedersen hypothesis (Macfarlane and Tsakalakos, 1988; Catalano et al., 
1995; Barker, 2002; Catalano et al., 2009; Catalano and Hauguel-De Mouzon, 2011). The 
maternal factors associated with dysglycaemia include dietary behaviours, pre-pregnancy 
obesity, GWG and GDM, all of which independently, or through interactive pathways, 






Figure 1.5: Associations between maternal dietary behaviours, pre-pregnancy obesity, 
gestational weight gain, gestational diabetes and other potential confounding factors 
implicated in the development of offspring adiposity. 
Abbreviations GDM- Gestational diabetes, GWG-Gestational weight gain, SES- Socioeconomic status 
(deprivation).  
 
1.3.5 Normal, healthy pregnancy 
An understanding of normal metabolic and physiological changes in relation to fetal 
growth is essential to understand the mechanistic pathways between the in-utero maternal 
environment, fetal growth and subsequent infant obesity, as described below. 
 
1.3.5.1 Normal fetal growth  
There are three phases to normal fetal growth during human pregnancy. Figure 1.6 
summarises normal fetal estimated weight, length and head circumference development 
throughout gestation. During early gestation, implantation, placentation and embryogenesis 




histotrophic phase of embryonic growth, placental nutrient transfer is established in the 
early 2nd trimester of pregnancy (Bauer et al., 1998). During the second trimester, growth, 
development and function of critical organs including the pancreas, brain and kidneys is 
established. By 20 weeks, the fetus has reached 20% of the potential weight and 60% of its 
total length at term (Zhang et al., 2010). During the early 3rd trimester, there is a phase of 
accelerated fetal growth and adiposity (Dunger et al., 2006). 
 
Figure 1.6: Normal development of fetal weight, length and head circumference trajectories as 
a function of gestational age in normal pregnancies. 
Source: Smith JB. Chapter 25- Initial Evaluation: History and Physical Examination of the Newborn. Avery’s 
Diseases of the Newborn (9th edition). 2012:1;277-299 (Smith, 2012). 
 
 
1.3.5.2 Physiological metabolism of normal pregnancy  
To establish normal growth and development of the fetus, complex interactions and 
alterations in maternal fat deposition, calorie intake and basal metabolic rate occur, as 
summarised in Figure 1.7. Early pregnancy is categorised as an anabolic phase, thereby 
increasing maternal fat mass through enhanced glycogenesis, lipogenesis and protein 
storage (Lain and Catalano, 2007). The third trimester is associated with a predominantly 




circulating glucose, free fatty acids, triglycerides and cholesterol (including lipoprotein 
components) increase to support the demands of the growing fetus (Godfrey et al., 1996a; 
Lain and Catalano, 2007). In addition to these maternal adaptations, maternal insulin 
secretion progressively increases throughout pregnancy with a subsequent decrease in 
insulin sensitivity (Rosso, 1988). These changes are associated with a continual rise of 
maternal fasting glucose throughout gestation, but in the context of a normal pregnancy, the 
thresholds for diagnosis of GDM are not exceeded (Bleicher  et al., 1964; Lain and 
Catalano, 2007).  
 
Figure 1.7: Maternal metabolic changes and fetal weight during normal pregnancy. 
Source: Adapted from Rosso, P. Regulation of Food Intake during Pregnancy and Lactation. Annals Academic 
Science,1988; 499: 191 (Rosso, 1988). 
 
 
1.3.6  The global obesity epidemic in the context of maternal obesity 
1.3.6.1 Global prevalence of maternal obesity 
Obesity is defined as a BMI ≥30kg/m2. The increase in obesity is a major health concern, 





























last twenty years. The World Health Organisation (WHO) has estimated that 300 million of 
the 1.5 billion adults in the world are currently defined as overweight or obese (WHO, 
2012). Furthermore, the Non Communicable Disease Risk Factor Collaboration reported a 
14.9% incidence of obesity in women, estimated from an international population of 19.2 
million adults (NCD-RisC, 2016).  
 
Obesity rates are greatest within high income countries, with a 25% incidence of maternal 
obesity in the UK (Poston et al., 2016) (Figure 1.8). Demographic forecasts demonstrate 
that the prevalence of female obesity will exceed 21% globally by 2025, based on the post-
2000 trends (NCD-RisC, 2016; Poston et al., 2016).  
 
Figure 1.8: Distribution of maternal obesity from the EURO-Peristat database. 
*From WHO database (2009); includes all women aged 20 years or above as proxy for maternal obesity. 
Source: Poston et al. Preconceptional and Maternal Obesity: Epidemiology and Health Consequences. Lancet 
Diabetes and Endocrinology, 2016;4:1025-1036 (Devlieger et al., 2016; Poston et al., 2016).  
A linear relationship exists between increasing pre-pregnancy BMI and the risk of many 
antenatal complications (O'Brien et al., 2003; Marshall et al., 2014). Maternal obesity is an 
independent risk factor for adverse outcomes in pregnancy; including pre-eclampsia, GDM 
and delivery of an LGA infant (Chu et al., 2007; Yu et al., 2013) all of which have been 




more likely to experience complications during labour, including higher rates of induction 
of labour and caesarean sections (Heslehurst et al., 2010). A high maternal BMI is also an 
important risk factor for intrauterine growth restriction (IUGR) (Ramachenderan et al., 
2008), associated with the development of later cardiovascular and metabolic disease in the 
offspring (Barker et al., 1993; Barker, 1997; Demicheva and Crispi, 2014).  
 
1.3.6.2 Maternal obesity and offspring obesity and body composition 
Observational studies have demonstrated that a higher pre-pregnancy BMI is associated 
with raised BMI in the adult offspring, independent of socioeconomic and dietary 
confounding (Yu et al., 2013). For example, within a large multi-ethnic observational 
cohort, Lemas et al, reported that maternal BMI prior to pregnancy was associated with 
increased umbilical cord blood leptin, glucose and reduced high density lipoprotein 
cholesterol (HDL-c) at delivery with neonatal adiposity (n=753), a metabolic profile 
favourable with the development of obesity in adulthood (Lemas et al., 2015).  
 
A report from a sub-group from the Generation R population cohort from the Netherlands 
assessed the influence of maternal obesity on childhood outcomes at 4 years of age. 
Maternal obesity was associated with an increased odds of developing childhood obesity 
(adjusted odds ratio (AOR) 5.02; 95% CI 2.97 to 8.45) (defined as ≥85th centile, 
International Task Force reference population) independent of socioeconomic deprivation 
and poor lifestyle behaviours (Gaillard et al., 2013). The ALSPAC cohort assessed 8234 
women using self-reported pre-pregnancy weight and offspring were followed up to 7 years 
where obesity was defined as BMI greater than the 95th percentile (equivalent to a standard 
deviation of ≥1.96) adjusted for age and gender. Pre-pregnancy obesity was independently 
associated (adjusted for maternal education, offspring energy intake at 3 years and 
offspring sex), with a significant increased risk of childhood obesity at 7 years (AOR 4.25; 




cohort study from the USA (Nurses’ Health Study II and the Nurses’ Mother cohort) where 
maternal obesity (n=26,506) was associated with a 6.1 fold increased risk of obesity in the 
offspring (Stuebe et al., 2009).  
 
However, childhood BMI has been shown to poor predictive measure of later clinical 
outcomes. Distinguishing the deposition of adiposity in relation to in-utero exposures may 
provide insight into the development of later adverse clinical outcomes. In a prospective 
cohort study of a subgroup of 216 women from the Southampton Women’s Survey (UK), 
data on maternal weight and skinfold measurements from pre-pregnancy to 34 weeks’ 
gestation were collected. Offspring adiposity was assessed in 9 year old offspring using the 
fat mass index (FMI) measured by dual energy X-Ray absorptiometry (DEXA). For each 
standard deviation increase in maternal pre-pregnancy BMI there was an increase in 
offspring FMI by 0.26 (95% CI 0.04 to 0.48) in males and 0.42 (95% CI 0.29 to 0.56) in 
females (Gale et al., 2007). These findings were further replicated in a large meta-analysis 
(including n=20 randomised controlled and cohort studies) which assessed the effect of 
pre-pregnancy maternal BMI on offspring fat-free mass, fat mass and % body fat. Maternal 
overweight and obesity was demonstrated to be positively associated with increased 
offspring adiposity (fat mass 0.38 kg, 95% CI 0.26 to 0.50; fat-free mass 0.18kg, 95% CI -
0.07 to 0.42), in comparison to offspring born to normal weight women (Figure 1.9) 





Figure 1.9: Standardized mean differences in offspring body composition (fat free mass and 
fat mass) stratified by maternal pre-pregnancy BMI category.  
Weights are from random effects analysis. 95%CI: 95% confidence interval; SMD: standard mean difference 
(%). Source: Castillo-Laura H et al. Maternal Obesity and Offspring Body Composition by Indirect Methods: A 
Systematic Review and Meta-Analysis. Cadernos de Saude Publica 2015;35:20173-92 (Castillo-Laura et al., 
2015). 
 
A study from the Generation R cohort, assessing the individual and combined exposure of 
maternal and paternal (n=4871) associations of childhood BMI has enabled clarification of 
a potential role of the maternal in-utero environment. Six year old offspring born to obese 
mothers had an increased risk of both being overweight in childhood (OR 3.84; 95% CI 
3.01 to 4.90) and of an increased cardiometabolic risk score including android fat mass 
percentage ≥75th percentile; systolic or diastolic blood pressure ≥75th percentile; high-
density lipoprotein cholesterol ≤25th percentile or triglycerides ≥75th percentile; and 
insulin ≥75th percentile (OR 3.00; 95% CI 2.09 to 4.34) in comparison to those of normal 




maternal pre-pregnancy BMI than paternal BMI, providing further support for the in-utero 
origins of adverse health in later life.  
 
Whilst observational studies have demonstrated the association of pre-pregnancy BMI and 
childhood obesity, RCTs and the use of Mendelian randomisation (MR) methodology are 
required to determine causality of these associations. MR methodology has recently been 
adopted to investigate the causal effect of in-utero exposure to increased maternal BMI and 
with offspring BMI in children aged between 3-17 years in the ALSPAC and Generation R 
cohort. This study reported limited evidence in support of a causal linear relationship 
between maternal BMI and childhood obesity (Berry et al., 2013). However, this 
methodology assumes that the genetic variants remain constant throughout the period 
studied and does not consider the interaction between genetic variants, early life 
environmental factors and the later development of obesity.  
 
1.3.7 Gestational weight gain 
Although elevated pre-pregnancy BMI has been associated with increased risk of adverse 
long-term offspring health, relationships between excess GWG and offspring body 
composition and obesity risk are less readily interpretable, partly because of differences in 
methods of measurements and because of the variable components of weight which can 
contribute to GWG (Gillman, 2012). It could be argued therefore, that the major focus on 
GWG which has predominated in studies assessing overweight and obese women could be 
misplaced due to these uncertainties (Gillman, 2012).  
 
The fetus, placenta, adipose tissue, amniotic fluid, mammary glands and uterus all 
contribute to GWG. However, the fetus, placenta and amniotic fluid account for only 35% 




accrual is another, but very variable component of GWG. Only 5% of maternal weight gain 
at 40 weeks’ gestation constitutes as fat mass (Rasmussen and Yatkine, 2009).  
 
The Institute of Medicine (IOM) recently published new recommendations for GWG 
(Rasmussen and Yatkine, 2009). The recommendations differ depending on the pre-
pregnancy BMI (Table 1.1).  
Table 1.1: Institute of Medicine gestational weight gain recommendations by body mass index 
categories.  
Adapted from the Institute of Medicine Guidelines on Gestational Weight Gain (Rasmussen and Yatkine, 2009).  
 
The wide range of weight gain for each BMI category recommended reflects the 
imprecision of the given estimates. The current IOM guidelines were derived from limited 
data on six main outcomes; small for gestational age (SGA), LGA, preterm birth, caesarean 
birth, maternal postpartum weight retention and early childhood obesity but not further 
stratified by the different classes of obesity (Kapadia et al., 2015). The IOM categories 
combine pre-pregnancy BMI and GWG. Therefore, it is difficult to distinguish the 
associations with offspring adverse health within the IOM categories and whether 
outcomes are contributed to pre-pregnancy BMI or GWG per se. There is also recognition 
by the IOM of the lack of evidence among socioeconomic and ethnic minority groups, 
potentially limiting translation to other populations (Rasmussen and Yatkine, 2009).  
 
Excessive and below recommended GWG have been associated with adverse long term 
outcomes in the offspring (Villamor and Cnattingius, 2006; Kapadia et al., 2015). Studies 
Pre-pregnancy 
BMI 
BMI (kg/m2) (WHO) Total Weight Gain 
Range (kg) 
Rates of Weight Gain 2nd 
and 3rd Trimester (mean 
range in kg/week) 
Underweight < 18.5 12.5 – 18.0 0.51 (0.44 – 0.58) 
Normal 18.5 – 24.9 11.5 – 16.0 0.42 (0.35 – 0.50) 
Overweight 25.0 – 29.9 7.0 – 11.5 0.28 (0.23 – 0.33) 




assessing relationships between GWG and offspring body composition outcomes indicate 
that excessive GWG is associated with an increased risk of obesity as well as adverse 
cardiometabolic health (Oken et al., 2007; Mamun et al., 2010; Fraser et al., 2011).  
 
A recent systematic review and meta-analysis (n=12 cohort studies included) from the 
same group demonstrated that the offspring of women who gained above the prescribed 
IOM weight gain criteria, had a 40% increased risk of obesity throughout the life course 
(Mamun et al., 2014). However, within this meta-analysis, none of the studies included, 
assessed associations by pre-pregnancy BMI but rather grouped the three BMI categories 
(normal, overweight and obese) together. Within other meta-analyses, GWG, defined 
above the IOM criteria (Rasmussen and Yatkine, 2009), has been associated with an 
increase in pre-school overweight and obesity (defined as overweight ≥ 85thpercentile and 
obesity BMI ≥ 95th percentile) and with the magnitude of effect increasing from 1.5 fold to 
4.4 fold, as recently shown by two meta-analyses in offspring after adjustment for offspring 
sex (Nehring et al., 2013; Mamun et al., 2014).  
 
An important element often under-recognised is the timing of weight gain. Observational 
studies have suggested that the first 24 weeks of pregnancy is a crucial time period during 
which excessive GWG is a key risk factor for the development of GDM which has also 
been independently implicated in offspring obesity (Gibson et al., 2012). Early weight gain 
has been shown to be a strong predictor of excessive GWG (Carreno et al., 2012; Overcash 
et al., 2015), rendering it a potential target for future interventions. This recommendation 
should be considered in light of the different components of GWG within the different 
trimesters, and is unlikely to reflect the relationship between measures of maternal 
adiposity and infant body composition. This is exemplified by one study which reported 
that rate of weight gain in mid-pregnancy, more likely to reflect maternal fat mass, was 




likely to be predominately fetal was strongly associated with infant fat-free mass 
(Karachaliou et al., 2015).  
 
1.3.8 Gestational diabetes 
Maternal obesity is an independent predictor for the development of GDM. Depending on 
the diagnostic criteria employed GDM affects as many as 30% of obese women in 
pregnancy (Poston et al., 2015; White et al., 2016). GDM is defined as a ‘degree of glucose 
intolerance, first recognised during pregnancy’ (ADA, 2010). The diagnosis is made 
regardless of whether glucose intolerance predated or persisted following pregnancy (ADA, 
2010). At present in the United Kingdom (UK), screening tests are performed in women 
with significant predictors for developing GDM, including macrosomia, ethnicity, previous 
history of GDM and BMI (NICE, 2015). GDM for the purpose of this thesis, was defined 
by the International Association of the Diabetes in Pregnancy Study Group (IADPSG) 
criteria. This compromised of fasting blood glucose >5.1mmol/l, or a 1 hour glucose 
>10.0mmol/l or a 2-hour glucose > 8.5mmol/l after a 75g glucose tolerance test (Metzger et 
al., 2009). 
 
The aetiology of GDM is heterogeneous and multifaceted, thought to result from the 
interaction between environmental, genetic and sociodemographic characteristics. 
Although increased insulin resistance is ubiquitous in pregnancy, additional factors must 
drive susceptible mothers to develop GDM. The most obvious contributor is pre-existing 
insulin resistance associated with obesity. Obesity in pregnancy is associated with an 
increase in adipokines and circulating inflammatory mediators which are in turn implicated 
in insulin resistance (Ramsay et al., 2002; Tinius et al., 2015). Dyslipidaemia, found to be 
more prevalent amongst obese women has also been associated with reduced insulin 





Maternal dysglycaemia and GDM are both associated with increased neonatal adiposity 
(Sebire et al., 2001; Metzger et al., 2009), having recently been demonstrated as causative 
through MR methodology (Tyrrell et al., 2016). Using continuous glucose monitoring, 
Harmon et al identified higher daytime and nocturnal profiles in obese women in 
comparison to lean women, which in turn were associated with raised neonatal body fat but 
not with birthweight (Harmon et al., 2011). Derangements in amino acids, fatty acids, 
carbohydrates and lipid species as well as elevated post-prandial glucose have been 
implicated as playing a mechanistic role with increased neonatal birthweight and adiposity 
in association with increased maternal insulin resistance in late second trimester (Scholtens 
et al., 2016) .  
 
Other reports have also documented that offspring exposed to GDM in-utero have an 
increased risk of developing obesity in later childhood (Gillman et al., 2003) and raised 
BMI in adulthood (Lawlor et al., 2011a), in comparison to those un-exposed. Exposure to 
maternal GDM in-utero has shown to increase the odds of childhood obesity from 1.6 to 
2.3 following adjustment for maternal pre-pregnancy BMI, suggesting an independent 
effect of GDM (Lawlor et al., 2011a; Lawlor et al., 2011b). The association between GDM 
and childhood adiposity has been reported as inconclusive in two meta-analyses (Kim et 
al., 2011; Philipps et al., 2011; Fraser and Lawlor, 2014), but has been complicated by the 
lack of universal screening for GDM in the included studies.  
 
The treatment of GDM encompasses treatment with diet, metformin and/or insulin. The 
modality of treatment used may be indicative of the severity of the disease and has been 
shown to influence body composition in offspring exposed to GDM in-utero (Rowan et al., 
2011). Within obese women, this increased risk of offspring adiposity is thought to be 
largely mediated by adverse in-utero exposure to maternal glycaemic profiles (Harmon et 




et al., 2011; Gishti et al., 2014), treatment for GDM may provide a role in preventing 
childhood obesity.  
 
As mentioned above, a recent, and important study has found maternal fasting glucose to 
be causally related to neonatal body composition, through utilisation of MR methodology 
(Tyrrell et al., 2016). However, the associations between maternal GDM and later 
childhood adiposity cannot be considered causal as this associative relationship has been 
derived predominantly from observational studies. There is some evidence from a follow-
up of RCTs in pregnancy that treatment of GDM may improve glycaemic profiles in 
children by improving maternal glycaemic profiles. A study of 9 year old children (n=905), 
whose mothers were randomised to treatment for mild GDM (including dietary advice and 
insulin) or to standard antenatal care at 20-28 weeks’ gestation (Landon et al., 2009), found 
no differences in offspring body composition at 5-10 years of age, but demonstrated 
significant improvements in fasting glucose in female offspring (Landon et al., 2015).  
 
It is important to recognise that excess early fetal growth; an independent risk for neonatal 
adiposity, occurs prior to the formal diagnosis of GDM at 24-28 weeks’ gestation as shown 
recently in a prospective cohort of 4,000 nulliparous women (Sovio et al., 2016), an 
association which was strengthened by maternal pre-pregnancy obesity. Therefore, early 
identification of maternal risk factors for GDM may provide a preferable approach for early 
preventive treatment for childhood obesity (White et al., 2016).  
 
1.3.9 Maternal demography 
1.3.9.1 Maternal age and parity 
Increasing maternal age is associated with adverse neonatal outcomes, which may be 
mediated through poor oocyte quality and increasing maternal parity; both of which have 




Myrskylä and Fenelon, 2012; Gaillard et al., 2014a). A large population study, 
incorporating data from five cohorts (n=22,188), demonstrated that older maternal age (≥35 
years) was independently associated with increased maternal fasting glucose (0.06 mmol/L, 
95% CI -0.01 to 0.12), in comparison to mothers aged between 20-35 years (Fall et al., 
2015). However, neonatal adiposity was not determined in this population study of women 
living in low income countries.  
 
Increasing maternal parity has also been associated with increasing birth weight (Catalano 
and Ehrenberg, 2006) and neonatal adiposity within a prospective population cohort study 
in the Netherlands (Generation R) (Gaillard et al., 2014a) and within a rural Indian 
population (Joshi et al., 2005); both are likely to reflect increasing maternal BMI resulting 
from cumulative weight retention following pregnancy (Villamor and Cnattingius, 2006), 
which may have an association with later childhood obesity.  
 
1.3.9.2 Smoking status 
Maternal smoking is associated with increased offspring adiposity, mediated primarily 
through low birthweight. Infants born to women who smoked in early pregnancy, were 
shown to have greater ‘catch-up growth’ in comparison to neonates of non-smokers 
(n=6,483, mean age 5-7 years of age); increasing the risk of later obesity and metabolic 
syndrome (Von Kries et al., 2002). A meta-analysis including 44 cohort studies (n=94, 
997) found that offspring born to women who smoked during pregnancy had an increased 
risk of obesity at 9 years (pooled AOR 1.64, 95% CI 1.42-1.90), independent of maternal 
socio-economic status, pre-pregnancy obesity, offspring birthweight and mode of early life 
feeding (breastfed vs. non-breastfed) (Ino, 2010). Causative mechanisms implicated 
include in-utero exposure to nicotine, resulting in abnormal adipocyte proliferation, and 
persistent changes in central autonomic pathways resulting in permanent effects on 




Recently, exposure to maternal smoking has shown to be associated with increased 
methylation of the MYOIG (involved in the regulation of cell elasticity) and FRMD4A 
gene (associated with nicotine dependence) in cord blood leucocytes and in whole blood of 
children at age 5.5 years (n=366) (Rzehak et al., 2016), suggesting a potential epigenetic 
transmission of an adverse in-utero environment in offspring.   
 
1.3.9.3 Socioeconomic status and educational attainment 
Maternal educational attainment is linearly associated with socioeconomic status and 
socioeconomic deprivation increases the risk of maternal obesity and subsequent childhood 
obesity (Heslehurst et al., 2010). Again fetal growth restriction may be implicated as 
infants born to women from socioeconomically deprived backgrounds, have been shown to 
be of reduced length at 2 months of age (difference −0.87 cm; 95% CI −1.16, −0.58) ,in 
comparison to those with no socioeconomic deprivation (Silva et al., 2012).  
 
1.3.9.4 Ethnicity  
Maternal ethnicity, specifically an Afro-Caribbean background is associated with increased 
neonatal morbidity and mortality (CMACE, 2011). Maternal obesity, GDM and excessive 
GWG; are all independent risk factors for neonatal adiposity and are increasingly prevalent 
within Afro-Caribbean and Asian populations (Rosenberg et al., 2005; Snowden et al., 
2016). The 3rd US National Health and Nutrition Examination Survey (n=2488) found that 
black ethnicity was associated with significantly lower birthweight in comparison to white 
and Hispanic ethnic groups (p<0.001), in turn associated with greater fat mass in mid-
childhood (Okosun et al., 2000). The causative mechanisms implicated include 
socioeconomic factors associated with poor dietary behaviours, increased total GWG and a 







1.3.10 Maternal diet 
Maternal pre-pregnancy obesity is an indicator of a poor quality diet, including 
consumption of a high fat or ‘Western’ diet (Flynn et al., 2016). There is strong evidence to 
suggest that maternal diet composition and quality is strongly correlated not only to 
maternal obesity but also to GWG and GDM (Poston, 2012). Therefore, there has been 
equal focus on maternal diet as on these variables in relation to childhood adiposity.  
 
The Generation R study (n=2695), observed that adherence to a ‘healthier’ dietary pattern 
in pregnancy was associated with lower offspring BMI, FMI and a reduced risk of being 
overweight at 6 years of age, in children born to women of heterogeneous BMI (van den 
Broek et al., 2015). However, when the results were adjusted for sociodemographic and 
lifestyle covariates, none of these relationships remained significant; potentially due to an 
interaction between maternal diet and socioeconomic status as previously reported 
(Falconer et al., 2014). Using a data driven approach to derive dietary patterns as 
undertaken in the Generation R study and UK Pregnancies Better Eating and Physical 
Activity Trial (UPBEAT) studies (Flynn et al., 2016), provides a practicable yet 
comprehensive assessment of the dietary behaviours of pregnant women which overcomes 
the limitations of single nutrient analysis (Hu, 2002).  
 
Findings from the Southampton’s Women survey have recently demonstrated that the 
gestational period at which maternal nutrition is determined may influence the degree of 
adiposity in the child (Okubo et al., 2014). This group reported that early dietary glycaemic 
load and glycaemic index assessed at 11 weeks’ gestation, following adjustment for 
potential confounders was positively associated with offspring fat mass at 4 and 6 years 




years, fat mass SDs per 50-unit glycaemic load increase: p< 0.001 at 4 years, p=0.007 at 6 
years) in comparison to maternal dietary intake collected at 34 weeks’ gestation. 
Observational studies such as these have provided some credence to the hypothesis that 
maternal dietary manipulation could influence childhood adiposity, however evidence from 
RCTs in pregnancy are needed to establish causality.  
 
Differentiating the effects of maternal obesity from maternal diet is obviously difficult to 
achieve in studies of pregnant women due to interaction between the two. It is therefore 
important that animal studies have shown proof of principle in this regard. Offspring of 
obese animals demonstrate similar phenotypes to the children of obese mothers (further 
details in Section 1.4) and these studies have provided evidence that diet alone e.g. high fat 
diet, can influence offspring obesity independent of maternal obesity (Samuelsson et al., 
2008; Parlee and MacDougald, 2014).  
 
In summary pre-pregnancy obesity, excessive GWG, GDM and maternal diet may be 
important determinants of later childhood adiposity and are therefore considered to be 
modifiable factors for the prevention of childhood obesity in-utero.  
 
1.3.11 Exposures in early infancy 
In addition to exposure to an adverse in-utero environment, early postnatal life exposures 
have also been implicated in the development of childhood obesity, including mode and 
duration of feeding, childcare and sleep, all of which interact as illustrated in Figure 1.10, 






Figure 1.10: Interactions of early postnatal life exposures on offspring adiposity.  
1.3.12 The relationship between mode of feeding and offspring adiposity was demonstrated as causal by a 
randomised controlled trial assessing lower protein vs. higher protein vs. breatfeeding and risk of 
later childhood obesity at 2years of age as illustrated by a red arrow (Koletzko et al., 2009). Early 
life growth trajectories have been shown to influence the development of offspring adiposity in early 
adolescence, with the strength of association being robust, as illustrated by a red arrow (Ong et al., 
2000; Tilling et al., 2011; Giles et al., 2015). However, the relationship between timing of 
introduction of solids, childcare and sleep with the development of offspring adiposity has primarily 
been derived from observational studies demonstrating inconsistent results (refer to Sections 
1.3.12.3: Timing of introduction of solid foods, 1.2.13: Childcare and 1.3.14: Sleep. Postnatal 
feeding 
1.3.12.1 Mode of infant feeding 
Epidemiological studies have provided substantial evidence demonstrating that breastfed 
and formula-fed babies consistently follow different growth trajectories which may 
influence the risk of future obesity and other adverse health outcomes. The observation that 
obese women have reduced rates of initiation and duration of breastfeeding in comparison 
to normal weight women may therefore have implications for the development of obesity 





Some studies have suggested that breastfeeding may influence infant regulation of appetite 
and satiety (Palou and Pico, 2009; Gridneva et al., 2017) and breastmilk composition has 
been shown to be influenced by maternal age, diet, BMI and GDM (Nommsen et al., 
1991). The composition of formula milk has been continuously changing over the last 
decade. Formula milk, until recently has had increased energy and protein in comparison to 
breastmilk, which has been related to increased concentrations of branched chain amino 
acids (BCAA), non-esterified fatty acids (NEFAs), organic acids, acylcarnitines and 
phospholipids in the offspring; all indicated as potential biomarkers for obesity (Hellmuth 
et al., 2016). The European Childhood Obesity Project, an RCT in which 1090 formula-fed 
infants were randomised to receive high or low protein content formula feed, has followed 
the children to 6 years of age. High protein formula feeding was associated with a 0.51 
kg/cm2 greater BMI and with a 2.43 increased risk of obesity at 6 years of age (Weber et 
al., 2014) compared with formula feeding, suggesting potential long-term adverse 
outcomes in association with a high energy protein diet. A systematic review assessing 10 
cohorts has also concluded that infants fed a lower protein formula had reduced weight and 
weight z-scores at 12 months, in comparison to those fed a high protein formula diet  
(Patro-Gołąb et al., 2016b).  
The Belarus Promotion of Breastfeeding Intervention Trial (PROBIT) was a RCT which 
sought to assess the effect of breastfeeding promotion on duration and exclusivity of 
breastfeeding (primary outcomes). Whilst the intervention had minor but significant effect 
on the duration of breast feeding, it was without effect on childhood obesity in early life 
(Kramer et al., 2004; Owen et al., 2005). However, the study was not designed to assess the 
effect of duration or intensity of breastfeeding on the risk of later development of obesity 
which was a secondary outcome (Patro-Gołąb et al., 2016a). A recent meta-analysis 
including 105 studies determined that breastfeeding was associated with a reduced odds of 
developing obesity throughout the life course (OR 0.74, 95% CI 0.70 to 0.78), but the 




al., 2015). One recent review also emphasises the promotion of breast feeding on the basis 
of protection against childhood obesity (Victoria et al, 2016).  
1.3.12.2 Duration of infant breast feeding  
The duration of infant breast feeding has been implicated with obesity risk in later life. 
Two systematic reviews have found a 20% reduction in obesity risk if the infant is 
exclusively breastfed in comparison with exclusively formula fed or mixed fed infants, 
suggesting a role of increased duration of exclusivity of breastfeeding in obesity protection 
(Arenz et al., 2004; Owen et al., 2005). Furthermore, an observational study of 2000 
women assessing the role of different feeding modalities (formula vs. mixed vs. breast) 
found that if breastfeeding comprised of <80% of all feeds within the first 6 months; there 
was an associated excess infant weight gain between 6-12 months (Li et al., 2008); a 
finding replicated in other populations including those exposed to GDM in-utero (Crume et 
al., 2011).  
 
1.3.12.3 Timing of introduction of solid food  
Weaning is defined as a gradual transition from a milk diet (breast or bottle) to a solid food 
based diet which is associated with an increase in energy intake (Cohen et al., 1994). 
Current WHO guidelines have recommended that solid food should be introduced from 6 
months of age. In the UK, the average age of weaning is currently estimated at 4.6 months 
(Moore et al., 2014).  
 
Observational studies have demonstrated an association between early introduction of 
solids and increased adiposity in later childhood. A recent systematic review including 26 
predominantly cohort studies reported that the introduction of solids <4 months of age was 
associated with an increased risk of developing obesity (Daniels et al., 2015). However the 
authors concluded that residual confounding could not be discounted. The review was 




months resulted in increased obesity risk due to limited evidence and methodological 
limitations (Daniels et al., 2015). Within an observational cohort, the delayed introduction 
of solid foods was associated with a reduced odds of childhood obesity at 10 years of age, 
independent of parental and child confounding (n=307; AOR 0.903 (95% CI 0.84 to 0.97); 
p=0.005) (Seach et al., 2010). This may be due to modification of early-life growth 
trajectories as a study in the UK birth cohort showed that early introduction of solids in 
infants formula fed predicted weight gain between birth to 3 years; mediated through 
increased energy intake (Ong et al., 2006).  
 
Formula feeding is generally associated with the infant being weaned at a younger age, 
together with increased consumption of calories and saturated fat. Weaning dietary 
composition in infancy has been shown to reflect maternal dietary composition (Robinson 
et al., 2015a). The mode of early infant feeding has also been shown to influence dietary 
composition of solids consumed in early infancy. For example, infants breastfed were 
shown to consume a healthier diet in a study from Holland of 2000 7 year old children; the 
study identified that those who were breastfed for at least 4 months were more likely to 
consume more fruit and vegetables, less soft drinks and fried food in comparison to those 
children who had been  formula fed (Scholtens et al., 2008). These studies suggest that 
breastfeeding, together with later, rather than earlier introduction of solid foods may be 
protective against childhood obesity. 
 
1.3.12.4 The influence of in-utero exposures on postnatal feeding 
Whilst the discussion above relates to exposure to in-utero or early life risk factors leading 
to childhood obesity, there is some evidence for interaction between the two. Infants may 
therefore experience a cumulatively increased risk of later obesity. A recent longitudinal 
cohort study carried out in 2014 found that maternal pre-pregnancy obesity significantly 




exclusively breastfeed and more likely to introduce solid foods earlier than those of a 
normal BMI (Kitsantas et al., 2016). Given the number of the factors associated with the 
development of childhood obesity, it is very important that potential in-utero confounders 
are accounted for including parental BMI, smoking, diet, activity levels and socioeconomic 
status in establishing potential associations of the maternal in-utero and early life 
environment and offspring adiposity.   
 
1.3.13 Childcare 
Many infants attend nursery or childcare facilities where meals and snacks are provided, 
which may promote early attitudes and beliefs regarding food. A study in 12,400 infants, 
found that infants cared for within an informal childcare setting were more likely to be 
overweight (adjusted risk ratio (ARR) 1.15; 95% CI 1.04-1.27) in comparison to those 
cared for by their parents (Pearce et al., 2010). Furthermore, stratification by 
socioeconomic status found that this risk increased amongst affluent families. This was 
replicated in a Canadian observational study of 1649 infants, in which infants who attended 
childcare in comparison to parental care were more likely to be overweight and obese 
throughout a ten-year follow-up period (Geoffroy et al., 2013). These findings add to the 
evidence that increased risk of obesity may be mediated at least in part through poor diet 
composition within early life.  
 
1.3.14 Sleep 
Sleep variation, both in duration and pattern, may also contribute to increased risk of 
childhood obesity. A longitudinal prospective cohort study found that from infancy to age 
7, children with the lowest sleep scores (i.e. poor sleep) had a higher BMI, total and truncal 
fat mass than children with high sleep scores (Taveras et al., 2014). Conversely, a Danish 
study found no association between sleep duration and measures of adiposity in infants 




whether reduced early sleep duration is associated with the development of later obesity 
and insulin resistance in older children and observational studies, as assessing sleep as a 
potential exposure is subjective and complicated by recall bias.  
 
1.4 Mechanisms implicated in the relationship between maternal obesity and 
childhood adiposity  
 
The following discussion addresses the many different biological pathways which have 
been implicated in the relationship between maternal obesity and later determinants of 
obesity in the child. These include adverse influences of maternal overnutrition on the 
developing embryo, overproduction of fetal insulin, maternal inflammatory and metabolic 
imbalance leading to adaptive responses in the fetal hypothalamus and adipose tissue 
(Waterland and Garza, 1999; Mamun et al., 2014). An understanding of the mechanisms 
associated with exposure to maternal obesity in-utero will enable the development of 
targeted interventions, within this high-risk population to address potential causative 
relationships and strategies to prevent childhood obesity.  
 
1.4.1 Background 











1.4.2 Oocyte quality and subsequent embryogenesis 
Obesity may have biological influences in the gamete at the earliest stages of life. Recent 
data from 218 oocytes from 29 women attending an in-vitro fertilisation clinic showed that 
increasing maternal BMI at conception was associated with phenotypic changes in the early 
embryo (Leary et al., 2015). In another report, obese women (n=32) attending an infertility 
clinic had higher than normal follicular fluid insulin and lipids, associated with poor quality 
of the oocytes (Robker et al., 2009). Leary et al, also showed reduced glucose 
consumption, increased endogenous triglycerides and abnormalities in amino acid 
metabolism in oocytes and maternal blastocysts from obese women; suggesting metabolic 
impairment (Leary et al., 2015). Experimental studies in diabetic and high fat fed mice 
models have demonstrated oocyte spindle defects, increased rates of follicular apoptosis 
and mitochondrial abnormalities (Seli et al., 2014) as well as increased oocyte lipotoxicity, 
with mitochondrial dysfunction (Dumollard et al., 2007; Wu et al., 2010). Our laboratory 
has also reported mitochondrial abnormalities in oocytes and early blastocysts from obese 
mice in comparison to lean dams which were associated with increased oxidative stress 
(Igosheva et al., 2010). These influences of maternal obesity on the oocyte and early 
embryo may have lasting consequences for the health of the offspring, as has been 
demonstrated with maternal under nutritional states in the rat (Kwong et al., 2000).  
 
1.4.3 Epigenetic modifications 
Growing evidence suggests that environmental factors including modifications of the diet 
in early life can alter the fetal or early postnatal epigenome. The hypothesis suggests that 
persistent modifications of the epigenome determine offspring gene expression whilst 
preserving nucleotide sequence and can subsequently influence metabolism in later life. 




genotype and subsequent phenotype. Associated mechanisms related to this change in gene 
expression could be a result of histone modification or DNA methylation.  
 
Figure 1.12: The influence of environmental exposure on the genotype and subsequent 
phenotype. 
Modifications in DNA methylation at CpG sites and post-transcriptional modifications on histones result in 
alterations in the chromatin profile. The combination of these alterations result in modification of the 
phenotype. Adapted from Cordero P, Li J, Temple JL et al. Epigenetic Mechanisms of Maternal Obesity Effects 
on the Descendants. Parental Obesity: Intergenerational Programming and Consequences; Physiology in 
Health and Disease. 2016;1:355-368 (Cordero et al., 2016).  
 
Several independent reports in different animal models of varying nutritional status 
highlight how changes in maternal diet associated with persistent metabolic dysfunction in 
the offspring, are accompanied with epigenetic changes in key genes involved in appetite 
control and metabolism (Cole et al., 1993; Lillycrop et al., 2005; Lillycrop et al., 2007; 
Lillycrop and Burdge, 2015). Of the few studies undertaken in mother-child pairs, one 
report by Godfrey et al has shown that alterations in epigenetic biomarkers can be 
predictive of later adiposity risk; for example, methylation of a single CpG site in the 
promoter region of the nuclear receptor Retinoid X Receptor-α (RXRA) in cord leucocytes 
was associated with the development of childhood adiposity (mean age 6.5 years) in two 
independent cohorts (Godfrey et al., 2011). Higher methylation of RXRA, was associated 




offspring adiposity (Godfrey et al., 2011). This independent finding provides evidence of a 
greater effect size estimate in relation to offspring adiposity than that observed with 
neonatal birthweight or maternal body composition; suggesting that epigenetic changes as a 
result of the in-utero environment may provide an improved assessment of later childhood 
obesity. A recent report using a epigenome-wide approach (Illumina Infinium® 
HumanMethylation 450 K BeadChip) in the ALSPAC cohort (1018 maternal-offspring 
pairs), has provided some of the strongest evidence to date in support of a change in DNA 
methylation status (as measured in cord leucocytes) associated with relationships between 
maternal obesity and increased offspring adiposity at mean ages of 9.9 and 15.5 years, in 
comparison to offspring from normal weight women (Sharp et al., 2015).  
 
Persistent changes in the epigenome offer a final pathway linking early life exposures such 
as maternal obesity with offspring health outcomes. Other interactions between 
environment and gene in fetal development may transiently influence gene expression 
causing lasting perturbations in organ growth and development (Godfrey et al., 2007; 
Sullivan and Grove, 2010; Sovio et al., 2011; Hanson et al., 2014; Cordero et al., 2016) .  
 
1.4.4 Hypothalamic changes in relation to the epigenome  
  
In animal models there is a well characterised leptin ‘surge’ in early postnatal life which 
plays a critical role in normal neuronal development of the hypothalamus (Bouret, 2010). 
Maternal obesity is associated an increased magnitude of the leptin surge in rodent 
offspring (Kirk et al., 2009). Although the origin is uncertain, there is no evidence of an 
association between maternal milk leptin and offspring serum leptin in rodents (Bautista et 
al., 2008; Kirk et al., 2009), whereas neonatal leptin is associated with increased 
expression of the Ob gene (the leptin gene) in offspring adipose tissue (Kirk et al., 2009). 
Samuelsson et al has also reported that exogenous leptin administration within normal pups 




(Samuelsson et al., 2013) indicating a potential associative role in long term adverse 
cardiovascular health and hyperphagia. 
 
1.4.5 Potential maternal influences as a cause of epigenetic modifications 
Maternal obesity is associated with changes in maternal metabolism which may be 
causative of offspring epigenetic modifications, persistent changes in tissue structure and 
function, associated with later development of an obese phenotype. In this thesis, 
metabolite exposures have been assessed by metabolomics. Metabolomic profiles signify 
the cellular response and represent a key link between the genotype and phenotype. This 
technique has become widely used to identify metabolite pathways modified by disease or 
adverse exposures. It is a now a well-established methodology providing a “top-down” 
approach that enables exploration of the downstream products of modifications to gene 
transcription (Figure 1.13). 
 
Metabolomics provides a novel methodological approach to gain insight into the 
mechanistic pathways associated with DoHaD (Rauschert et al., 2014; Hivert et al., 2015). 




Figure 1.13: The integration of the "Omic" classification and their associated downstream 
products. 
Metabolomics is the downstream product of the genome allowing the study of the metabolite profile within a 












In relation to maternal obesity, two studies have, to date assessed the maternal metabolomic 
profile in relation to neonatal body composition (Scholtens et al., 2014; Scholtens et al., 
2016). Network analysis from 400 maternal samples from the HAPO study has 
demonstrated clusters of fatty acids and carnitine esters that were related to maternal 
fasting glucose at 20-29 weeks’ gestation, and subsequently with neonatal adiposity. 
Neonatal adiposity was also associated with the concentrations of ketone bodies, amino 
acids and fatty acids measured in samples collected at one hour post glucose load at the 
time of an oral glucose tolerance test (OGTT) (Scholtens et al., 2016). This approach, 
which has proved invaluable in understanding the metabolic profile in type 2 diabetes and 
cardiovascular, is open to investigation in contemporary cohorts of obese mothers and their 
children. 
 
To date, few studies have addressed whether the cord blood metabolome at birth, as a 
proxy of fetal exposures, could provide insight into mechanisms of programming by early 
life maternal exposures. One report has examined the metabolome in low birthweight 
(n=20) and normal birthweight (n=30) neonates, demonstrating differences in the clustering 
of amino acids and lipids. The metabolic profile associated with low birthweight 
demonstrated similar patterns to type 2 diabetic adults (Isganaitis et al., 2015). A recent 
study assessed the association of the maternal urinary metabolome with that of the 
offspring’s cord blood, stratified by pre-pregnancy BMI (normal, overweight and obese) in 
321 maternal-offspring pairs. There was no significant differences in the cord blood 
metabolic profiles of offspring stratified by maternal BMI group; although infants born to 
obese mothers had a higher birth weight and lower Apgar Scores (Desert et al., 2015).  
 
1.4.6 Maternal stress and inflammation  
See also Section 1.4.4. Obesity is associated with the development of chronic systemic low 




2015) and there is a suggestion that inflammation in-utero predisposes the offspring to 
metabolic compromise from birth (Catalano et al., 2009) (Figure 10). Low grade maternal 
inflammation has been shown to lead to both short and long term epigenetic modification 
of fetal genes involved in regulation of the central hypothalamic pituitary axis (HPA) 
pathway (Moisiadis and Matthews, 2014). Glucocorticoids readily cross the placenta and 
enter the fetal brain (McCabe et al., 2001) and it is proposed that downregulation of the 
fetal HPA axis permanently influences myelination and neurogenesis of the fetal brain and 
may influence hypersensitivity within the peripheral organs responsive to the HPA pathway 
(Moisiadis and Matthews, 2014). Sheep models have demonstrated that excess 
glucocorticoid exerts a persisting influence on the adult offspring including increased blood 
pressure, glucose and insulin levels (Gatford et al., 2000).  
 
A growing body of evidence show that changes in the inflammatory profile are predictive 
of later cardiometabolic disease in the non-pregnant population (Dandona et al., 2004). 
Whether this pathway may be of relevance to maternal obesity and influences the 
developing fetus is not known, as studies have demonstrated inconsistent associations 
(Reynolds, 2013). Whilst there are reports of raised maternal glucocorticoids in obese 
rodents (Zambrano and Nathanielsz, 2013), there is no evidence of increased 
glucocorticoids in obese pregnant women (Reynolds, 2013).  
 
1.4.7 Maternal adipokines 
Maternal inflammation is associated with increased circulating adipokines, both 
contributing to the insulin resistance pathophysiology. The principal adipokines implicated 
with maternal obesity and subsequent offspring obesity are leptin and adiponectin (Figure 
1.11). As discussed previously in the Section 1.4.4, leptin has been implicated in the ‘re-
wiring’ of the fetal hypothalamus, associated with offspring adiposity. Maternal adipokines 




Maternal leptin and fasting glucose concentrations are linearly associated with cord leptin 
concentrations, a proxy measure for neonatal fat mass (Geary et al., 1999; Fairley et al., 
2015). In a prospective birth cohort including 599 children, cord blood leptin 
concentrations were associated with reduced birthweight, but increased weight gain within 
the first 6 months of life; suggesting potential modifications in appetite and satiety 
regulation within early life (Mantzoros et al., 2009) 
 
1.5 Defining neonatal and infant adiposity 
As this thesis, has addressed “in-utero and early life origins of infant adiposity born to 
obese women”, methods of assessment of infant adiposity will be discussed in the section 
below.  
 
Distribution of adiposity is defined based on its anatomical site. It is divided into two main 
locations; subcutaneous and visceral. Visceral adipose tissue is associated with features of 
hyperglycaemia and hyperinsulinemia (Ibrahim, 2010), whereas subcutaneous adiposity is 
thought to be highly sensitive to insulin and hence protective against cardiometabolic 
disease (Moran et al., 2017). Measurements defining increased levels of adiposity in 
children are needed that are closely related to the accumulation of body fat, independent of 
overall body size, as a child’s body size modifies during the different phases of 
development.  
 
1.5.1 Measures of general adiposity 





1.5.1.1 Weight  
Weight is a simple and easily collected measure that is reasonably correlated with total 
body fat within adult populations irrespective of sex. However, in children, weight is 
variable due to age, sex and height. Current WHO recommendations, adopted in clinical 
practice in the UK, suggest that plotting the child’s height and weight on sex-specific 
growth trajectories provide an assessment of longitudinal growth including development of 
obesity over time (de Onis and Blössner, 2003).  
 
1.5.1.2 Body mass index 
BMI is defined as weight in kilograms divided by the square of height. At present, there is 
no universally agreed definition for childhood obesity and overweight due to a variety of 
methodologies and thresholds available (de Onis et al., 2010). Using simple thresholds, as 
in the adult population, has limited use in children, as BMI varies significantly by gender 
and age groups (Berentzen et al., 2016). This lack of continuity between childhood and 
adult measurements could lead to significant disparities when assessing obesity throughout 
the life course.  
 
1.5.1.3 Growth reference curves 
The WHO’s development of growth charts for infants aged between 0-5 years has enabled 
longitudinal tracking of obesity within early childhood. These charts recommend the use of 
standardised z-scores for children from birth to age 5 years. The z-score expresses the 
anthropometric value as a number of standard deviations below or above the reference 
mean or median value. Prevalence based data are commonly reported using a cut-off values 
(<-2 and >+2 z-scores). However, it should be noted that the rationale behind the cut-off 
values are based on the statistical definition which assumes that 95% of values centred 




point in relation to clinical or prediction of adverse outcomes. Ideally, the criteria should be 
established based on their associations with the risk of adverse growth.  
 
Overweight and obesity is defined as BMI >2 or >3 standard deviations above the WHO 
growth standard median respectively (WHO, 2006). Differences arise due to various 
thresholds for defining obesity, from different reference populations, making comparisons 
to infant anthropometric measures problematic. The WHO growth centiles were derived 
from an international sample from Brazil, Ghana, Norway, Oman and United states 
including 26,985 infants. These cohorts also provide longitudinal follow-up anthropometric 
measures of length and weight from birth to 24 months and a cross sectional survey of 
children aged between 1.5 years to 6 years of age (de Onis and Blössner, 2003; WHO, 
2006).  
 
An appreciation of other reference populations is essential when drawing comparisons from 
other studies using various definitions. The UK90 BMI reference centile curves are based 
on a sample of 32,222 measurements from 12 surveys, collected between 1978 to 1994, 
before the exponential rise in childhood obesity (Wright et al., 2002). These provided 
reference data in children from birth to 23 years. Here childhood obesity is defined as ≥95th 
centile for population monitoring and 98th centile for clinical assessment (Wright et al., 
2002). The use of two different cut-offs for the same condition, provides difficulty in 
tracking obesity through the life course and results in inconsistencies in findings from a 
clinical and research settings.  
 
The International Obesity Task Force provides growth centiles curves for children aged 
between 2-18 years derived from multiple international cohorts (n=192,727), including 




2004). Age specific cut-offs points were extrapolated from adult BMI cut-offs for 
overweight and obese, which are widely used.  
 
The thresholds, as defined by the WHO Global Database on Child Growth and 
Malnutrition, are used to define infant overweight and obesity for the purpose of this thesis 
(de Onis and Blössner, 2003), as these are applicable irrespective of mode of early life 
feeding, ethnicity and socioeconomic deprivation. Table 1.2 summarises the WHO 
thresholds which will be used for this thesis.  
Table 1.2: WHO thresholds used for the definition of infant overweight and obesity at 6 
months of age. 
Abbreviations: WAZ- weight for age z-score; WLZ- weight for length z-score. 
 
As previously mentioned, BMI is an inaccurate estimate of body fat mass in children, 
therefore accurate estimation requires an understanding of infant body composition as well 
as complex methodologies used in its assessment.  
 
1.5.2 Methods of measuring infant body composition 
To address the hypothesis that the in-utero environment associated with maternal obesity 
influences neonatal and infant fat deposition, accurate and practical assessment of body 
composition was necessary for the work described in this thesis.  
 
Variables Z-Score Definition 
Z-score 
Thresholds will be used for 
WLZ and WAZ standard 
deviation scores 
<-3 Standard Deviations Severe infant undernutrition 
<-2 Standard Deviations Infant under-weight for defined 
parameters 
>+2 Standard Deviations Infant over-weight for defined 
parameters 
>+3 Standard Deviations Infant obesity for defined 
parameters 
BMI (kg/m2) ≤ 2nd centile Underweight 
>2nd to <85th centile Healthy weight 
≥85th centile Overweight 




Body composition is traditionally classified as two component models; where assessment 
of fat mass and fat free mass is made. The use of a multi-compartment model further 
divides fat free mass into protein, water, mineral and bone. These distinctions are essential 
as when BMI is measured, it is not known whether this increase is due to increased fat 
mass or decreased fat free mass. Distinguishing between fat mass or fat free mass is 
important as total body water and mineral content are higher in obese children, and the 
proportion of protein is reduced in comparison to non-obese children (Haroun et al., 2004).   
 
1.5.2.1 Isotope dilution (hydrometry) 
Estimated fat free mass can be derived from measurement of total body water by deuterium 
dilution. Here, a small volume of water labelled with deuterium is given and assessed using 
an isotope ratio mass spectrometry once ‘enrichment of the total body pool’ has been 
reached (Wells and Fewtrell, 2006). For this methodology, fat free mass is estimated on an 
assumed value of hydration from published reference values. This method is advantageous 
as it provides an accurate longitudinal assessment of adiposity throughout the life course. 
Although this methodology is simple, inexpensive to undertake and reliable, it has limited 
use in infants due to potential dose spillage, time to achieve enrichment of the total body 
pool and difficult in collection of samples (Traver et al., 2009).  
 
1.5.2.2 Air displacement plethysmography (PEAPOD) 
This method assesses body volume by detecting subtle differences in air pressures between 
the infant (test chamber) and reference chamber that has controlled, pre-defined air 
pressure. Fat mass, fat free mass and percent of body fat is calculated using body mass, 
volume, density of fat, age specific coefficients (Demerath and Fields, 2014). Although a 
relatively new method, it has been validated for use in both neonates and infants and is also 




methodology has been undertaken at birth and 2 months of age in the Cork Baseline Birth 
Cohort study (O'Donovan et al., 2015), where detailed measures of fat mass were able to 
predict childhood BMI accurately in 922 infants (Hawkes et al., 2016). This method has 
advantages over DEXA as its does not involve radiation exposure therefore enabling serial 
and comparable measurements. Although, this method for assessing adiposity was made 
available in the UPBEAT study to measure neonatal adiposity, it had limited acceptance 
with mothers at the time of delivery and was practicably difficult to obtain as the neonates 
were discharged from hospital within 24 hours following delivery.  
 
1.5.2.3 Dual energy X-ray absorptiometry  
This methodology involves the use of X-ray with varying photon energies to determine 
body composition. The use of DEXA has been found to be more accurate than the use of 
SFTs, however it may result in a cumulative radiation exposure (Wells et al., 2012). Whilst 
DEXA can be used in swaddled neonates, parental consent is frequently disallowed 
because of exposure to X-rays. In young infants and children under the age of 5 years, 
DEXA is also seldom used due to child movement.  
 
1.5.2.4 Bioelectrical impedance 
 Bioelectrical impedance can also be used to assess body fat mass. The principal of 
bioelectrical impedance measurement of body fat relies on the fact that lean body mass is a 
good conductor of electricity because of a high fluid and electrolyte content, whereas 
adipose tissue and bone are resistant. Bioelectrical impedance assesses the direct 
relationship between the electrical conductivity and concentration of ions (lean body mass), 
together with the indirect relationship between the ion concentration and resistance to 
conductivity (fat mass) (Dehghan and Merchant, 2008). Assumptions are made including 
the validity of the derived prediction equations for the population assessed and that the 




against known reference methods including DEXA in children aged 4-18 years, but has 
provided inconsistent results in neonates and infants (Ellis et al., 1999; Sesmero et al., 
2005). Validation studies have found that bioelectrical impedance underestimates body fat 
in lean infants (aged 2.4 years) and overestimates it in obese infants (Horan et al., 2015), 
therefore this method was not chosen for use in the UPBEAT infants at 6 months of age.  
 
1.5.2.5 Skinfold measurements 
Skinfold thickness measurements using validated callipers have provided a reliable 
estimate of subcutaneous fat for many years (Freedman et al., 2009). Under experimental 
conditions, these measurements provide an accurate estimate of total body fat in children 
(Freedman et al., 2009). Although training is required to ensure accuracy, these 
measurements are inexpensive. Childhood skinfold measurements in cohort studies are 
predictive of later cardiometabolic health in comparison to the use of other measurements 
including waist circumference (Juonala  et al., 2011); suggesting that these measurements 
may provide a better reflection of adiposity. Measurement of skinfolds are prone to 
measurement error if incorrectly undertaken, which may limit translatability (Mueller and 
Malina, 1987; WHO and de Onis, 2006). Within infants, measurements commonly 
undertaken include subscapular SFT, a measure of central adiposity and triceps SFT, a 
measure of peripheral adiposity. In light of several studies reporting associations between 
early life exposures and later childhood adiposity as measured by SFTs, this method was 
chosen for the present study as it is reliable, inexpensive and feasible in young infants.  
 
1.5.2.5.1 Estimated total fat mass  
SFTs can be used to estimate total fat mass using validated, formulated equations 
(Slaughter et al, 1988). Using this method, estimate of total body fat are highly correlated 




Slaughter et al proposed the use of 2 SFTs to predict fat mass, which are used within this 
thesis. 
  
1.5.2.5.2 Subscapular: Triceps ratio 
This measure reflects a central skinfold measure to a peripheral measure, which have been 
shown to moderately predict dyslipidaemias (area under receiver operator curve ≥0.7), with 
the exception of low HDL, in 905 Mexican children at 6 years of age (García et al., 2011). 
This measurement, may therefore provide an accurate assessment of central adiposity and 
associated adverse cardiometabolic traits in response to exposure to an adverse in-utero 
environment.  
 
1.5.2.6 Abdominal, waist and arm circumferences  
These circumferences are easily obtained within a clinical or research setting. The three 
measurements provide an indirect measurement of visceral fat mass and in adults are 
associated with an increased risk of type 2 diabetes, hyperlipidaemia and cardiovascular 
disease. However, in neonates this measurement is largely variable as the reliability is 
influenced with feeding. Despite these limitations, these circumferences together with BMI 
and skinfold measurements throughout childhood may provide insight into the deposition 
of central adiposity into adulthood (Jago et al., 2013).  
 
1.6 Caveats and drawbacks of the developmental programming literature  
1.6.1 Observational studies 
The fundamentals of the ‘developmental origins of adult disease’ hypothesis were derived 
from observational data, with focus on in-utero exposure of risk factors during early life 
periods of development plasticity on a given offspring outcome. Population based birth 




of later disease; in particular, the relationship between birthweight with adulthood 
cardiovascular disease (Barker et al., 1989; Barker, 2002). More recently, investigations of 
a myriad of maternal variables including diet, behavioural factors, biomarkers and the 
metabolome, as well as the epigenome in the infant and child has facilitated the 
investigation of biological pathways by which environmental exposures may convey 
disease risk in adulthood (Godfrey et al., 2016). Distinguishing causality from association, 
whilst difficult, is essential to identify key early life modifiable causes of infant adiposity, 
and thereby direct interventions to key targets.  
 
Observational studies describe a natural process, in contrast to a controlled experiment. The 
long interval between measurement of exposures (both maternal and early infancy) and 
outcome data (childhood, adulthood) can be problematic if there is limited availability of 
longitudinal outcome, exposure and confounder data. Confounding factors or biases can 
influence the association within longitudinal studies, and thereby the outcome of interest. 
Statistical adjustment for confounders in multivariate modelling techniques may not fully 
correct for the effects of social interaction for example, and unadjusted cofounding is a 
common cause of inconsistency between results from cohorts and RCTs (Mathews et al 
1999, Poston et al 2006). Another consequence of these long intervals is the questionable 
relevance of the observations to contemporary pregnant populations.  
 
Although evidence has accumulated in support of the DoHaD, some critics have argued 
there are alternative explanations for the observed associations. These include confounding 
by genetic factors and sociodemographic characteristics. It has been suggested, for 
example, that variants of the Insulin Receptor Substrate-2 gene may account for the 
observed association between low birthweight and vascular disease, as this is a pleiotropic 
gene which theoretically could result in two phenotypes, one in the fetus (low birthweight) 
and the other in the adult (type 2 diabetes and cardiovascular disease) (Hattersley and 




implicated in both offspring birth weight and adult-onset hypertension and type 2 diabetes 
(Li et al., 2001). The social environment may also play a causal role. Some, but not all 
studies have adjusted for baseline maternal socioeconomic deprivation as assessed by the 
Index of Multiple Deprivation; at best a crude proxy of socioeconomic status (Caspi et al., 
2016). Furthermore in observational epidemiology causal inference is also limited due to 
selection bias and reverse causation (Gaillard, 2015).  
 
Robust statistical methods have been developed, considering the limitations of 
observational epidemiology to enable further insight into the role of confounding factors in 
relation to maternal exposures and offspring outcomes and to further strengthen causal 
inference. These include maternal and paternal offspring comparisons, MR and the use of 
instrumental variables robustly associated with the exposure, thereby controlling for 
confounding and measurement error (Richmond et al., 2014). Sibling comparison studies 
offer an innovative approach to enable determination of the causal relationship between 
maternal exposures and offspring outcomes; Lawlor et al found that increasing maternal 
weight gain was associated with increased offspring BMI at 18 years in only overweight 
and obese mothers (n=146,894 individuals from 136,050 families) after controlling for 
familial genetic and environmental influences (Lawlor et al., 2011a). By using a within and 
between sibling association study design, the environmental and social confounders are 
effectively controlled for, thereby providing convincing evidence of a causal relationship of 
the intrauterine mechanisms of weight gain and later obesity. However, this methodology is 
also not without its limitations. Sibling comparison studies are formulated on the 
assumption that the effect of each participant’s exposure to a risk factor does not influence 
other unexposed outcomes (Rubin, 2006).  
 
MR is a statistical procedure based on the assumption that candidate genetic variants which 




environmental exposure on a disease risk (Smith and Ebrahim, 2003). Genetic variants are 
used as are thought not to be influenced by behavioural, psychological or social 
circumstances (Smith, 2006). The use of MR, through the use of  sophisticated statistical 
methodology has provided support for the developmental overnutrition hypothesis as the 
association may not be present in the preconception period (Lawlor et al., 2008). Although 
MR enables establishment of causality with a certain degree of certainty, it requires a large 
sample size and the methodology is not suitable for genetic variants having a direct 
pleiotropic effect on both exposure and outcome of interest (Smith and Ebrahim, 2003). 
 
1.6.2 Use of animal models 
Observational cohorts have provided a strong association between a sub-optimal in-utero 
environment and the development of adverse offspring outcomes (Patel et al., 2015). 
Animal models have been the primary tool to understand mechanisms implicated with the 
developmental programming hypothesis (Patel et al., 2015). 
 
Replication in rodent models, where diet can be tightly controlled further enables the 
examination of the underlying physiological and biochemical mechanisms behind the 
nutritional programming of offspring disease; further aiding identification of the 
mechanisms and critical windows of intervention (Litten-Brown et al., 2010; Lillycrop and 
Burdge, 2015). However, it is critical to appreciate the differences in the stages of 
development between animals and man, to infer generalisability to humans. Rodents are 
altricial species, born with an underdeveloped endocrine system and brain, and undergo 
significant maturation of their organs during the weaning period, reflecting the third 
trimester in human pregnancies. Non-human primates are the most appropriate model, but 
are limited due to their long lifespan, resulting cost and ethical considerations. Many 




similar rate of pre and postnatal growth to humans and produce fewer offspring than 
rodents, comparable to humans.  
 
Although it is fully appreciated that there are many biological and species differences, 
response to interventions often provide valuable insight into the mechanisms implicated 
with improvement in human outcomes (Litten-Brown et al., 2010). For example, increased 
physical activity during rodent obese pregnancies can potentially be used to determine the 
adult offspring response in humans. Animal models have been used to determine the 
effectiveness of interventions especially dietary and physical activity due to the ease of 
enforcing exercise and controlling diet. Interventions within the preconception period and 
during lactation have demonstrated an improved glucose homeostasis and adipocyte 
deposition in adulthood (Zambrano et al., 2010). These studies provide a convincing basis 
to guide future human translational studies by allowing investigation of interactions 
between genetic and environmental factors. However, further investigation is required 
within animal models to determine the effective timing and intensity of such interventions 
in humans.  
 
1.6.3 Intervention studies 
The gold standard for the estimation of the causal effects implicated with lifestyle 
interventions on offspring outcomes is prospective RCTs. By undergoing randomisation, it 
is assumed that potential confounders in association with exposure and outcomes are 
avoided. Several RCTs have been extended to follow up of the offspring in mid-childhood. 
Intervention studies to date in obese women have focused on the prevention of excessive 
GWG or mild dysglycaemia and insulin resistance. The primary strategies have included 
advice to change dietary and physical activity through modification of lifestyle behaviours, 






Two recent notable follow up studies of a well conducted observational study and RCT 
have demonstrated that maternal fasting glucose during pregnancy is not associated with 
the development of childhood obesity at 5 to 7 years (n=1320). In the first study, Thaware 
et al followed-up participants of the HAPO study, a multicentre observational study 
undertaken to assess the associations of gestational hyperglycaemia with maternal and fetal 
outcomes (n=25,505) (Metzger et al., 2008). In children of participants enrolled in a 
multicentre RCT to assess the treatment of mild GDM (n=958; control arm- normal 
antenatal care, intervention arm- dietary intervention, self-monitoring of blood glucose 
and/or insulin therapy (Landon et al., 2009), were followed up at 5-10 years and treatment 
of mild hyperglycaemia was found not to be associated with a reduction in childhood 
obesity and metabolic dysfunction at 5-10 years (Landon et al., 2015). However, follow up 
was unplanned and incomplete (n=500). Further sub-group analysis revealed that treatment 
of mild GDM was associated with a significantly lower childhood obesity in those infants 
with the greatest adiposity at birth (Landon et al., 2015). These reports apparently 
challenge the role of maternal hyperglycaemia in the developmental programming of 
childhood obesity (Thaware et al., 2015 ). Without an intermediate point in early infancy, 
an interaction between fetal and postnatal exposures cannot be assumed as components of 
postnatal growth,  for example mode of infant feeding  may confound the observed 
relationship (Castillo-Laura et al., 2015). Both analyses adjusted for many prenatal 
confounders but neither accounted for growth and environmental factors including 
breastfeeding and diet in early infancy (Harder et al., 2005; Ong and Loos, 2006).  
 
The EMPOWaR study, a randomised double-blinded placebo trial, recruited obese 
pregnant women at 12 to 16 weeks’ gestation with a normal glucose tolerance test, to 
receive metformin throughout pregnancy (Chiswick et al., 2015). There were no 
differences in birthweight or in neonatal or maternal anthropometry. The study 




in fasting glucose, insulin and reduction in inflammatory markers (C Reactive protein 
(CRP) and interleukin 6 (IL-6)), all of which have been implicated with the developmental 
origins of adverse health and disease. Better pregnancy outcomes for the offspring have 
been reported in GDM diagnosed mothers with reduced central or visceral adiposity, due to 
metformin treatment (Rowan et al., 2011), as well as improved fetal outcomes compared to 
those treated with insulin. The long-term follow of these pharmacological studies is 
required to determine the effects of metformin and whether this may beneficial or not for 
offspring health.  
 
In 2014, the LIMIT RCT in 2212 overweight and obese pregnant women published its 
findings. This was one of the first notable studies, of adequate sample size and study design 
which randomised overweight or obese women (n=2212) to lifestyle advice or standard 
antenatal care, with the primary aim to reduce delivery of a LGA infant (Dodd et al., 
2014b). Although the trial’s primary outcome was not reached, the study found fewer 
infants who were born greater than 4kg in the intervention arm (15% vs. 19%; p=0.04) in 
comparison to standard care. Ongoing follow-up has been conducted and are yet to be 
reported. The low glycaemic index diet in pregnancy (ROLO study) to prevent macrosomia 
assessed the influence of a behavioural lifestyle intervention to prevent recurrence of a 
macrosomic delivery in 800 women (mean BMI 26.8 kg/m2) without a diagnosis of 
diabetes (Walsh et al., 2012). Similar to the LIMIT study, the ROLO study found no 
difference in neonatal birthweight, but found significant reductions in maternal GWG 
(intervention 12.2 kg versus control 13.7 kg; p=0.01) and reduced glucose intolerance 
(intervention 21% vs. control 28%; p=0.02) (Walsh et al., 2012). However, the lifestyle 
intervention, or its subsequent changes including GWG were not associated with changes 
in infant body composition or growth at 6 months of age (Horan et al., 2016). Despite 
recent efforts, a Cochrane review of the available evidence from randomised trials (49 




can occur, it has limited success in reducing GWG or GDM. Furthermore, the intervention 
studies included have not been successful in improving neonatal outcomes, including 
excessive fetal growth and caesarean sections (Bain et al., 2015; Muktabhant et al., 2015), 
but lacked long-term follow-up of offspring.   
 
As discussed in Section 1.3.8, the incidence of GDM is strongly associated with maternal 
obesity, therefore it could be argued that interventions aimed at preventing GDM should be 
undertaken in high-risk populations. The Finnish Gestational Diabetes Prevention Study 
(RADIEL), assessed a behavioural intervention compromised of a physical activity and diet 
intervention in 540 pregnant women (Koivusalo et al., 2016). Analysis was undertaken by 
intention to treat, however only 269 women were included within the final analysis. The 
incidence of GDM (intervention 13.9% vs. control 21.6%; 95% CI 0.40 to 0.98; p=0.044) 
and total GWG (mean difference -0.58kg; 95%CI -1.12 to -0.04; p=0.037) were found to be 
significantly lower in the intervention arm in comparison to the control arm (Koivusalo et 
al., 2016), providing evidence that an individualised intervention has the potential to reduce 
the incidence of both GDM and GWG. However, replication within larger populations are 
required to determine whether these findings are causal as well as long-term follow-up of 
the offspring to determine a beneficial influence.  
 
The recently undertaken RCT of a dietary and physical activity intervention, the UPBEAT 
trial in 1555 obese pregnant women, is the largest study powered for clinical outcomes, and 
recently published (Poston et al., 2015). Women were randomised to standard antenatal 
care or an intervention delivered by health trainers over 8 weeks (weekly sessions). The 
intervention focused on improving glycaemic control through a low glycaemic index diet 
and increased physical activity. This intervention differed from previous studies, through 
development and delivery of the intervention. The intervention focused on approaches to 




well as advice on self-monitoring, social support and problem solving to barriers of 
behaviour change (Poston et al., 2013). Women were advised on reducing saturated fat 
intake and glycaemic load as well as increasing time spent doing low/moderate physical 
activity. This study did not meet its primary endpoints of reducing maternal GDM or 
delivery of a LGA infant. However, significant changes were observed in maternal 
antenatal diet, physical activity and measures of maternal body composition throughout 
pregnancy. These included significant reductions in total energy intake (MJ/day), saturated 
fat (% energy) and glycaemic load per day and increased physical activity as assessed by 
the metabolic equivalent of task (MET) from 15+0-18+6 to 26+0-28+6 weeks’ gestation, in 
comparison to the control arm. This was associated with changes in maternal body 
composition in the intervention arm, including a reduction of total GWG and sum of 
skinfolds (SSFT) throughout pregnancy (Poston et al., 2015). However, it remains to be 
determined, whether this degree of change observed in the mother has an influence in 






1.7 Hypothesis, specific objectives and aims  
 
1.7.1 Hypothesis  
This thesis assesses the hypothesis that the in-utero environment influences neonatal and 6 
month old infant’s body composition in offspring born to obese women, which has the 
potential to be modified by an intensive behavioural lifestyle intervention.  
 
1.7.2 Specific aims and objectives of this thesis 
For this thesis data from the UPBEAT; an RCT assessing the influence of a dietary and 
physical activity intervention in obese pregnancies was used to address the following aims 
and hypothesis:  
Aim 1: To determine the relationship between early maternal risk factors and 
neonatal adiposity in obese women.  
Objectives;  
a. To assess the association between maternal demographic, clinical and biochemical 
characteristics at 15-18+6 weeks’ gestation and neonatal adiposity.  
b. To assess the association between a comprehensive maternal fasting metabolic 
profile including candidate biomarkers and metabolome in the late 2nd trimester and 
neonatal adiposity.   
c. To assess whether maternal metabolic profile assessed in the 2nd late trimester 
acted as intermediates in any observed associations between early pregnancy 
maternal risk factors and neonatal adiposity.  
 
Aim 2: To investigate the cord blood metabolic profile as a measure of the fetal 





a. To assess the effect of a behavioural lifestyle intervention (UPBEAT) on the cord 
blood metabolic profile.  
b. To assess the role of in-utero exposure to early pregnancy BMI, GDM and GWG 
on the cord blood metabolic profile.  
c. To explore the relationship between the cord blood metabolic profile in relation to 
neonatal and subsequent infant body composition, growth and growth velocities at 
6 months of age.  
 
Aim 3: To determine the effect of a behavioural lifestyle intervention in obese 
pregnancies on infant outcomes at 6 months of age. 
Objectives;  
a. To assess the effect of a behavioural intervention on measures of infant adiposity at 
6 months of age.  
b. To examine whether the antenatal intervention had sustained effects on maternal 
diet, physical activity as well as known postnatal determinants of childhood 
adiposity. 
 
Aim 4: To determine the influence of early life feeding patterns on infant body 
composition. 
Objectives; 
a. To assess whether mode of early feeding influenced infant body composition at 6 
months. 
b. To determine whether early introduction of solids influenced infant anthropometry 
at 6 months of age. 
c. To assess whether appetite and satiety responsiveness differed by early life feeding 
method at 6 months of age.  
d. To investigate the relationship between measures of infant appetite and satiety and 




Chapter 2 Methods  
2.1 Study population 
2.1.1 UK Pregnancies Better Eating and Activity Trial  
Analyses presented in this thesis were performed using data from the UPBEAT randomised 
controlled trial (ISRCTN89971375; Chief Investigator Professor Lucilla Poston). This 
multicentre, RCT was designed to evaluate a complex behavioural intervention in obese 
pregnant women, focusing on provision of physical activity and dietary advice, to reduce 
the incidence of maternal GDM and delivery of LGA infants. The study was conducted in 
accordance with the Medical Research Framework for the development and evaluation of 
RCTs for complex interventions to improve health (Craig et al., 2008). The UPBEAT study 
comprised of three stages: Phase I; trial development and literature review, Phase II, a pilot 
RCT which commenced in May 2011, and the full Phase III RCT which completed 
recruitment (n=1555) in August 2014 (Poston et al., 2015). NHS Research Ethics 
Committee approval was obtained at all centres (UK Integrated Research Application 
System; reference 09/H0802/5). All aspects of the trial, including data collection, 
monitoring and analysis were overseen by members of the UPBEAT consortium and an 
external Trial Steering Committee. 
 
2.1.2 UPBEAT hypothesis  
The primary hypothesis of the UPBEAT RCT was to assess a lifestyle, antenatal 
intervention aimed at promoting a low glycaemic diet and increasing physical activity, to 
reduce the incidence of maternal GDM (primary maternal outcome) and delivery of a LGA 
neonate (primary neonatal outcome). A secondary pre-defined hypothesis of the study, was 





2.1.3 UPBEAT study endpoints 
The primary maternal aim of the study was to determine whether the intervention, 
delivered in the early 2nd trimester over an eight week period, was associated with a 
reduction in the incidence of GDM at 27+0–28+6 weeks’ gestation diagnosed by an OGTT 
using the IADPSGs’ diagnostic criteria; fasting glucose ≥5.1 mmol/L and/or 1 hour glucose 
≥10.0 mmol/L; 2 hour glucose ≥8.5 mmol/L. For the neonate, the primary objective was to 
determine whether the intervention led to fewer deliveries of LGA infants defined as 
birthweight ≥90th using a customised centile adjusted for maternal height, weight, ethnicity, 
parity, gestation at delivery, birthweight and neonatal sex (Gardosi and Francis, 2014).  
 
2.1.4 UPBEAT study population  
Obese women were recruited from 8 tertiary maternity units, located within inner city 
populations across the UK at 15-18+6 weeks’ gestation. These included, London (St 
Thomas’s Hospital, St Georges’ Hospital and King’s College Hospital), Newcastle 
University/ Newcastle NHS Foundation Trust, Glasgow University and Greater Clyde 
Health Board, Central Manchester Hospital Foundation Trust, City Hospital Sunderland 
and Bradford Royal Infirmary. Obese women were identified at the first hospital antenatal 
appointment or from midwife and General Practitioner referral letters.  
 
Women were eligible for the study if they had a BMI ≥30kg/m2 and a singleton pregnancy 
at 15-18+6 weeks’ gestation. Women were excluded if unable to provide informed consent, 
suffered from gestational hypertension requiring treatment, pre-existing renal disease, 
systematic lupus erythematosus, antiphospholipid syndrome, sickle cell disease, 
thalassemia, coeliac disease, thyroid disease, current psychosis, multiple pregnancy, pre-





2.1.4.1 Sample size  
1546 women (including an allowance for 20% drop-out) (773 per arm) were required for 
recruitment to provide 80% power to detect a 25% reduction in the incidence of GDM. For 
the delivery of LGA neonates; to achieve a 30% relative risk reduction from a calculated 
estimate of 17.5% to 12.0% (the incidence of LGA within the pilot study was 15.8%) 
within the intervention arm; 1546 women would provide 80% power.  
 
2.1.5 UPBEAT randomisation procedures  
Women were randomised using a secured, online data repository (MedSciNet™), where 
data was stored. The randomisation procedure was minimised according to the women’s 
ethnicity, parity (0 vs. ≥1), age and BMI (BMI class 30-34.9 kg/m2 vs. 35-39.9 kg/m2 vs. 
>40kg/m2). Women were either randomised to the UPBEAT intervention with standard 
antenatal care according to local clinical guidelines or standard antenatal care alone 
according to local guidelines.  
 
2.1.5.1 Components of the intervention and delivery  
The UPBEAT intervention was devised on the basis of psychological models of health 
behaviour including control theory and social cognitive theory (Poston et al., 2013). These 
models incorporate self-regulation techniques suggesting that behaviour change should be 
encouraged by continual feedback regarding performance together with the development of 
pre-specified goals. The lifestyle intervention was delivered via weekly sessions over an 
eight week period at 15-18+6 and 27-28+6 weeks’ gestation by a health trainer, at which 
“SMART” (Specific, Measurable, Achievable, Relevant and Time Specific) goals were set. 
Through weekly contact sessions with a health trainers, barriers to behaviour change were 




that were unable to attend the weekly sessions, the session content was delivered via phone 
or email.  
 
Obese pregnant women were encouraged to increase consumption of foods with a lower 
dietary glycaemic index through exchanging foods rather than limit energy intake per se. 
Furthermore, advice was provided to replace foods with high saturated fat content with 
unsaturated fats and replacement of sugar sweetened beverages with low glycaemic index 
alternatives. As well as dietary advice, women were encouraged to increase daily physical 
activity by setting incremental step counts (aided by a pedometer) and recommended to 
maintain the same level of physical activity following the intervention period.  
 
2.1.6 UPBEAT study assessment time points  
Women were assessed at three time points during pregnancy; 15-18+6, 27-28+6, 34-36 
weeks’ gestation and 6 months postpartum. Offspring were followed up within 72 hours of 












































Figure 2.1: Summary of the UK Pregnancies Better Eating and Activity Trial protocol. 
Abbreviations: ANC; Antenatal clinic, BEBQ; baby eating behaviour questionnaire, BMI; Body mass index, 
DNA; Deoxyribonucleic acid, EPAU; Early pregnancy assessment unit, EPDS; Edinburgh postnatal depression 
score questionnaire. EQ-5D; EuroQuo-5 European Quality of life questionnaire-5; FFQ; Food frequency 
questionnaire, GP; General Practitioner, IBQ-R: Infant behaviour questionnaire revised; IPAQ; International 
physical activity questionnaire; LGA; Large for gestational age OGTT; Oral glucose tolerance test, SGA; 
Small for gestational age, TFEQ-18; Three-factor eating questionnaire-R18, USS; Ultrasound scanning. 
 
14 weeks’ gestation: Research midwife approaches eligible women- verbal and written explanation of study 
given, permission sought to proceed 
10-14 weeks’ gestation: Research midwife identifies eligible women by GP/midwife referral letters, USS, EPAU, 
ANC, Fetal Medicine 
 
DECLINED: Routine ANC. 
BMI, ethnicity, age & 
pregnancy outcome recorded 
(if agreed) 
 
14-15 weeks’ gestation: Research midwife makes telephone/ 
email contact to answer queries and obtain verbal consent 
 
 
Baseline/Randomisation visit:  
15+0-18+6 weeks’ gestation 
Eligibility confirmed; written informed consent obtained. 
RANDOMISATION, demography, maternal history, maternal 
family history, current pregnancy health. Questionnaires: 
dietary assessment (FFQ), binge eating,  
EQ-5D, IPAQ, EPDS. Anthropometry 




Appt with Health 
Trainer followed by 8 
weekly sessions 






28 week visit: 
27+0-28+6 weeks’ 
Consent confirmed 
Current pregnancy health  
Questionnaires FFQ, EQ-5D, 
EPDS, binge eating & IPAQ.  
Anthropometry. 
Samples OGTT, Blood & urine. 
Fetal USS   
 
36 week visit: 
34+0 -36+0 weeks’ 
Consent confirmed, current pregnancy health. 
Questionnaires: FFQ , EQ-5D, binge eating, EPDS,IPAQ.  
Anthropometry, Samples: blood & urine 
 
Pregnancy, Delivery and Neonatal Data: 
Maternal late pregnancy, delivery data newborn data, 
neonatal anthropometry, cord blood sample, maternal 
postnatal and neonatal discharge information 
 






6 month Follow-Up 
Mother: Registration- contact details, 
eligibility, consent. Demography, smoking, 
general health and anthropometry. 
Samples, blood & urine Questionnaires: 
FFQ,EPDS, TFEQ-18, Binge eating, IPAQ, 
IBQR 
Child: eligibility, hospital admissions, 
medications & supplements. 
Anthropometry. Questionnaires: BEBQ, 
feeding  & growth, early care/education; 
sleep and activity 
 
 
CONSENT NOT GIVEN 
Routine ANC.  
BMI, ethnicity, age & 













Session -week 1 
Session -week 2
  






At trial entry, detailed maternal demography, familial environment characteristics, medical 
and family history were collected. A short-validated FFQ was completed to evaluate 
dietary glycaemic load, glycaemic index, saturated fat, total sugar and other dietary 
variables at each UPBEAT study assessment visit. Anthropometric measurements 
including SFTs and circumferences together with the collection of blood and urine samples. 
Behavioural and psychological measures were assessed by questionnaire at each study 
visit. Women, irrespective of randomisation allocation were invited to attend for an OGTT 
at 27-28+6 weeks’ gestation, having fasted for a minimum of 10 hours. Women were 
provided with a 75gram glucose load and diagnosis of GDM was made in accordance to the 
IADPSG’s diagnostic criteria (Metzger et al., 2008).  
 
Late pregnancy data was collected from hospital medical records including 3rd trimester 
maternal health, mode of delivery and number of antenatal inpatient nights. Neonatal 
outcomes, including collection of cord blood samples and detailed anthropometric 
measurements were collected within 72 hours of birth where possible.  
 
Mothers and infants were followed up at 6 months postpartum. Mothers’ pregnant at the 
time of the postpartum visit were excluded from the study but not their children. Infants 
were excluded from the follow-up visit if suffering from a major medical condition at 6 
months of age. Detailed demography, clinical, anthropometric (maternal and infant), 
lifestyle and biochemical variables were recollected at this visit. Known determinants of 
childhood obesity were also collected including a detailed feeding and growth 
questionnaire, a validated questionnaire addressing appetite (Baby Eating Behaviour 
Questionnaire), a revised infant behaviour questionnaire (IBQ-R), childcare and sleep 
patterns. Data collected including relevant questionnaires for both mothers and their 



















Table 2.1: Data collected throughout the UK Pregnancies Better Eating and Activity Trial.  
Including questionnaires and biochemical samples collected for mother and offspring throughout the UPBEAT study to 6 months postpartum. Abbreviations; BEBQ- Baby Eating Behaviour 
Questionnaire; FFQ- Food Frequency Questionnaire; IPAQ- International Physical Activity Questionnaire.








Birth  6 months postpartum  
Maternal 
Demography (Including socioeconomic status) X    X 
Diet  FFQ & 24 hour recall X X X  X 
Physical activity  IPAQ X X X  X 
Clinical history  Hospital admissions X X X X X 
Clinical assessment  X X X X X 
Anthropometry  X X X  X 
Biochemical analyses  X X    
Metabolomics analysis  X X X  X 
Neonate  
Clinical history  Hospital admissions     X  
Clinical assessment     X  
Anthropometry     X  
Metabolomics (cord)    X  
Infant  
Clinical history  
Hospital admissions      X 
Medicines & supplements      X 
Anthropometry      X 
Diet  
Feeding and growth      X 
BEBQ     X 
Lifestyle  
Childcare      X 




I joined the UPBEAT group following completion of the trial and 6 month follow up. My 
involvement included data monitoring of the study database followed by extensive data 
management including development of the data dictionary, devising a statistical analysis 
plan, a major role in the main trial analysis and preparation of the trial outcome manuscript 
for publication. 
 
2.1.7 UPBEAT data management  
2.1.7.1 UPBEAT data monitoring  
Weekly reports were generated to aid the midwives in following up missing data and 
checking inconsistencies within the data (Figure 2.2). Throughout the data monitoring, 
randomisation allocation was masked by generation of a random number sequence. If 
inconsistencies in the data were identified, the data was discussed with the appropriate 
midwife team in detail and where possible the data was rechecked with clinical notes at the 
individual centres.  
 
Figure 2.2: Data monitoring; example of missing data report by trial centre.  




2.1.7.2 Data dictionary at six months 
The UPBEAT RCT and 6 month follow-up collected >6000 variables. To fully utilise the 
database and available data, a data dictionary was created (an extract of the data dictionary 
is shown in Figure 2.3), by merging the individual datasets corresponding to each study 
visit. Furthermore, new names were derived for the variables by the addition of the prefix 
to identify the time point and type of participant (for example maternal body weight at 6 
months postpartum; “bodyc_weight” changed to “f9b_bodyc_weight”) to ease the import of 
data in statistical software packages and analyses. The dictionary incorporated all variables 
collected, including dietary, physical activity and biochemical data. Details were also 





Figure 2.3: An extract of the UK Pregnancies Better Eating and Activity Trial data dictionary at 6 month follow-up visit. 





2.1.8 UPBEAT study results  
The UPBEAT study did not meet its primary endpoints of reducing maternal GDM or 
delivery of a LGA infant (Table 2.2). The intervention was however, associated with 
significant changes in maternal antenatal diet, physical activity and measures of body 
composition. These include significant reductions in total energy intake (Mj/day) (-0.70; 
95% CI -0.96 to -0.45; p <0.0001), saturated fat (% energy) (-0.85; 95% CI -1.2 to -0.51; 
p<0.0001) and glycaemic load per day (-21; 95% CI -26 to 16; p<0.0001) and increased 
physical activity as assessed by the MET (min/week) (295; 95% CI 105 to 485; p=0.0015) 
from 15-18+6 to 26-28+6 weeks’ gestation, in comparison to the control arm. There were 
also associated changes in maternal body composition in the intervention arm, including a 
reduction of total GWG (kg) (mean difference -0.55; 95% CI 1.08 to -0.02; p=0.041) and 
SSFT throughout pregnancy (mean difference -3.2; 95% CI -5.6 to -0.8; p=0.0081) (Poston 
et al., 2015). 
 Standard care Intervention  Effect of Intervention  p-value  
Gestational 
diabetes * 
172/651 (26%) 160/629 (25%) Risk Ratio 0.68 
0·96 (0·79 to 1·16) 
Risk difference 





61/751 (8%) 71/761 (9%) Risk ratio 0.40 
1.15 (0.83 to 1.59) 
Risk difference  
1.2% (-1.6% to 4.1%) 
 
Table 2.2: UK Pregnancies Better Eating and Activity Trial primary outcomes by 
randomisation to standard care and intervention arms.  
*Primary maternal outcome: Gestational diabetes diagnosed at 27+0 to 28+6 weeks’ gestation by oral glucose 
tolerance test by IADPSG criteria14. Included were 8 (4.7%) of women with a diagnosis of gestational diabetes 
in the control group and 10 (6.3%) in the intervention group whose glucose tolerance test was undertaken 
within 6 days, (mean 3.0) of 27+0 to 28+6 weeks. A sensitivity analysis using only tests within the pre-defined 
window showed similar results (intervention 26.5% vs. control 25.5%; risk ratio 0.96, 95% confidence intervals 
0.79 to 1.16; p=0.67). **Neonatal outcome defined using customised centiles (Gardosi and Francis, 2014). 
Source: Poston L et al. Effect of a Behavioural Intervention in Obese Pregnant Women (the UPBEAT study): A 







2.2 Study design  
For this thesis, two predominant study designs were utilized; RCT and cohort design. In 
this thesis, the study design used was based on the hypothesis of interest and the aims and 
objectives of each analysis.  
 
2.2.1 Randomised controlled trials 
Within this study design, participants are randomly allocated to a treatment group and 
outcomes of interest are followed up. RCTs are regarded as the ‘gold standard’ to establish 
causal association (Richmond et al., 2014). Within a well-designed study, randomisation 
ensures that any imbalance between the two groups at baseline is purely due to chance, 
thereby limiting potential confounding.  
 
2.2.2 Cohort studies 
Cohort studies are observational studies which seek to investigate causes of disease within 
an unselected population. As cohort studies are observational studies, there may be 
influenced by confounding and bias.  
 
2.3 Primary outcome of this thesis 
The primary outcome of interest in this thesis was neonatal and infant adiposity as assessed 
by skinfold thicknesses in neonates and infants at 6 months of age.  
 
SFTs were collected within 72 hours of birth in neonates, and at 6 months of age in the 
infants. All measurements were collected in triplicate. Details of methods of measurement 












Triceps (mm) Using the Harpenden skinfold callipers, measured at the 
posterior aspect of the arm over the triceps muscle, at a midway 
point between the lateral projection of the acromion process of 
the scapula and the inferior margin of the olecranon process of 
the ulna.  
Subscapular 
(mm) 
Using the Harpenden skinfold callipers, measured at the inferior 
lateral border of the scapula.  
Birthweight (grams) Defined as the first weight recorded after delivery in grams.  
Length (cm) Measured using the neonatometer 
Midarm circumference (cm) Circumference measured midway between the elbow and 
shoulder bone.  
Abdominal circumference 
(cm) 
Circumference measured at the point of the umbilicus.  
Occiptofrontal 
circumference (cm) 
Circumference measured at the maximal Occiptofrontal 
diameter with the neonate supine.  
Infant at 6 months  
Skinfold 
thicknesses  




Using Holtain callipers, measured at the lower most tip of the 
scapula.  
Length (cm) Measured with the infant in the supine position with his/her 
back flat on the infantometer.  
Weight (grams) Measured using SECA scales ideally weight naked.  
Abdominal circumference 
(cm)  
Circumference measured at the level of the umbilicus  
Upper midarm 
circumference (cm) 
Circumference measured at the midpoint of the upper left arm.  
Table 2.3: Offspring anthropometric measurements and associated methodology for assessing 
neonates and infants at 6 months of age in the UPBEAT study. 
 
All staff underwent rigorous training for the measurement of neonatal SFTs. Intra-observer 
and intra-subject variations were continually assessed at each participating centre by 
collaborators at the University of Southampton. Assessment was undertaken by fitting 
analysis of variance models looking at the effect of staff and order. Results were visualised 
graphically to determine if the differences were clinically important. An example of intra-
observer variations by two research midwives at a particular centre are shown in Figure 2.4 
for neonatal subscapular SFTs. There was no significant difference between research staff 






Figure 2.4: Intra-observer variation in assessment for neonatal subscapular skinfold 
thicknesses.  
 
2.3.1 Derived measures of offspring adiposity 
Neonatal SSFTs were calculated by the addition of triceps and subscapular SFTs. For the 
infant at 6 months of age, SSFTs were calculated as the addition of triceps and subscapular 
SFTs and individual SFTs (subscapular and triceps SFTs) z-scores were determined using 
the WHO reference population (WHO, 2006). This reference population adjusts for 
offspring sex, age and is applicable irrespective of ethnicity and mode of early infant 
feeding.  
 
2.4 Secondary outcomes  
2.4.1 Neonatal secondary outcomes  
Secondary neonatal outcomes included mid-upper arm circumference (methodology for 
collection summarised in Table 2.3) and birthweight z-score calculated using external 
statistics derived from UK population data taking into account sex and gestation at delivery 
using the following formula (Cole et al., 2011);  
 








where z-standard deviation score; x-observed weight; and l, m, s are parameters dependent on 
gestation at delivery & offspring sex (Cole et al., 2011). 
 
2.4.2 Infant secondary outcomes at 6 months of age 
Infant secondary outcomes are summarised in Table 2.4.  
Variable generated  Variable type  Definition  
Weight for length z-scores Continuous  Generated using growth standards from the 
WHO Anthro (de Onis and Blössner, 2003)*  
Infant body mass index z-
scores  
Continuous  Generated using growth standards from the 
WHO Anthro (de Onis and Blössner, 2003)* 
Binary  BMI z-score ≥85th centile- infant BMI 
subcategorised as per WHO thresholds (de 
Onis and Blössner, 2003).  
Binary  BMI z-score ≥95th centile- infant BMI 
subcategorised as per WHO thresholds. 
Length for age z-score  Continuous  Generated using growth standards from the 
WHO Anthro (de Onis and Blössner, 2003)* 
Occiptofrontal for age z-
score  
Continuous  Generated using growth standards from the 
WHO Anthro (de Onis and Blössner, 2003)* 
Midarm circumference for 
age z-score  
Continuous  Generated using growth standards from the 
WHO Anthro (de Onis and Blössner, 2003)* 
Catch up growth Binary  An increase in of >0.67∫ standard deviations 
of weight from birth to 6 months of age was 
defined as clinically significant catch up 
growth at 6 months (de Onis and Blössner, 
2003). 
Catch down growth  Binary  A decrease of >0.67∫ standard deviations of 
weight from birth to 6 months of age was 
defined as clinically significant catch down 
growth a 6 months (de Onis and Blössner, 
2003).  
Table 2.4: Derived measures of infant body composition and methodology for calculation of 
measures used within the presented analyses. 
*The WHO Anthro z-scores are calculated considering the infant’s age (days) and sex. Biological implausible 
values are highlighted for each anthropometric z-score and are defined as ±5 SDS with the exception for infant 
length (±6 SDS). Biological implausible values were dropped from the analysis.  
 
Estimated total body (%) for infants at 6 months was also calculated from 2 skinfold 
measurements (triceps and subscapular SFT). Total body fat estimation was calculated 
using cross-validated skinfold equations (Slaughter et al., 1988) using the addition of 




𝑀𝑎𝑙𝑒 𝑖𝑛𝑓𝑎𝑛𝑡𝑠 𝑏𝑜𝑑𝑦 𝑓𝑎𝑡 (%) = 1.21(Σ 2 𝑆𝐹𝑇) − 0.008(Σ 2 𝑆𝐹𝑇) − 1.7  
𝐹𝑒𝑚𝑎𝑙𝑒 𝑖𝑛𝑓𝑎𝑛𝑡𝑠 𝑏𝑜𝑑𝑦 𝑓𝑎𝑡 (%) = 1.33 (Σ 2 𝑆𝐹𝑇) − 0.013 (Σ 2 𝑆𝐹𝑇) − 2.5 
 
2.5 Exposures 
2.5.1 Maternal in-utero exposures 
2.5.1.1 Demographic variables  
At trial registration, maternal age and pre-pregnancy BMI were collected at 15-18 weeks’ 
gestation. Inconsistencies were checked with recorded date of birth and objectively 
assessed maternal weight and height at trial entry. Clinical factors for example maternal 
parity, educational attainment (≤11 years vs. > 11 years of full time education) or ethnicity 
(White vs. Black vs. Asian vs. Other) were generated as binary and categorical variables, 
where appropriate. Maternal smoking, was generated as both binary (current smoker vs. 
non-smoker) and categorical (current smoker in early pregnancy vs. gave up smoking in 
early pregnancy vs. ex-smoker vs. non-smoker). 
 
Socio-economic deprivation was measured using the Lower Super Output Area which was 
collected from participants and corresponded to the census region of the participant’s 
residence. These were subsequently mapped to the corresponding index of multiple 
deprivation quintiles and subscales. As the index of multiple deprivation scores are not 
directly comparable to the four constituents regions of the UK, a methodology proposed by 
Payne et al was used to combine the four regions; allowing generation of an adjusted index 
of multiple deprivation score using Scottish Index of Multiple Deprivation as a baseline 
(Payne and Abel, 2012). Through publicly available data; an adjusted index of multiple 
deprivation score was created using employment and income domains of the individual 
country together with coefficients and residual values, generated by regression analyses of 





2.5.1.2 Family history of medical disorders.  
Family history of cardiometabolic health and pregnancy history were collected for all first-
degree relatives. The data was collapsed to generate individual variables for any maternal, 
paternal or sibling history of cardiometabolic disease and pregnancy outcomes including 
previous GDM or pre-eclampsia where appropriate. 
 
2.5.1.3 Maternal anthropometric measurements  
Methods for anthropometric data collection for mothers are summarised in Table 2.5. SFTs 





Waist circumference  Circumference measured at the half way point between the 
iliac crest and inferior margin of the lowest rib. 
Hip circumference  Circumference from the maximal diameter of the buttocks.  
Thigh circumference  Circumference measured from the observed largest part of 
the thigh. 
Mid arm circumference  Circumference measured from the midway point between 
the elbow and apex of the shoulder.   
Skinfold 
thicknesses 
Triceps  Using Harpenden skinfold callipers, measured at the 
posterior aspect of the arm over the triceps muscle, at a 
midway point between the lateral projection of the acromion 
process of the scapula and the inferior margin of the 
olecranon process of the ulna.  
Biceps  Using the Harpenden skinfold callipers, measured at the 
anterior aspect of the arm over the biceps muscle with the 
upper extremity relaxed to the side.  
Subscapular  Using the Harpenden skinfold callipers, measured at inferior 
lateral border of the scapula with the calliper jaws placed 
infero-laterally, 45o to the horizontal plane.  
Suprailiac  Using the Harpenden skinfold callipers; measured above the 
crest of the ilium.  
Table 2.5: Maternal anthropometric measurements and associated methodology for collection 
in the UPBEAT study.  
 
2.5.1.3.1 Gestational weight gain 
Maternal weight was objectively recorded at three time points during pregnancy (15+0 to 




cohort was defined as total weight gained from a calculated pre-pregnancy weight to late 
third trimester.  
 
As pre-pregnancy weight was subjectively obtained from medical notes, an assumed fixed 
first trimester weight gain of 1.25kg as recommended by the IOM weight gain guidelines 
was used to more accurately estimate pre-pregnancy weight. 1.25kg is the midpoint of the 
range specified by the IOM guidelines (0.5 to 2.0kg) (Rasmussen and Yatkine, 2009). In 
order to estimate as accurately as possible, 1.25kg was subtracted from each objectively 
measured maternal weight at 15+0 to 18+6 weeks’ of gestation, to generate an estimated pre-
pregnancy weight (Fall and Ingelsson, 2014). Total GWG was defined as the last recorded 
weight measured prior to delivery minus the derived pre-pregnancy weight.  
 
2.5.1.4 Maternal clinical factors  
The methodology described below includes principles of data management and statistical 
analyses applied to the pre-specified maternal and infant clinical factors taken within the 
trial and at six months postpartum. Maternal clinical variables and their definitions, which 







Table 2.6: Definitions of derived maternal clinical variables used throughout the UPBEAT 
study. 
 
2.5.2 Maternal dietary and physical activity data 
2.5.2.1 Dietary recording 
Dietary intake of the UPBEAT participants was assessed using FFQs administered by 
research midwives at 15-18+6, 27-28+6 and 34-36+0 weeks’ gestation. In addition, the same 
FFQ was used to assess maternal dietary intake at 6 months postpartum.  
 
The UPBEAT FFQ is an adaptation of the questionnaire used for the European Prospective 
Investigation into Cancer study in the UK (Bingham et al., 2001; Riboli et al., 2002), 
consisting of 50 questions to establish average use of foods during the preceding month. 
The questionnaire consisted of two parts; Part 1, food types including milk, breakfast 








Binary Defined as fasting glucose ≥5.1mmol/L; and/or 1 
hour glucose ≥10.0 mmol/L; and 2 hour glucose ≥8.5 
mmol/L following a 75g glucose load and oral 
glucose tolerance test undertaken in late second 
trimester  
Pre-eclampsia Binary Pre-eclampsia/ severe pre-eclampsia was defined as 
new hypertension presenting after 20 weeks 
associated with significant proteinuria. Severe pre-
eclampsia was defined as pre-eclampsia with severe 
hypertension and/or with symptoms, and/or 
biochemical and/or haematological impairment. Both 
variables are collected retrospectively and therefore 





Subcategorised to blood loss at delivery ≥1000ml and 
≥2000mls. 
Mode of delivery Categorical Categorised to vaginal vs. instrumental vaginal vs. 
elective C-section vs. emergency C-section.  
Hospital inpatient 
hospital nights  
Continuous Defined as total number of days admitted into 
hospital for ≥24 hours.  




cereal, bread, butter and cheese; Part 2, food groups, included as individual or groups of 
foods. Accompanying the list was a multiple response grid in which the respondents 
estimated frequency of consumption of foods eaten over the last month, ranging from never 
or less than once a month to 6 or more times per day. An automated programme was 
developed by the trial database team to transform data from the food frequency 
questionnaires into nutrient intakes based on the Compositional Analyses developed for 
European Prospective Investigation into Cancer Study nutritional data analysis (Riboli et 
al., 2002). Single food and beverage items listed in Part 1 of the questionnaire were 
assigned food codes and combination of foods were selected from food composition tables 
representing an average nutrient composition for each group (Robertson, 2003). Food codes 
were entered into WISP 3.0 (Tinuviel Software) dietary analysis software which produced 
nutritional composition and glycaemic load per 100g for each food code. Each glycaemic 
load value was manually checked by the trial dietician and updated glycaemic load values 
were assigned using published glycaemic index tables (Foster-Powell et al., 2002; Aston et 
al., 2010) . 
 
Using principal component analysis, four dietary patterns were developed defined as ‘Fruit 
and vegetable’, ‘Processed’, ‘African/Caribbean’ and ‘Snacks’ (Figure 2.5) (Flynn et al., 
2016). Women with unusually high and low energy intakes (>4780 Kcal and < 1780 Kcal) 
at 15-18 weeks’ gestation were omitted in accordance with previously reported analyses 





Figure 2.5: Maternal dietary patterns at 15-18+6 weeks’ gestation from the UK Pregnancies 
Better Eating and Activity study.  
Dietary patterns derived by principal component analysis and factor loadings ≥0.25 were considered 
significant. Source: Flynn AF, Goff L, Seed PT, Patel N et al. Dietary Patterns in Obese Pregnant Women; 
Influence of a Behavioural Intervention of Diet and Physical Activity in the UPBEAT Randomized Controlled 
Trial. International Journal of Behavioural Nutrition and Physical Activity 2016;13:124-128 (Flynn et al., 
2016). 
 
2.5.2.2 Physical activity  
Maternal physical activity was assessed throughout pregnancy and at 6 months postpartum 
by the short form of the International Physical Activity Questionnaire (IPAQ) (Ekelund et 
al., 2006). The self-administered questionnaire collected information on frequency and 
duration of three types of physical activity including walking, moderate and vigorous 
intensity physical activity over the previous 7 days.  
 
The IPAQ was summarised in accordance with published guidance (Ekelund et al., 2006). 
Outliers were defined as data which were unreasonably high; for example, physical activity 




to the IPAQ guidelines, walking, moderate and vigorous activity time >4 hours/ 240 
minutes were recoded to equal 4 hours/ 240 minutes; to take into account subjective bias 
(Ekelund et al., 2006). To summarise total physical activity, MET was generated, using the 
following formula:  
𝑀𝐸𝑇 = ( 𝑤𝑎𝑙𝑘𝑖𝑛𝑔(𝑚𝑖𝑛𝑠 𝑝𝑒𝑟 𝑤𝑒𝑒𝑘) 𝑥 3.3) + ( 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (𝑚𝑖𝑛𝑠 𝑝𝑒𝑟 𝑤𝑒𝑒𝑘) ∗ 4.0)
+ (𝑣𝑖𝑔𝑟𝑜𝑢𝑠 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (𝑚𝑖𝑛𝑠 𝑝𝑒𝑟 𝑤𝑒𝑒𝑘) 𝑥8.0) 
MET scores were subcategorised using the following pre-defined criteria below (Ekelund 
et al., 2006):  
a. High physical activity; vigorous activity on at least 3 days per week achieving a 
total physical activity of at least 1500 MET in minutes per week or a combination 
of walking, moderate activity or vigorous activity on 7 days per week, achieving a 
total physical activity of at least 3000 MET minutes per week.  
b. Moderate physical activity; 3 or more days per week of vigorous intensity activity 
of at least 20 minutes per day or 5 or more days per week of moderate intensity 
activity or walking for at least 30 minutes per day or achieving total physical 
activity of at least 600 MET in minutes per week.  
c. Low physical activity; participants not meeting the moderate or high physical 
activity criteria will subsequently be allocated to the low activity group. 
 
2.5.3 Neonatal birth outcomes  
Neonatal outcomes collected from maternal medical records and Electronic Patient 
Records™ including gestation at delivery, admission to neonatal intensive care and 
offspring sex. Gestation at delivery was subcategorised to preterm delivery (≤37 weeks’ 





2.5.4 Candidate biochemical markers 
Maternal venous samples were collected at each study time-point and underwent 
biochemical and metabolomics analyses at the University of Glasgow and Brainshake Ltd® 
respectively. Mixed-blood cord samples were collected at the time of delivery for 
metabolomic (Ludwig Maximilian, University of Munich) and candidate biomarker 
analyses (University of Glasgow). The gestation at sample collection was calculated at each 
time-point using the exact date that the blood sample was taken. The following definitions 
were used to create the variables  
1. 15-18+6 weeks’ study visit. Gestation at randomisation to the UPBEAT intervention 
calculated from gestational age at trial entry.  
2. 27-28+6 weeks’ study visit. Gestation calculated from date at sample collection 
minus gestational age at trial entry. 
3. Cord metabolome. Taken as gestation at delivery. 
 
2.5.4.1 Maternal biochemical markers  
Maternal biochemical analyses undertaken at the time of writing this thesis are 




















X X High-throughput serum nuclear magnetic resonance metabolomics platform was used simultaneously 
quantify lipids, 14 lipoprotein subclasses and major fractions, fatty acids, amino acids, ketone bodies 
and gluconeogenesis related metabolites; all previously implicated with insulin resistance. 
Total cholesterol  X X Enzymatic, colorimetric using Roche, Cobas c311 (CV low 1.8%, high 1.1%) 
LDL cholesterol  X X Homogenous enzymatic colorimetric using Roche Cobas c311 (CV low 2.0%) 
HDL cholesterol  X X Homogenous Enzymatic, colorimetric using Roche Cobas c311 (CV low 2.0%) 
Glucose  X X Enzymatic, hexokinase using Roche Cobas c311  
Fructosamine  X X Colorimetric, nitroblue tetrazolium using Roche Cobas c311 (CV low 3.4%) 
HbA1c X  Turbidimetric inhibition immunoassay using Roche Cobas c311 (CV low 1.4%, high 1.3%) 
Insulin  X X Electrochemiluminescence immunoassay using Roche Cobas c411 (CV low 7.8%, high 5.4%) 
C-peptide  X X Electrochemiluminescence immunoassay using Roche Cobas c311 (CV low 6.2%, high 5.1%) 
hs-CRP X X Particle enhanced immunoturbidimetric using Roche Cobas c411 (CV low 7.15)  
gGT X X Enzymatic, colorimetric using Roche Cobas c311 (CV low 3.9, high 3.9%) 
ALT X X Enzymatic, spectrophotometric using Roche Cobas c311 (CV low 3.3%, high 3.1%) 
AST X X Enzymatic, spectrophotometric using Roche Cobas c311 (CV low 2.1%, high 1.8%) 
Triglycerides  X X Enzymatic, colorimetric using Roche Cobas c311 (CV low 2.2, high 1.8%) 
Leptin  X X Enzyme-linked immunosorbent assay using R&D systems (CV intra 2.0%, inter 9.3%) 
Adiponectin X X Enzyme-linked immunosorbent assay using R&D systems (CV intra 5.4%, inter 12.0%) 
IL-6 X X Enzyme-linked immunosorbent assay using R&D systems (CV intra 9.8%, inter 12.8%) 
Table 2.7: Maternal biochemical analyses undertaken including specific candidate biomarkers. 




2.5.4.2 Cord blood biochemical markers  
Candidate cord biochemical analyses were chosen based on previous published research in 
relation to offspring adiposity and subsequent growth. Cord insulin, C-peptide and glucose 
were measured as these have been shown to be reflective of maternal glycaemic status and 
offspring adiposity (Metzger et al., 2009; Catalano et al., 2012). Plasma insulin and          
C-peptide, were measured by electrochemiluminescence on a clinically validated 
automated platform (e411, Roche Diagnostics, Burgess Hill, UK). The adipokines leptin 
and adiponectin were assessed as these have been shown to correlate highly with neonatal 
fat mass at birth and in early infancy (Clapp and Kiess, 1998; Fairley et al., 2015). 
Inflammatory markers IL-6 and Tumour Necrosis Factor (TNF-α) were measured, as both 
have been implicated as endocrine and paracrine signals to induce insulin resistance and 
shown to correlate with infant weight gain in the first year of life (Hotamisligil et al., 1993; 
de Toledo Baldi et al., 2016). Cord adiponectin, IL-6, TNF-α, adiponectin and leptin were 
measured by enzyme-linked immunosorbent assay (R&D Systems, Abingdon, U.K.). 
Insulin growth factors (IGF) I & II were also assessed as critical determinants of fetal and 
infant growth; cord blood IGF-I and IGF-II, correlated positively with birth weight and 
with measures of neonatal adiposity respectively (Lawlor et al., 2014), and have been 
shown to be associated with the cord lipid profile in offspring born to type 1 diabetic 
mothers (Nelson et al., 2007). Furthermore, three studies have reported reduced 
methylation status of IGF-II in obese mothers associated with increased IGF-II 
concentration in cord blood. IGF I and II were determined using a two-site 
immunoenzymometric assay (IDS, Fountain Hills, USA). 
 
2.5.5 Metabolome  
Metabolomics is the quantitative analysis of low molecular weight molecules within a 
biological tissue or fluid. Metabolites are end products of enzymatic processes and 




organism. Metabolomic analysis thus enables the examination of metabolic signatures, 
providing detailed insight into physiological or pathophysiological processes. At present, 
there are two principal methods of metabolomics analysis; targeted or untargeted. Targeted 
metabolomics are typically a-priori driven, where the analysis plays focus to a finite 
number of molecules. In comparison, untargeted metabolomics is an unbiased approach, in 
which multiple metabolites are measured for the discovery of novel biomarkers in relation 
to a disease state or physiological process. Table 2.8 summarises the differences between 
the two approaches.  
 Untargeted metabolomics  Targeted metabolomics  
Summary  Detection of many metabolites 
to provide insight into 
multiple metabolite pathways. 
Provides relative metabolite 
concentrations.  
Detection of a small number 
of metabolites associated with 
an a-priori hypothesis. Able to 
provide absolute metabolite 
concentrations.  
Platform  Mass spectrometry  Mass spectrometry or nuclear 
magnetic resonance 
spectroscopy 
Uses Discovery of novel 
biomarkers. Provides 
information of numerous 
biological pathways. 
Hypothesis testing with the 
ability to provide detailed 
insight into the related 
metabolic pathways.  
Advantages  Discovery of novel 
biomarkers/ metabolites. 
Shorter analysis time with 
high specificity and accuracy 
of derived metabolite 
concentrations.  
Disadvantages  Findings may require 
replication using targeted 
approaches. Possibly low 
specificity and accuracy.  
Potentially miss important 
metabolites or biological 
pathways.  
Table 2.8: Comparison of characteristics associated with untargeted and targeted metabolome. 
 
There are two main analytical approaches associated with metabolomics analysis; mass 
spectrometry (MS) and nuclear magnetic resonance (NMR). NMR spectroscopy is a highly 
reproducible technique requiring minimal sample preparation, which allows quantification 
of the concentration of the metabolites and detailed structural information. However, the 
main disadvantage of NMR is that smaller molecules (for example those with smaller 
energy transitions including amino acids), potentially may be concealed by larger 
molecules (for example metabolites with higher energy transitions including phospholipids 




gas-liquid chromatography or liquid chromatography. In comparison to NMR, MS has 
higher sensitivity but is limited by capturing multiple structures with varying dimensions of 
the same metabolite, therefore resulting in over-representation of the same molecule.  
 
For this thesis, maternal serum samples were analysed using NMR, whereas cord samples 
were analysed using MS. Reasons for methodology selection are discussed below.   
 
2.5.5.1 Maternal metabolomics samples  
Maternal antenatal samples were analysed using NMR profiling in collaboration with 
Professor Ala Korpela (Brainshake Ltd®) using a patented platform. Directly measured 
metabolites include lipoprotein subclasses, low-molecular-weight metabolites (amino acids, 
ketone bodies and creatinine) and detailed molecular information on serum lipid extracts 
including free and esterified cholesterol, sphingomyelin, degree of saturation and ω-3 fatty 
acids. This methodology was developed, internally validated and quality controlled to not 
exhibit machine ‘drift’ from batch to batch; thereby providing comparable results to 
measurement by routine assay. Previous studies have demonstrated that maternal obesity is 
associated with alterations in branched amino acids and degradation products related to 
glycolysis, however the mechanisms associated with the development of offspring 
adiposity born to obese mothers are unknown. For the purposes of this thesis, a targeted 
metabolomic analysis was undertaken to provide clear biochemical significance of 
metabolites associated with maternal insulin resistance and offspring adiposity. 
 
The high throughput proton NMR metabolomics platform used, provided rapid 
quantification of 64 primary metabolic measures (summarised in Table 2.7) as well as over 
>100 derived measures. The platform quantifies metabolites using a 600MHz spectrometer. 
These spectra were recorded, each yielding different subclasses of metabolites;  




2. Window 2 (LMWH window) provides information on several low molecular weight 
metabolites including amino acids, creatinine and ketone bodies.  
3. Window 3 (LIPID window) is applied to a serum lipid extract therefore measuring 
available serum lipid constituents and fatty acid saturation including 
sphingomyelins.  
 
The metabolomics samples were quality controlled by Brainshake Ltd®. Abnormal blood 
samples were marked as; 
1. High pyruvate/ high lactate. Whole blood kept at room temperature during sample 
collection procedure allows continued metabolism of glucose to pyruvate/ lactate. 
These were thought to be study-specific issues, potentially influencing the absolute 
metabolite concentrations.  
2. Low protein content. Samples were tagged when comparisons were made to the 
distribution of albumin concentrations within large populations. Low protein 
content was thought to arise from potential dilution of samples.  
3. High ethanol based. Arise from contaminations with the blood donation/ collection 
procedure therefore preventing quantification of glycerol and beta-
hydroxybutyrate. High levels of ethanol may also artificially increase acetate 
concentrations. 
 
2.5.5.2 Cord blood metabolome  
The serum cord blood metabolome was analysed at Ludwig Maximilian, University of 
Munich using MS. At the time of analysis, there was no validated methodology for 
analysing the cord blood using NMR. MS is suitable for almost all specimen types and is 
associated with high sensitivity and therefore able to detect subtle changes in fetal 
exposures at the time of birth. Although it is acknowledged that MS can be associated with 




known maternal standard; providing further detailed insight into the subtle changes of fetal 
exposures in offspring born to obese mothers. 
 
Cord blood samples with a minimum volume of at least 150μl were sent to the University 
of Munich on dry ice and immediately stored at -80oC. 50 µL of plasma were thawed and 
diluted with 450 µl methanol, containing internal standards representing different groups of 
metabolites (Harder et al., 2011; Hellmuth et al., 2012). After centrifugation, the 
supernatants were separated to enable the quantification of polar lipids, acylcarnitines, 
NEFAs and amino acids. Centrifugation was undertaken to obtain supernatants which were 
divided using the following techniques; 
1. Polar lipids. Quantification by flow-injection mass spectrometry was used to 
analyse polar lipids. Samples were analysed with a triple quadrupole mass 
spectrometer (QTRAP4000, Sciex, Darmstadt, Germany) with an electrospray 
ionization source. The analysis comprised diacyl-phosphatidylcholines, acyl-alkyl-
phosphatidylcholines, sphingomyelins, lysophosphatidylcholine and sum of 
hexoses. However, the analytical technique applied here was not capable of 
determining the position of the double bonds and the distribution of carbon atoms 
between fatty acid side chains. The nomenclature for polar lipids are described as: 
𝐶𝑋: 𝑌 
X is the length of the carbon chain 
Y is the number of double bonds 
OH indicates the presence of a hydroxyl group 
a indicates an acyl chain bounded by an ester bond 
e indicates an acyl chain bounded by an ether bond 
 
2. Carnitines. Flow-injection mass spectrometry was used to analyse acylcarnitines. 
Samples were analysed with a triple quadrupole mass spectrometer (QTRAP4000, 





3. Amino acids. Amino acid butylesters were determined by ion-pair liquid 
chromatography coupled with mass spectrometry detection (Bradfield et al., 2012). 
Mass spectroscopy detection was performed with an API 2000 triple quadrupole 
instrument (Sciex, Darmstadt, Germany) with an APCI source operating in a 
positive ion ionization mode.  
 
4. NEFAs. An ultra-performance liquid chromatography diphenyl column (Pursuit 
UPS Diphenyl, Varian, Darmstadt, Germany) was used for chromatographic 
separation with high performance liquid chromatography system (Bouchard, 2009). 
A hybrid triple quadrupole mass spectrometer, coupled to a high-performance 
liquid chromatography system was used for the identification of NEFAs. Fatty 
acids are separated according to chain length and number of double bonds. Similar 
to polar lipids, NEFAs are described as:  
𝐶𝑋: 𝑌 
X is the length of the carbon chain 
Y is the number of double bonds 
 
Intra-assay quality control of each metabolite was defined as coefficient of variation of 
<30% within a single batch in comparison to control samples.  
 
2.6 Data management  
 
2.6.1 Data management for clinical, anthropometric and lifestyle data 
Continuous data including anthropometric data were checked by assessing normal 
probability plots and histograms to identify potential outliers. Outliers were defined ±≥ 4 
standard deviations from the mean as well as from the previous measurement. Scatter plots 
were used to compare follow-up measures to baseline values. Measurements that appear 




deemed ‘normal’ if consistency was shown within scatter plots. Potential outliers were 
checked for data entry and measurement errors. If an anthropometric measurement for 
example was thought to be a ‘true’ outlier, the observation was dropped from the analysis. 
Variables generated for example total GWG and SSFT, were recalculated excluding the 
dropped observation to ensure consistency of the data.  
 
2.6.2 Data management of biochemical variables  
Normal probability plots and histograms were used to determine appropriate 
transformations and to identify potential outliers. If the distribution of a variable was non-
normal, transformations to a logarithmic base 2 were undertaken as it was thought that this 
would ease interpretability for non-specialists. Scatter plots of the transformed data were 
constructed to compare the follow-up measures to baseline. For the biochemical analysis, 
outliers were defined as ≥ 3 standard deviations from the line of best fit on the scatter plot.  
 
Outliers were assessed for measurement problems. Measurements considered outliers or 
biochemical values above or below levels outside the level of calibration range, a new 
variable was derived marking the value as an implausible value.  
 
2.6.3 Metabolomics data management  
Similar data management procedures were undertaken for both the maternal and cord blood 
metabolome. Metabolites were dropped if ≥70% values were unmeasurable or missing. 
Assessment was made for the variation of metabolite distribution by gestational age at 
sample collection by assessing the R2 and scatter plots as shown in Figure 2.6. If significant 
variation (defined as R2 ≥0.1) was present, metabolites were adjusted for gestational age at 





Figure 2.6: An example of a scatter plot for the maternal metabolite XXLVLDLP as 
demonstration of data management techniques undertaken. 
Variation was assessed with increasing gestational age of sample collection at each time point of biochemical 
collection, for maternal and offspring samples.  
 
Statistical definitions of outliers were derived based on the number of samples analysed at 
each pregnancy time-point. An assumption was made that a biochemical outlier within a 
normal population has a 1 in 20 chance of occurring; therefore 1 in 40 chance of occurring 
below the level of detection and 1 in 40 chance of occurring above the level of detection. 
The following formula was used to calculate the number of standard deviations an outlier 






where invnorm is the inverse of the cumulative of the normal distribution function and NS is the number 
samples analysed at each time point.  
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1. 15-18+6 weeks’ gestation: 1083 samples underwent targeted NMR metabolomics 
therefore an outlier was defined as ± 4.074 standard deviations (SDs).  
2. 27-28+6 weeks’ follow-up visit: 977 samples underwent targeted NMR 
metabolomics therefore an outlier was defined as ±4.050 SDs 
3. Cord metabolome: 607 samples underwent mass spectroscopy metabolomics 
analysis therefore an outlier was defined as ±3.937 SDs 
 
Box plots and scatter graphs were used to detect potential outliers using the original and 
transformed variable and subsequently characterised as an outlier when present in both the 
original and transformed data (Figure 2.7).   
 
Figure 2.7: An example of a box plot for the cord blood metabolite alanine. 
Plotted is the median, 25th and 75th percentiles for the cord metabolite.   
 
Identified potential outliers were also checked for quality control issues (for example high 
pyruvate, ethanol, lactate). Outliers were assessed by 3 independent people and 
subsequently marked as an outlier within a new dataset. During analysis of the 






Transformation of the metabolomics data were checked using distributional plots (Figure 
2.8). Where required, logarithmic transformation of the metabolites were undertaken. This 
method was undertaken to ensure that metabolites at the lower and upper levels of 
detection were not reported as missing values, as would occur if a logarithmic 
transformation was undertaken; thereby maintaining statistical power.  
 
 
Figure 2.8: An example of the maternal metabolite XXLVDLP data management assessing for 














































































2.7 Statistical analyses  
2.7.1 Summary statistics  
Binary and categorical variables were summarized using counts and percentages. The 
distribution of continuous variables was assessed using coefficients of skewness and then 
summarised by mean and standard deviation or median and interquartile range where 
appropriate. 
  
2.7.2 Univariate analysis 
Univariate analyses were undertaken if the outcome of interest was binary or categorical 
where the chi-square test was used. Mann-Whitney U tests or t-test were undertaken for 
continuous data dependent on the distribution. A 2-sided p-value with a statistical 
significance set as p<0.05 was used throughout this thesis, for rejection of the null 
hypothesis.  
 
2.7.3 Confounder selection  
Confounders were selected a-priori with relevant clinical knowledge and the use of direct 
acyclic graphs. This method identifies potential confounders as variables along a biasing 
confounding pathway. Direct acyclic graphs select the smallest number of covariates to 
control for bias (also known as the minimal sufficient adjustment set). It should be noted, 
that due to the non-parametric nature, direct acyclic graphs are limited in their ability to 
describe many developmental programming hypothesis including interaction. Confounders 





2.7.4 Multivariate analysis 
Linear and logistic multivariate regression were used to estimate the relationship between 
exposures and continuous and binary outcomes respectively with adjustment for 
confounders. Regression analyses provide an equation of the best straight line through the 
observed data: 
𝑦 = 𝑎 + 𝑏𝑥 
where y is the outcome of interest, a is the intercept, b is the gradient of the line and x is the exposure variable. 
The gradient of the line, also known as the regression coefficient provides that change in the outcome for each 
unit change of the exposure. Calculations are based on the least squares method which is based on minimizing 
the differences between the observed and mean values.  
 
Regression analyses assumes that the distribution of the residuals are normal, the 
relationship is linear and the standard deviation of the outcome is constant at all values of 
the exposure (i.e. no heteroscedasticity).  
 
2.7.5 Interaction analysis 
Interaction between two variables is defined as the presence of a varying association 
between the outcome of interest and the exposure, through an intermediary third variable. 
An interaction term is specified as the following equation within a model;  
𝑦 = 𝑎 + 𝑏𝑥 + 𝑐𝑥 + (𝑏𝑥 × 𝑐𝑥) 
where y is the outcome of interest, a is the intercept, b is the gradient of the line, x is the exposure variable and 
c is a categorical/ continuous or binary confounder variable. The multiplicative term “𝑏𝑥 × 𝑐𝑥” is the 
interaction term which is pre-specified based on an a-priori knowledge added to the regression analyses. To 
assess if there is evidence of interaction, likelihood ratio tests were undertaken on nested models containing the 
interaction term as an additional factor.  
 
2.7.6 Mediation analysis  
Mediation analysis allows the investigation of an indirect relationship between an exposure 




Baron Kenney Procedure which described a three-step method prior to undertaking a 
mediation analyses (Baron and Kenny, 1986); 
1. Establishment of an exposure associated with the outcome  
2. The exposure is a significant predictor of the proposed mediator variable (therefore 
if the mediator is not associated with the independent variable, there is no 
mediating role of the mediator).  
3. The mediator is a significant predictor of the dependent variable. 
 Other statistical methods necessary to undertake causal mediation analyses for RCTs are 
described in the relevant chapters.  
 
2.7.7 Missing data  
Within the UPBEAT study missing data mostly resulted from consent withdrawal or 
attrition. The presence of missing data, has three important implications for the analyses of 
longitudinal data;  
1. Under certain circumstances, missing data can introduce bias, potentially leading to 
misleading inferences. 
2. Missing data in longitudinal studies tends to be spread sporadically over many 
subjects, and depending on how highly correlated the missing data is in comparison 
to the observed data, it may result in a loss of precision and power. 
3. Missing data may be unbalanced between the two arms within a randomised 
controlled trial setting. 
 
Statistical methods considering missing data require careful assumptions on the nature and 
pattern of missingness which if misunderstood may result in the introduction of significant 
biases. For this thesis, review of methods of data collection, preparation and analysis were 





2.7.7.1 Mechanisms of missing data  
Understanding the mechanisms of missing data is critical in understanding the influence of 
missing data on specific analysis and undertaking specific missing data techniques. The 
missing data mechanisms were first classified by Rubin as Missing at Random (MAR), 
Missing Completely at Random (MCAR) and Missing Not at Random (MNAR) (Rubin, 
1976). MNAR assumes that this missingness is dependent on the unobserved data, 
therefore cannot be ignored. MAR refers to a situation where the probability of data being 
missing is not associated or dependent on the unobserved observations but shares relation 
to the observed data, i.e. the pattern of missing data is conditional on another variable. 
MCAR refers to data, where complete cases are representative of the original sample 
therefore associations based on these complete cases are thought to be applicable to the 
larger population (Little 1992).  
 
2.7.7.2 Strategies to deal with missing data  
Missing data is common within follow-up of RCTs and observational studies. Separate 
strategies for clinical and biochemical (including metabolomic data) were devised to deal 
with missing data including the use of complete case analysis.   
 
2.7.7.2.1 Missing clinical data  
Missing data following randomisation was assumed as lost to follow-up. A step-wise four 
point framework adapted from White et al, was devised to deal with incomplete 
observations, allowing the correct statistical method to be chosen and subsequently 
implemented (White et al., 2011; Dziura et al., 2013), as described below;  
1. Perform a main analysis of all observed data that are valid under a plausible 




2. Perform a sensitivity analyses to explore the influence of departures from 
assumptions made within the main analysis.  
3. Account for all randomised participants, at least within sensitivity analyses using 
multiple imputation under the MAR assumption where feasible.  
 
2.7.7.2.2 Missing data methods  
Complete Case analysis  
Complete case analyses are undertaken under the MCAR assumption. However, complete 
case analysis can result in loss of statistical power due to list-wise deletion of variables and 
may result in bias because of partial loss of data. Within longitudinal analyses groups with 
missing data are likely to have significantly different demographic characteristics in 
comparison to those with complete data. Inclusion of these differing variables within 
regression, can be included within the multivariate models to reduce potential biases 
(Graham & Donaldson 1993). 
 
Multiple imputation  
Within this thesis, multivariate imputation by chained equation was used as a sensitivity 
analysis when comparing results obtained from complete case analysis, where applicable. 
Imputation by chained equations models a plausible set of values reflecting the uncertainty 
regarding the correct value to impute (Rubin 1987). Imputation introduces an error based 
variation within the parameter estimates known as ‘between imputation error’, i.e. 
modelling the uncertainty associated with the missing values therefore reducing potential 
biases.  
 





1. The missing data are filled in n times (defined by the user) to generate complete 
data sets (the number of complete data sets defined by the user). 
2. Complete data sets are analysed using standard procedures in each individual 
dataset. 
3. Results from all imputed datasets are combined to estimate inference between the 
outcomes and exposures.  
 
For this thesis, comprehensive imputation models were, selecting a-priori predictors of 
missingness to preserve the associations or relationships among variables. With regards to 
repeated measures, baseline values for both maternal and infant data were used within the 
model. Where multiple imputation was used, the dataset was replicated 50 times with 10 
burn-in iterations.  
 
2.7.8 Multiple testing  
Performing many statistical tests, associations may be statistically significant purely by 
chance, resulting in many false positives. For example, if assessment was made of 200 
maternal exposures on a chosen offspring outcome, based on α=0.05, it is assumed that 
there will be 10 significant results. Statistical methods have been developed to account for 
the multiplicity of statistical testing. These methods are subcategorised into controlling the 
family-wise error rate and false discovery rate. The aims of both these statistical tests are to 
control the type 1 error, defined as incorrect rejection of the null hypothesis. When 
controlling for the family wise error rate or the false discovery rate, it is assumed that the 
individual tests are independent of one another and are not correlated within groups of 
comparisons. Within this thesis, correction for a false discovery rate using the Benjamin-





2.7.8.1 False discovery rate  
The false discovery rate (FDR) controls for significant results which are false positives in 
relation to the outcome. This methodology was originally devised by Benjamin & 
Hochberg and robustly controls for the type 1 error without loss of statistical power 
(Benjamini and Hochberg, 1995). This methodology ranks the p-values for a given number 




𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑒𝑠𝑡𝑠
) ×  𝐹𝑎𝑙𝑠𝑒 𝑑𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 𝑟𝑎𝑡𝑒  
Therefore, the largest p- value was determined by;  
𝑝 < (
𝑟𝑎𝑛𝑘
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑒𝑠𝑡𝑠 
) × 𝐹𝑎𝑙𝑠𝑒 𝑑𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 𝑟𝑎𝑡𝑒 
Those p-values smaller than this calculated value are statistically significant. It should be 
noted to report a false discovery p-value, generated p-values by the Benjamin and 
Hochberg methodology need to be transformed using the following equation; 




The Benjamin-Hochberg methodology is suitable for use when undertaking large number 
of comparisons, for example assessing the metabolome in relation to an outcome.  
 





Chapter 3 Relation of clinical and metabolic characteristics to 
neonatal adiposity among obese pregnant women 
 
3.1 Background 
One in four women of childbearing age globally are obese (Ng et al., 2014). As discussed 
in Chapter 1: Introduction, obesity represents a significant burden to antenatal healthcare 
in 21st century medicine, the predominant complication being a heightened risk of GDM 
(Kim et al., 2014). Fetal macrosomia, associated with increased fetal and neonatal 
adiposity, is a major determinant of adverse pregnancy outcomes in obese women and has 
been independently associated with childhood and adolescent obesity (Metzger et al., 2009; 
Huang et al., 2011; Cunningham et al., 2014; Sovio et al., 2016).  
 
A central role for fasting maternal glycaemia in fetal fat accretion is widely accepted, being 
exemplified by the HAPO study which identified a linear relationship between mild 
hyperglycaemia and neonatal adiposity in women without overt GDM (Metzger et al., 
2009; Farrar et al., 2016a). As well as glucose, fatty acids, triglycerides and amino acids 
have also been implicated (Friedman, 2015; Scholtens et al., 2016). High throughput 
metabolomics now enables quantification of a wider range of maternal metabolites to better 
characterise the determinants of neonatal adiposity, and this approach was recently adopted 
for samples obtained from a sub-group of HAPO women, at the time of the OGTT at 28 
weeks’ gestation. Scholtens et al reported that increased neonatal adiposity, assessed as 
SSFT, was associated with maternal clusters of acylcarnitines, ketone bodies, long and 
medium chain fatty acids when measured at one hour post glucose load at the time of the 
OGTT challenge, suggesting a possible mechanistic role for these metabolites (Scholtens et 
al., 2016).  
 
Amongst obese women, excessive fetal growth precedes the clinical diagnosis of GDM at 




and obese women in early pregnancy, including a recent report identifying overt insulin 
resistance in 30% of women (<20 weeks gestation) (Harreiter et al., 2016). It is currently 
unknown whether early pregnancy maternal exposures in obese women, including 
demographic and metabolic variables, contribute to the development of fetal adiposity. 
Precise characterisation of early pregnancy maternal risk factors for neonatal adiposity 
would offer the potential for development of targeted early interventions to prevent 
excessive fetal fat accretion in obese women (Sovio et al., 2016).  
 
The overall aim of this study was to examine the relationship between early (15-18 weeks’ 
gestation) pregnancy maternal clinical and biochemical variables with neonatal adiposity as 
assessed by SSFT.  
 
Using data from the UPBEAT trial, maternal demographic, clinical, anthropometric data 
together with biochemical markers previously associated with insulin resistance (including 
candidate biochemical markers and metabolome analysed by NMR, as discussed in 
Chapter 2: Methods) were assessed using multivariable regression. Late second trimester 
biochemical variables were assessed as potential mediators of early pregnancy maternal 




3.2 Research design and methods  
3.2.1 Study design and population  
The study was undertaken with data and samples from UPBEAT; a multicentre RCT 
assessing the effect of a behavioural lifestyle intervention in 1555 obese pregnant women 
(Poston et al., 2015). Further details of the study participants including trial inclusion and 
exclusion criteria are provided in Chapter 2: Methods. As the incidence of GDM (IADPSG 
criteria), delivery of a LGA neonate and neonatal fat mass distribution did not differ 
between the intervention and control arms of the UPBEAT study (Poston et al., 2015); the 
study was treated as a cohort for the purposes of this analysis. Live-born neonates with 
anthropometric measurements within 72 hours of birth were included in the analysis. 
Neonates with major congenital abnormalities were excluded. 
 
3.2.2 Neonatal outcomes  
The neonatal anthropometric outcomes of interest were continuous measures of adiposity 
assessed by SSFT (subscapular and triceps SFT combined). As secondary outcomes, 
individual SFT (subscapular and triceps) were assessed to determine the relative 
contribution of each, to the observed associations. Further details regarding measurement 
of neonatal anthropometric measures are provided in Chapter 2: Methods.  
 
3.2.3 Maternal variables 
Maternal early pregnancy sociodemographic, medical and family history were recorded at 
15-18+6 weeks’ gestation. Measures of maternal anthropometry including height, weight, 
waist, arm and thigh circumferences and 4 SFT (suprailiac, subscapular, triceps and biceps) 
were made at 15-18+6 and 24-28+6 weeks’ gestation. Further details regarding collection of 
maternal anthropometric measurements are provided in Chapter 2: Methods. Non-fasting 




seventeen candidate biochemical markers previously implicated with insulin resistance, 
together with quantification of 46 relevant metabolites related to amino acids, fatty acids, 
cholesterol, glycolysis and carbohydrates, all components of a targeted metabolome 
obtained by NMR spectroscopy (Wurtz et al., 2016). Details of measurement of candidate 
biomarkers and metabolomics analytical methods are provided in Chapter 2: Methods.  
 
At 24-28+6 weeks’ gestation, all women underwent an OGTT. IADPSG criteria were used 
for GDM diagnosis (fasting venous glucose >5.1mmol/l, 1hour venous glucose 
≥10.0mmol/L and 2hour venous glucose ≥8.5mmol/L). The candidate biochemical marker 
analyses at 24-28+6 weeks’ were undertaken on fasting samples obtained at the OGTT visit. 
 
3.2.4 Statistical analysis 
Maternal and neonatal demographic and clinical characteristics were summarised using the 
mean or percentages as appropriate. Anthropometric measures were treated as continuous 
variables. Selection bias was assessed by comparing maternal and offspring characteristics 
between infants with and without neonatal anthropometric measurements. Data for all 
biochemical markers including those derived from targeted metabolomic analysis were 
transformed to a normal distribution where appropriate and assessed for linearity. Data 
management techniques including outlier detection and transformations are discussed in 
Chapter 2: Methods. Possible non-linearity of associations between maternal exposures and 
neonatal outcomes were tested by assessment of fractional polynomial statistics and with 





3.2.4.1 Relationship with maternal demographic, anthropometric and biochemical 
variables at 15-18+6 and 24-28+6 weeks’ gestation and neonatal adiposity 
To assess the association between early pregnancy maternal exposures and continuous 
measures of neonatal adiposity (SSFT, subscapular and triceps SFT), univariate analysis 
were undertaken using linear regression. Significance tests are presented as unadjusted p-
values, and with correction for multiple testing using FDR< 0.05 (Benjamini and 
Hochberg, 1995). Multivariate linear regression was then performed, adjusting for maternal 
confounders (described below). Confounders were determined using a-priori knowledge 
based on established associations, and direct acyclic graphs were drawn to identify 
potential sources of bias (Greenland et al., 1999). Associations between maternal 
biochemical variables measured in fasting samples at 26-28 weeks’ with neonatal adiposity 
were similarly investigated with adjustment for a-priori defined confounders (described 
below). Associations between neonatal sex and SSFT and individual SFT were also 
explored for evidence of interaction. 
  
3.2.4.2 Confounder selection  
As this study was an exploratory analysis, only environmental characteristics were 
considered as potential confounders. Maternal confounders adjusted for were; current 
smoking status in early pregnancy (smoker in early pregnancy vs. non-smoker/ ex-smoker), 
socioeconomic status (socioeconomic deprivation defined as 4th and 5th socioeconomic 
deprivation quintiles vs. no socioeconomic deprivation defined as 1st to 3rd socioeconomic 
deprivation quintiles) and educational attainment (>11 years in full time education vs. <11 
years in full time education) as well as neonatal gestation at delivery (Model 1). Further 
adjustment was made for GDM (presence of GDM vs. no GDM) and GWG (assessed as 
net weight gain from early pregnancy to the end of pregnancy) (Poston et al., 2015) (Model 




OGTT as well as the development of neonatal adiposity (Rowan et al., 2011; Scholtens et 
al., 2016). Biochemical variables were further adjusted for maternal parity (nulliparous vs. 
multiparous) and ethnicity (reference population- white ethnicity).  
 
3.2.4.3 Mediation analysis to assess the association between maternal variables collected 
in early and late 2nd trimester with neonatal adiposity 
To assess whether maternal biochemical variables at 24-28+6 weeks’ acted as intermediates 
in any observed associations between early pregnancy maternal variables and neonatal 
adiposity, mediation analysis with parametric regression was performed. This involved 
estimation of multivariate regression models; one with the mediator conditional on early 
pregnancy variables and covariates, and the second with neonatal adiposity, conditional 
with early maternal exposures and potential confounders (Hicks and Tingley, 2011) (Figure 
3.1).  
 
3.2.4.4 Sensitivity analysis 
A sensitivity analysis was undertaken following exclusion of infants delivered pre-term 
(<37 weeks’ gestation). A second sensitivity analysis was performed, removing 








Figure 3.1: Diagrammatic illustration of mediation analysis.  
 Diagram to show multivariate regression analyses undertaken to establish whether greater neonatal adiposity 
associated with maternal obesity is the (1) direct influence of maternal characteristics in early pregnancy or (2) 
whether this is mediated through maternal biochemical pathways in late pregnancy as measured at the time of 







Of the 1522 live-born neonates, 502 (32.3%) had anthropometric measurements within 72 
hours of birth (Figure 3.2). Their mother’s median BMI was 35.5kg/m2 (range 32.9 to 
38.9). 30.1% of women developed GDM, with dietary advice being the most common 
mode of treatment (11.6% of the total cohort) (Table 3.1). The median (IQR) gestational 
age at delivery for the neonates was 39.8 (38.7 to 40.9) weeks and mean (SD) birthweight 
was 3.49kg (0.47). Table 3.1 shows mean values for SSFT, abdominal and mid-upper arm 
circumferences. 
 
Compared with the 1019 neonates not followed up at birth, there were no differences in 
maternal age, socioeconomic deprivation, BMI or incidence of GDM in comparison to 
those studied (Table 3.2). There were fewer neonates born to black mothers among those 
with anthropometric measures compared to those without (Table 3.3). Those included in 
this study had higher gestational age at delivery and neonatal birthweight (Table 3.3). Non-
linear regression (fractional polynomials) statistics and scatter plots were used, but these 
did not suggest the presence of non-linear associations between continuous predictors and 
measures of neonatal adiposity. Following assessment of the distribution of neonatal SSFT 
using kernel density plots and interaction analyses; there was no evidence of moderation by 
neonatal sex (Figure 3.3). Multivariate analyses were adjusted for offspring sex and not 
further stratified by neonatal sex. 
 
3.3.2 Associations between maternal exposures assessed at 15-18+6 weeks’ gestation and 
neonatal adiposity  





3.3.2.1 Maternal demography 
Following multivariate analyses, multiparity was the strongest determinant of neonatal 
adiposity as assessed by SSFT, being positively associated with an increase of 1.06mm 
(0.58 to 1.53; p<0.001) compared to nulliparous women (Model 1 and 2; Table 3.4). Each 1 
kg increase in maternal birthweight was associated with a 0.55 mm increase in neonatal 
SSFT (95% CI 0.58 to 1.53; FDR adjusted p-value= 0.04) independent of GDM, total 
GWG, gestation at delivery and offspring sex (Model 1 and 2; Table 3.4). Similarly, 
maternal parity and maternal birthweight (per 1kg increase) were positively associated with 
neonatal subscapular SFT (multiparous vs. nulliparous, 0.45mm; 0.19 to 0.71; p=0.01; 0.34 
mm; 0.11 to 0.58; p=0.02 respectively) (Table 3.5). Maternal parity was also positively 
associated with neonatal triceps SFT (0.61; 0.33 to 0.88; p<0.001) (Table 3.5). Maternal 
Black ethnicity was associated with lower neonatal SSFT after adjustment for maternal 
confounders, gestation at delivery and offspring sex (Model 1) but not after adjustment for 
GDM and GWG (Model 2) (Table 3.4). 
 
3.3.2.2 Maternal anthropometry, 15-18 week’s gestation 
Following multivariate analyses, maternal triceps SFT at 15-18 weeks’ was positively 
associated and suprailiac SFT negatively associated with neonatal SSFT; 0.04mm per 1mm 
(0.01 to 0.07; FDR adjusted p=0.02); -0.04mm per 1mm (-0.06 to -0.01; FDR adjusted p= 
0.01), respectively (Model 1 and 2; Table 3.4). Similarly, maternal triceps SFT (per 1mm) 
was positively associated with neonatal triceps SFT (0.02; 0.01 to 0.04; p=0.02) and 
maternal suprailiac SFT (per 1mm) was negatively associated with neonatal triceps SFT  (-





3.3.2.3 Maternal biochemical variables, 15-18 weeks’ gestation. 
Independent of maternal GDM, total GWG, socioeconomic deprivation, educational 
attainment and early pregnancy smoking, parity and ethnicity, higher vitamin D, serum 
glutamine, ketone bodies (serum acetate, acetoacetate and 3-hydroxybutyrate) and serum 
glycoprotein acetyls were positively associated with higher neonatal SSFT prior to 
correction for multiple testing (Models 1 and 2; Table 3.4). Serum cholesterol, aspartate 
transaminases and alkaline phosphatase were associated with a decrease in neonatal SSFT 
independent of maternal confounding but none remained significant after correction for 
FDR (Models 1 and 2).  
 
3.3.3 Association between maternal metabolic profile assessed in late 2nd trimester and 
neonatal adiposity  
Univariate analyses are summarised in Figure 3.5. Following multivariate analyses, 
maternal fasting serum glucose, insulin, C-peptide and glycoprotein acetyls, were 
positively associated with increasing neonatal SSFT following adjustment for confounders 
and FDR (Model 1 and 2; Table 3.6). Although metabolites including lactate, pyruvate and 
amino acids (including leucine, valine, tyrosine) were positively associated with neonatal 
SSFT, these were no longer significant following correction for multiple testing (Models 1 
and 2). Maternal serum cholesterol and valine were negatively associated with neonatal 
SSFT (Model 1 and 2), but no longer significant following correction for multiple testing 
(Model 2, Table 3.6). Maternal fasting glucose, serum C-peptide and insulin at 24-28+6 
weeks’ gestation, were positively associated with neonatal subscapular SFT, whereas none 
of the 153 biochemical measures assessed at 24-28+6 weeks’ were associated with neonatal 





3.3.4 Inter-relationships between early pregnancy maternal characteristics, late 2nd 
trimester maternal metabolic profile and neonatal adiposity  
Mediation analyses identified an indirect partial mediation of the relationship between 
maternal parity, fasting glucose at 24-28+6 weeks’ and neonatal adiposity (multiparous vs. 
nulliparous; indirect effect 0.05; 0.01 to 0.03; p=0.01) (Table 3.8). Similarly fasting 
glucose partially mediated the relationship between increasing maternal triceps SFT at 15-
18+6 weeks’ gestation and neonatal SSFT (per 1mm increase; indirect effect 0.01; 0.00 to 
0.01; p=0.04) but no biochemical mediator was identified for the observed association with 
maternal birthweight and neonatal SSFT (Table 3.8). In contrast an inverse, partial indirect 
effect was observed between maternal suprailiac SFT, fasting glucose and neonatal SSFT 
(per 1mm increase; indirect effect –0.01; -0.01 to 0.00; p=0.04) (Table 3.8). For the 
remaining biochemical markers (insulin, C-peptide and glycoproteins acetyls) which at 24-
28+6 weeks’ gestation were associated with neonatal SSFT, there was no evidence of an 
indirect mediatory role with early maternal pregnancy variables.   
 
3.3.5 Sensitivity analysis  
Exclusion of pre-term births (n=20) and removal of observations demonstrating significant 







Figure 3.2: Flow diagram of neonates with anthropometric measures included in this analysis.  
Abbreviations; LGA- Large for Gestational Age infants; RCT- Randomised Controlled Trial; UPBEAT- UK 
Pregnancies Better Eating and Physical Activity Trial.  
  
8820 women assessed for inclusion to the 
UPBEAT RCT
1555 women randomised
N=1522 liveborn infants analysed for trial 
primary neonatal outcome (LGA)
N=502 (32.3): Neonates with anthropometric     
measurements
N=1019 (66.9): Neonatal  anthropometry not 
measured at birth
N=1 (0.06): Congenital abnormality at birth
N=32 withbout birthweight
N=8: lost to follow up
N=6: Withdrew consent
N=8: Miscarriage
N=6: Fetal death in-utero 
N=4: Terminations 
7265 women excluded:
438: not eligible when reassessed
6704: declined to participate




Maternal  Mean (SD)/Median (Range)/N (%) 
N=502 
Clinical history  
Age (years)  30.9 (5.5) 
BMI (kg/m2)  35.5 (32.9 to 38.9) 
Ethnicity 
   
  
  
White  344 (68.5) 
Black  108 (21.5) 
Asian  25 (5.0) 
Other  25 (5.0) 
Time spent in full time education <12 
years 
 55(10.9) 
Socioeconomic deprivation   393 (78.6) 
Multiparous  246 (49.0) 
Smoker in early pregnancy   29 (5.8) 
Clinical examination  
Systolic blood pressure (mmHg) N=495 119 (11) 
Sum of skinfolds (mm) N=496 124.0 (26.0) 
Upper midarm circumference (cm) N=497 37.0 (4.0) 
Antenatal history 
GDM    149 (29.6) 
GWG (kg)   7.52 (4.2) 
Treatment for GDM   
Insulin, diet and metformin N=149  32 (21.5) 
Metformin and diet N=149  35 (23.5) 
Diet only N=149  56 (37.6) 
None/Other  N=149  26 (17.4) 
Neonatal  
Gestational age at delivery   39.9 (38.7 to 40.9) 
Birthweight (kg)  3.5 (0.47) 
Sum of skinfold thicknesses (mm)  11.0 (2.6) 
Upper midarm circumference (cm)  11.5 (1.0) 
Subscapular skinfold thickness (mm)  5.7 (1.4) 
Triceps skinfold thickness (mm)   5.3 (1.5) 
 
Table 3.1: Demographic and clinical data of maternal-neonate pairs included within this 
analysis (n=502). 






Table 3.2: Comparison of maternal demography, anthropometry and antenatal clinical history 
for neonates with and without anthropometric measurements (included n=502, excluded 
n=1052). 
Abbreviations; BMI-Body Mass Index; IMD-Index of Multiple Deprivation; GDM-Gestational diabetes; GWG-














Maternal demographics  
Maternal age (years) N=502 309 (5.5) N=1052 30.30 (5.53) 0.06 
Maternal BMI (kg/m2) N=502 36.6 (5.0) N=1052 36.14 (4.63) 0.07 
Maternal 
ethnicity 
White N=502 344 (68.5) N=1052 629 (6.7) 0.20 
Black  108 (21.5)  293 (27.9) 0.01 
Asian   25 (5.0)  70 (6.7) <0.001 
Other  25 (5.0)  60 (5.7) 0.56 
Multiparity N=502 246 (49.0) N=1052 634 (60.3) <0.001 










2 37 (7.4) 66 (6.3) 
3 46 (9.2) 131 (12.5) 
4 169 (33.8) 364 (34.7) 
Most 
deprived 5 
224 (44.8) 446 (42.6) 
Pre-pregnancy Maternal anthropometry 
Triceps (mm) N=498 32.7 (8.3) N=1036 33.4 (9.5) 0.14 
Biceps (mm) N=498 21.5 (7.1) N=1040 22.3 (8.4) 0.06 
Subscapular (mm) N=497 36.3 (10.3) N=1041 35.0 (10.0) 0.02 
Suprailiac (mm) N=497 33.3 (10.9) N=1040 31.5 (11.0) <0.001 
Sum of skin folds (mm)  N=496 123.9 (26.3) N=1038 122.2 (28.1) 0.23 
Antenatal clinical history  
GDM N=494 138 (27.9) N=811 200 (24.7) 0.19 
PET N=499 19 (3.8) N=1008 35 (3.5) 0.74 









Mean (SD)/N (%) Mean (SD)/N (%) 
Birthweight (grams) 3.5 (0.5) 3.4 (0.7) <0.01 
Birthweight >4kg 609 (13.7) 141(13.9) 0.96 
Birthweight <2.5kg  8 (1.6) 66 (6.5) <0.001 
Birthweight <1.5kg 0 (0.0) 21 (2.1) . 
LGA >90th  47 (9.4) 86 (8.4) 0.52 
LGA >95th  22 (4.4) 48 (4.7) 0.77 
SGA <10th  56 (11.2) 120 (11.8) 0.72 
SGA <5th  24 (4.8) 61 (6.0) 0.34 
Gestation at birth (weeks) 39.8 (1.5) 39.4 (2.6) <0.001 
Delivery <34 weeks 1 (0.2) 35 (3.4) <0.01 
Delivery <37 weeks  20 (4.0) 79 (7.8) <0.01 
Admission to NICU 14 (2.8) 108 (10.6) <0.001 
Table 3.3: Comparison between offspring birth characteristics of neonates with and without 
anthropometric measurements (included n=502, excluded n=1018). 
Abbreviations; LGA-Large for Gestational Age; NICU- Neonatal Intensive Care Unit; SGA-Small for 
gestational age.  
 
 
Figure 3.3: Distribution of neonatal sum of skinfold thicknesses stratified by offspring sex 
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Figure 3.4: Univariate analysis of maternal demography, anthropometry and biomarkers 
measured at 15-18+6 weeks' gestation and neonatal adiposity assessed as sum of skinfold 
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Table 3.4: Association of early 2nd trimester maternal demography, clinical, anthropometry and biochemical factors with neonatal adiposity assessed as sum of 
skinfold thicknesses, in offspring born to obese women (n=502).  
Results are presented as beta regression coefficients, 95% confidence intervals and p-value. Model 1- Adjustment made for maternal socioeconomic status, educational attainment and current 
smoking status, neonatal sex and gestation at delivery. Model 2- Adjustment made for ‘Model 1’, Gestational diabetes and total gestational weight gain. *Statistically significant at conventional 
p < 0.05 level, after correction for false discovery rate adjustment. Abbreviations; ALT-Alanine transaminase; AST- Aspartate transaminase; SFT-Skinfold thickness; 95% CI- 95% Confidence 
interval.  
 Model 1 Model 2 
β 95% CI P-value β 95% CI P-value FDR adjusted 
p-value  
Demographic & Clinical 
Black ethnicity -0.79 -1.35 to -0.22 0.01 -0.46 -1.06 to 0.139 0.13 0.25 
Multiparous 0.82 0.36 to 1.28 <0.001 1.06 0.58 to 1.53 <0.001 <0.001* 
Maternal Birthweight 
(kg) 
0.58 0.15 to 1.01 0.01 0.55 0.13 to 1.02 0.01 0.04* 
Triceps SFT (mm) 0.04 0.01 to 0.07 0.01 0.04 0.01 to 0.07 <0.01 0.02* 




-1.56 -2.57 to -0.55 0.01 -1.44 -2.46 to -0.43 0.05 0.42 
(log2) AST (U/L) -0.77 -1.29 to -0.26 <0.01 -0.61 -1.15 to -0.07 0.03 0.57 
(log2) ALT (U/L) -0.39 -0.73 to -0.06 0.02 -0.36 -0.70 to -0.02 0.04 0.59 
(log2) Fructosamine 
(μmol/L) 
-1.74 -3.30 to -0.18 0.02 -1.60 -3.17 to -0.02 0.05 0.65 
(log2) Vitamin D 0.42 0.13 to 0.72 0.01 0.40 0.10 to 0.70 0.01 0.48 
Metabolome 
Glutamine (mmol/L) 6.91 1.69 to 12.13 <0.01 6.72 1.34 to 12.10 0.02 0.37 
Acetate (mmol/L) 0.77 0.23 to 1.32 0.01 0.71 0.15 to 1.27 0.01 0.50 
Acetoacetate (mmol/L) 0.79 0.22 to 1.36 0.01 0.73 0.15 to 1.32 0.01 0.42 
Glycoprotein acetyls 
(mmol/L) 




 Model 1 Model 2 
β Confidence Interval p-value  β Confidence interval  p-value  FDR corrected p-value  
LL UL LL UL 
Neonatal subscapular thicknesses  
Multiparity 0.34 0.10 0.59 <0.01 0.45 0.19 0.71 <0.01 0.01 
Maternal birthweight (grams) 0.00 0.00 0.00 <0.01 0.34 0.11 0.58 <0.01 0.02 
Neonatal Triceps thicknesses  
Multiparity 0.49 0.23 0.75 <0.001 0.61 0.33 0.88 <0.001 <0.001 
Skinfold 
thicknesses 
Biceps (mm) 0.02 0.00 0.04 0.02 0.03 0.01 0.05 <0.01 0.02 
Triceps (mm) 0.02 0.00 0.04 0.01 0.02 0.01 0.04 <0.01 0.02 
Suprailiac 
(mm) 
-0.02 -0.04 -0.01 <0.001 -0.02 -0.03 -0.01 <0.001 0.01 
Table 3.5: Significant associations shown after multivariate analysis of maternal demography, anthropometry and biomarkers measured at 15-18+6 weeks' gestation 
and neonatal adiposity assessed as subscapular skinfold thickness and triceps skinfold thickness, in offspring born to obese women (n=502).  
 Model 1; Adjustment made for maternal socioeconomic status, early pregnancy smoking status, educational attainment, offspring sex and gestation at delivery; Model 2; Adjustment made for 





Figure 3.5: Univariate analysis of maternal biomarkers measured at 24-28+6 weeks' gestation 
and neonatal adiposity as assessed as sum of skinfold thicknesses in offspring born to obese 
women (n=502). 
Abbreviations; ALT-Alanine transaminase; AST-Aspartate transaminase; CRP-C-Reactive protein; HDL-High 
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Table 3.6: Associations of late 2nd trimester maternal biochemical variables with neonatal adiposity assessed as sum of skinfold thicknesses, in offspring born to 
obese women (n=502). 
Results are presented as beta regression coefficients, 95% confidence intervals and p-value. Model 1- Adjustment made for maternal socioeconomic status, educational attainment and current 
smoking status. Model 2- Adjustment for ‘Model 1’, Gestational diabetes and total gestational weight gain. * Significant at conventional p < 0.05 level, after false discovery rate adjustment. 




Model 1 Model 2 




0.86 0.42 to 1.30 <0.001 1.07 0.50 to 1.63 <0.001 0.02* 
(log2) Cholesterol 
(mmol/L) 
-1.05 -1.96 to -0.15 0.02 -1.17 -2.07 to -0.26 0.01 0.26 
(log2) CRP (mg/L) -0.70 -1.31 to -0.10 0.02 -0.55 -1.16 to 0.06 0.08 0.37 
(log2) Insulin (μU/ml) 0.34 0.14 to 0.54 <0.01 0.31 0.11 to 0.51 0.03 0.01* 
(log2) C-peptide (mg/ml) 0.57 0.29 to 0.84 <0.001 0.50 0.23 to 0.78 <0.001 0.01* 
Metabolome 
Lactate (mmol/L) 0.81 0.26 to 1.36 <0.01 0.62 0.06 to 1.18 <0.01 0.06 
Pyruvate (mmol/L) 9.45 2.44 to 16.47 0.01 8.39 1.24 to 15.54 0.02 0.35 
Leucine (mmol/L) -23.01 -44.96 to -1.06 0.04 -26.15 -48.85 to -3.44 0.03 0.38 
Valine (mmol/L) -16.02 -27.46 to -4.57 0.01 -18.21 -29.86 to -6.57 <0.01 0.04 
Tyrosine (mmol/L) -51.60 -93.92 to -9.28 0.02 -51.83 -94.50 to -9.16 0.02 0.35 
Acetate (mmol/L) -0.51 -0.99 to -0.02 0.04 -0.49 -0.98 to -0.01 0.05 0.23 
Glycoprotein acetyls 
(mmol/L) 
















Table 3.7: Significant associations following multivariate analysis of maternal biomarkers measured at 24-28+6 weeks' gestation and neonatal adiposity assessed as 
neonatal subscapular skinfold thickness and triceps skinfold thickness in offspring born to obese pregnant women (n=502). 
Model 1; Adjustment made for maternal socioeconomic status, early pregnancy smoking status, educational attainment, offspring sex and gestation at delivery; Model 2; Adjustment made for 
maternal socioeconomic status, early pregnancy smoking status, educational attainment, total gestational weight gain, gestational diabetes, offspring sex and gestation at delivery. There were 
no significant associations between maternal biomarkers measured at 24-28+6 weeks’ gestation and neonatal triceps skinfold thickness.  
 Model 1 Model 2 
 β Confidence Interval p-value  β Confidence interval  p-value  FDR corrected p-
value   LL UL LL UL 
Neonatal subscapular thickness  
Fasting glucose  0.59 0.35 0.83 <0.001 0.61 0.30 0.92 <0.001 0.01 
(log2) Insulin 
(uU/ml) 
0.20 0.09 0.31 <0.001 0.18 0.07 0.29 0.001 0.05 
(log2) C-peptide 
(uU/ml) 
0.31 0.16 0.46 <0.001 0.27 0.12 0.41 <0.01 0.02 




Pre-pregnancy and early 2nd 
trimester maternal 
characteristics  
Maternal biochemical variables measured at  
24-28+6 weeks’ gestation  
Estimate * 




Fasting blood glucose (mmol/L) 0.05 0.01 0.03 0.01 
(log2) Insulin (μU/ml) -0.02 -0.10 0.06 0.69 
(log2) C-peptide (ng/ml) -0.07 -0.18 0.03 0.18 
Glycoprotein acetyls, mainly a1-acid glycoprotein 0.00 -0.02 0.02 0.85 
Maternal birthweight (kg) 
Fasting blood glucose (mmol/L) 0.01 -0.07 0.09 0.88 
(log2) Insulin (μU/ml) -0.01 -0.07 0.05 0.72 
(log2) C-peptide (ng/ml) 0.01 -0.07 0.08 0.88 
Glycoprotein acetyls, mainly a1-acid glycoprotein -0.00 -0.02 0.01 0.80 
Maternal Triceps SFT (mm) 
Fasting blood glucose (mmol/L) 0.01 0.00 0.01 0.04 
(log2) Insulin (μU/ml) 0.00 -0.00 0.01 0.13 
(log2) C-peptide (ng/ml) 0.00 -0.00 0.01 0.56 
Glycoprotein acetyls, mainly a1-acid glycoprotein 0.00 -0.00 0.00 0.73 
Maternal suprailiac SFT (mm) 
Fasting blood glucose (mmol/L) -0.01 -0.01 0.00 0.04 
(log2) Insulin (μU/ml) -0.00 -0.01 0.00 0.36 
(log2) C-peptide (ng/ml) -0.00 -0.01 0.00 0.21 
Glycoprotein acetyls, mainly a1-acid glycoprotein 0.00 -0.00 0.00 0.70 
Table 3.8: Indirect mediation analysis of early pregnancy characteristics, late 2nd trimester biochemical factors and neonatal adiposity, in offspring born to obese 
women (n=502). 
* Adjusted for maternal socioeconomic status, current smoking in early pregnancy, gestational diabetes, total gestational weight gain, offspring sex and gestation at delivery. Abbreviations; LL-






Figure 3.6: Sensitivity analyses following removal of pre-term deliveries (<37 weeks) and observations demonstrating high leverage (excluded n=43).  
Abbreviations; ACE- serum acetate metabolite; Chol- plasma cholesterol; hsCRP- high sensitivity C-Reactive Protein; GP- serum glycoprotein acetyls; LA-serum lactate metabolite; Leu- 
serum leucine metabolite; Pyr- serum pyruvate metabolite; Suprailiac-maternal suprailiac skinfold thickness; Triceps- maternal triceps skinfold thicknesses; Tyr- serum tyrosine metabolite; 
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3.4.1 Summary of overall findings 
 Modifiable maternal risk factors including early pregnancy (15-18 week’ gestation) 
measures of maternal adiposity were linearly associated with measures of neonatal 
adiposity. 
 An independent association was demonstrated with maternal birthweight and 
neonatal adiposity 
 Maternal fasting glucose in the late second trimester was also found to partially 
mediate the effect of maternal parity and measures of early pregnancy adiposity 
with neonatal adiposity.  
 
In this study the role of early and late second trimester pregnancy clinical and biochemical 
risk factors associated with neonatal adiposity, in offspring born to obese mothers was 
assessed, to better understand the mechanisms underlying increased offspring adiposity in 
early gestation. Increased neonatal adiposity is associated with greater adolescent obesity 
and insulin resistance (Huang et al., 2011). Associations were investigated using a wider 
range of biochemical factors implicated with insulin resistance than previously explored 
(Metzger et al., 2009; Harmon et al., 2011; Friis et al., 2013), including those determined 
within a targeted metabolome (Wurtz et al., 2016). Using statistical modelling, key early 
pregnancy relationships of neonatal adiposity were identified, providing an improved 
understanding of early pregnancy risk factors for neonatal adiposity amongst obese women.  
 
3.4.2 Early pregnancy maternal associations 
The finding that maternal birthweight was associated with neonatal adiposity independent 
of gestational weight gain and gestational diabetes is, to our knowledge, novel. This 
relationship could potentially be explained by previously observed associations between 
high birthweight and maternal obesity mediated by maternal glycaemia which would be 
 147 
 
anticipated, but was not observed (Sebire et al., 2001). Population studies from Sweden 
have identified intergenerational associations of large for gestational age risk, which the 
authors suggest may be of genetic or epigenetic origin (Cnattingius et al., 2012), although 
this may arise from strong intergenerational association of socioeconomic status, and 
associated lifestyle characteristics. Maternal birthweight may be a previously unrecognised 
and independent risk factor for neonatal adiposity which could contribute to early 
pregnancy risk assessment in clinical management.  
 
The linear relationship between maternal parity and neonatal adiposity, concurs with 
observed associations of increasing maternal parity and higher birthweight (Wilcox et al., 
1996) and with one previous study describing an association of multiparity with neonatal 
adiposity, within a rural Indian population (Joshi et al., 2005). These observations are 
likely to reflect cumulative weight retention associated with consecutive pregnancies 
(Rasmussen and Yatkine, 2009), an hypothesis which was supported by the observed 
partial mediation by fasting glucose within this study.  
 
Previous reports of linear relationships between measures of maternal adiposity and 
neonatal sum of skinfold thicknesses were confirmed within this study, especially maternal 
peripheral fat as measured by triceps skinfold thickness, and increased neonatal adiposity at 
birth (Dube et al., 2012). Triceps skinfold thickness in adults is commonly associated with 
an unfavourable metabolic profile (Björntorp, 1991; Jensen, 2008) and has been shown to 
track from childhood to adulthood (Santos et al., 2016). Through the reported study, it has 
been demonstrated that increased maternal adiposity may influence this skinfold 
measurement in neonates predominately through maternal dysglycaemia.  
 
The inverse relationship between a measure of maternal lower body fat, suprailiac skinfold 
thickness, and adiposity at birth may have a protective role as adipose tissue deposition 
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within the suprailiac region, has been associated with protection against cardiovascular 
disease as it is a recognised storage depot for dietary fat (Björntorp, 1991; Jensen, 2008). 
The unexpected lack of association with maternal BMI in this obese cohort and neonatal 
adiposity is likely to reflect the narrow range of maternal BMI and disparate body fat 
distribution (Farah et al., 2011). 
 
In assessment with previous findings, Black ethnicity was negatively associated prior to 
correction for multiple testing, with neonatal adiposity independent of maternal 
demographic characteristics, gestational diabetes and gestational weight gain.  Although 
associations have been reported between Black ethnicity in relation to lower birthweight 
rather than measures of central adiposity (Singh and Yu, 1996; Okosun et al., 2000), an 
association with reduced muscle rather than fat mass cannot be discounted within these 
reports. It may be relevant to longer term obesity risk that lower birthweight within Black 
ethnic groups, has been negatively associated with measures of adiposity in children 
between 5 and 10 years of age (Okosun et al., 2000). Together, these observations suggest 
that Black ethnicity may have a protective effect on neonatal adiposity.  
 
3.4.3 Late 2nd trimester maternal metabolic profile associations with neonatal adiposity 
To our knowledge this is the most comprehensive analysis yet undertaken of biochemical 
markers of insulin resistance at the time of the oral glucose tolerance test and of 
relationships with neonatal adiposity. This data adds to previous reports that the permissive 
milieu leading to increased fetal fat accretion occurs before the diagnosis of gestational 
diabetes (Sovio et al., 2016). Of the biochemical variables associated with dysglycaemia or 
insulin resistance measured in fasting maternal samples in late second trimester, four were 
positively associated with increasing neonatal adiposity, before and after adjustment for 
maternal gestational diabetes and gestational weight gain. Of these, three agree with a study 
from the HAPO cohort describing linear relationships between the associations with 
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maternal fasting glucose, raised insulin and C-peptide at the time of the oral glucose 
tolerance test with neonatal adiposity, as assessed by sum of skinfold thicknesses (Metzger 
et al., 2009). A relevant study using Mendelian randomisation in up to 30,000 European 
origin mother-offspring pairs also supports a causal linear effect of greater maternal BMI 
and fasting glucose measured at the time of the oral glucose tolerance test with neonatal 
birthweight and ponderal index (Tyrrell et al., 2016). 
 
Glycoprotein acetyls, as identified by the metabolome; a known marker of inflammation, 
were positively associated with neonatal sum of skinfold thicknesses at 24-28+6 weeks’ 
gestation. This novel finding may have relevance to a growing body of evidence that 
maternal markers of inflammation could contribute to persistently altered development of 
central pathways associated with satiety and appetite regulation in the offspring (Gaillard et 
al., 2016).  
 
Insulin resistance as assessed by fasting glucose, insulin and C–peptide at 24-28+6 weeks’ 
gestation in obese pregnant women, was more strongly associated with neonatal 
subscapular than neonatal triceps skinfold thickness, and may have functional 
consequences as subscapular skinfold thickness, a measure of central body fat, with a lower 
measurement error compared to other skinfolds (Peiris et al., 1988), is implicated in 
impaired glucose tolerance in children at 9-10 years of age, and with cardiovascular disease 
in adulthood (Srinivasan et al., 2003; Freedman et al., 2009).  
 
As adiposity tracks through childhood (Huang et al., 2011), the prevention of maternal 
dysglycaemia by pharmacological or lifestyle intervention has the potential to modify the 
life course trajectory of adiposity through early modification of central fat mass. However, 
two recent RCTs have reported no effect of early metformin treatment on the incidence of 
GDM or neonatal outcomes in a heterogeneous population of obese women (Chiswick et 
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al., 2015; Syngelaki et al., 2016). This study implies that risk stratification of obese 
pregnant women e.g. by birthweight, parity, upper body fat adiposity or late second 
trimester glycaemia, would enable targeted pharmacological intervention in those at 
greatest risk, to achieve a meaningful reduction in dysglycaemia and subsequent neonatal 
adiposity.  
 
Contrary to previous reports, there was no evidence for an association between early or late 
2nd trimester triglycerides or non-esterified fatty acids concentrations and neonatal 
adiposity (32). This contrasts with findings from Catalano et al., who proposed that a 
relationship between fatty acids and neonatal adiposity in women with gestational diabetes, 
may reflect a third trimester lipid rise rather than early pregnancy lipid metabolism 
(Catalano et al., 2002; Schaefer-Graf et al., 2008). This lack of association of triglycerides 
is consistent with the recent Mendelian randomisation study which found no evidence for a 
causal effect of triglycerides with neonatal birthweight or ponderal index (Tyrrell et al., 
2016). 
 
3.4.4  Strengths and limitations  
Strengths of this prospective longitudinal cohort study include, the measurement of a wide 
range of known candidate biochemical markers implicated with insulin resistance, 
including determinants of neonatal adiposity, enabling an a-priori data driven approach to 
assess the influence of early pregnancy in-utero exposures in obese pregnant women. This 
is one of the first exploratory studies assessing an extensive number of early maternal 
biochemical markers and high-throughput metabolomics of samples from pregnant obese 
women. Limitations include multiple testing to determine associations of early pregnancy 
maternal associations with neonatal adiposity, however correction for multiple testing using 
a false discovery rate was undertaken with application of a stringent threshold. However, 
findings require replication in independent cohorts. Neonatal anthropometric measures 
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were available in only a sub-group of the original cohort, but there were no differences in 
the maternal clinical characteristics and anthropometry between those without and with 
anthropometry at birth. The conclusions from the study are therefore potentially 
generalisable to other inner-city, socio-economically deprived populations. Maternal 
biochemical markers, in early pregnancy were assessed in non-fasting samples. Although 
measurement of fasting samples in early 2nd trimester may identify additional associations 
with neonatal adiposity, these would have limited clinical relevance for intervention where 
early pregnancy fasting samples are not collected within routine antenatal care. As this 
study was observational, causality cannot be assumed for the observed direct associations 
or mediation analyses (Richmond et al., 2014).  
 
3.4.5 Conclusion  
In conclusion, further research is warranted to determine whether the associations reported 
here are likely to be causal. The study highlights the potential for targeted intervention in a 
stratified obese cohort including multiparous pregnant women, and those with excessive 
upper body fat deposition to successfully modify neonatal adiposity. This study also 
provides some support for early recognition and intervention of fasting dysglycaemia 
(Rowan et al., 2011; Barker et al., 2016) in obese pregnancies. Further randomised 
controlled trials are required to ascertain the potential influence of early risk stratification 
together with early pregnancy treatment for dysglycaemia within obese pregnancies to 
modify neonatal body composition.  
 152 
 
Chapter 4 Cord blood metabolic profiles in obese pregnant 
women; insights into offspring growth and body composition. 
 
4.1 Background 
The increasing incidence of childhood obesity is a major public health concern. Recent 
global estimates from the WHO, suggest that 41 million children under the age of 5 years 
are overweight or obese (WHO, 2016). Observational cohort and experimental animal 
studies have strongly suggested that both the pre- and postnatal environments modulate 
developmental pathways that increase susceptibility to later obesity (Patel et al., 2015). 
Offspring exposed to maternal obesity, excessive GWG and/or GDM in-utero are at an 
increased risk of obesity and altered glucose metabolism throughout the life-course (Lawlor 
et al., 2011a; Fraser and Lawlor, 2014; Patel et al., 2015; Sharp et al., 2015). Exposure to 
maternal obesity in-utero is proposed to set the offspring on a trajectory of increased 
adiposity throughout life due to persistent changes in metabolic function (Giles et al., 2015; 
Jin et al., 2016). It is also suggested that altered fetal development is associated with 
exposure to excessive maternal nutrition in-utero influencing fetal developmental pathways 
leading to a persistent increased risk of obesity (Barker, 1997; Patel et al., 2015). 
 
Metabolomics has emerged as a tool which provides insight into the downstream products 
of transcriptional and translational processes as well as environmental exposures (Hivert et 
al., 2015). This method enables the investigation of low-molecular weight molecules such 
as intermediate metabolites and signalling molecules which can be used as a tool to provide 
insight in the systemic perturbations of an individual as a result of pathophysiological in-
utero exposure. Metabolites assessed in cord blood at delivery reflect fetal metabolic 
exposures during late gestation. However, few studies have assessed whether the cord 
blood metabolic profile could provide insight into mechanisms of offspring ‘programming’ 




Investigations of cord blood metabolic profiles have previously been conducted within 
small cases-control studies assessing associations with birth weight or postnatal growth 
velocities and with limited adjustment for in-utero confounding variables (Desert et al., 
2015). In a large birth cohort from Germany, certain cord blood metabolites were 
associated with birth weight (Taveras et al., 2004). However, neonatal adiposity explains 
only 40% of the observed variation in birthweight, which may provide an improved 
assessment of fetal fat mass deposition in-utero.  
 
The aim of this study was to assess whether a behavioural lifestyle intervention in obese 
pregnant women, focused on increasing physical activity, reducing dietary saturated fat and 
glycaemic load (Poston et al., 2015), resulted in changes in the cord blood metabolic 
profile, including cord blood metabolome assessed using mass spectrometry and candidate 
biomarkers previously implicated with excess fetal growth and obesity in early life.  
 
The secondary aim of the study, was to explore the relation between maternal antenatal 
characteristics including total GWG, early pregnancy BMI and GDM with the cord blood 
metabolic profile. As adiposity, has shown to track through childhood (Huang et al., 2011; 
Giles et al., 2015), further assessment was made for potential relationships between 
metabolites in the cord blood and measures of anthropometry in offspring at birth and at 6 
months of age. Associations were also explored between cord blood metabolites and infant 





4.2 Research design and Methods  
4.2.1 Study Design  
This study was a secondary analysis from the UPBEAT trial. To assess the primary aim of 
this study, the influence of the UPBEAT lifestyle intervention on the cord blood metabolic 
profile; the UPBEAT study was treated as an RCT (Briley et al., 2014). As the secondary 
aim of the study was to assess the relationship of the cord blood metabolic profile with 
maternal clinical characteristics and neonatal and infant anthropometry, a cohort study 
design was chosen. 
 
4.2.2  Study population  
4.2.2.1 Primary aim  
Women over the age of 16 years were recruited to the UPBEAT trial between 15-18+6 
weeks’ gestation, from inner-city populations with high socioeconomic deprivation. 
Detailed study design and protocol including inclusion and exclusion criteria are provided 
in Chapter 2: Methods.  
 
4.2.2.2 Secondary aim  
Mother-neonate pairs were included in the analyses if detailed neonatal anthropometric and 
cord blood metabolic data were available. Infants were included within a secondary 
analysis if they attended the follow-up appointment at 6 months of age and did not suffer 




4.2.3 Cord blood metabolic profile 
For this analyses, assessment of the cord blood metabolic profile was compromised of 
candidate biomarkers previously implicated with obesity and adverse growth together with 
cord blood metabolome quantified by MS. 
 
4.2.3.1 Cord blood biomarkers  
Candidate cord blood biomarkers assessed in this study include cord blood insulin,           
C-peptide, glucose, LDL-c, HDL-c, triglycerides, adiponectin, leptin, IGF I, II, IL-6 and 
TNF-α. 
 
4.2.3.2 Metabolomic analyses  
The cord blood metabolome comprised of lysophosphatidylcholines (LPCs), 
phosphatidylcholines, sphingomyelins, NEFAs, carnitines, tricarboxylic acid intermediates 
and amino acids.  
 
Further details of methods of analyses for candidate biomarkers and metabolomic analyses 
in the cord blood are provided in Chapter 2: Methods.  
 
4.2.4 Maternal variables   
Maternal clinical characteristics investigated, included maternal early pregnancy BMI 
(kg/m2); total GWG (kg) defined from pre-pregnancy to 34-36 weeks’ gestation; GDM 
defined using the IADPSG’s diagnostic criteria at 24-28+6 weeks’ gestation as well as 
fasting glucose, 1 and 2 hour glucose concentrations at the time of the OGTT (Metzger et 




4.2.5 Offspring anthropometry  
4.2.5.1 Neonate  
Further details provided in Chapter2: Methods. Anthropometric measurements were made 
within 72 hours of birth by a trained midwife. Birthweight was recorded from maternal 
medical records and birthweight z-scores calculated (WHO, 2006; Briley et al., 2014). 
Neonatal subscapular and triceps SFT were measured using Harpenden skinfold callipers in 
triplicate and SSFT were calculated (Briley et al., 2014). Neonatal length was assessed 
using a neonatometer. Abdominal circumference was assessed at the level of the umbilicus 




Further details provided in Chapter2: Methods. Anthropometric measurements were 
collected at 6 months of age by a trained midwife. Weight was assessed using SECA® 
scales, and length assessed in the supine position using an infantometer (Briley et al., 
2014). Triceps and subscapular SFT were measured in triplicate using Holtain callipers 
(Briley et al., 2014). Midarm circumference was measured using the same methodology as 
the neonates. Where reference WHO population data were available, z-scores were 
calculated, adjusting for infant sex and age at measurement (WHO, 2006). At 6 months of 
age, these standards are applicable regardless of maternal ethnicity, socioeconomic status 
and mode of feeding (WHO, 2006; WHO and de Onis, 2006). The WHO definitions of 
catch-up and catch-down growth were used and specific definitions can be found in 




4.2.6 Statistical analysis  
4.2.6.1 Cord blood metabolic profile  
Metabolites were standardized to mean metabolite concentrations and standard deviation 
over all eight batches for the purpose of this statistical analysis. Metabolites were included 
in the analyses if <70% data was missing. Cord blood biomarkers and metabolomic 
variables were assessed for normality and transformed appropriately. Dummy variables 
were generated for potential outliers defined as >4SDs, as discussed in Chapter 2: 
Methods. Variables were summarised using mean (SD) and median (IQR) where 
appropriate.  
 
Principal component analysis was undertaken for the metabolomic data only, to reduce the 
number of metabolites based on a series of uncorrelated linear combinations of variables 
containing the most variance (Wold et al., 1987). Following orthogonal rotation and 
identification of the number of clusters that best represented the data, metabolites with a 
loading ≥0.1 were considered to have a strong association with the cluster.  
 
4.2.6.2 The effect of a UPBEAT lifestyle intervention on the cord blood metabolic 
profile  
Assessment was made for any differences in maternal characteristics and birth outcomes 
between those included vs. those excluded from the analysis. Adjustment was made for any 
apparent differences in maternal characteristics at trial entry (15-18+6 weeks’ gestation) 
between the two arms. The effect of the UPBEAT intervention were assessed using linear 
regression adjusting for minimisation variables used at trial randomisation (ethnicity, parity 





4.2.6.3 Maternal associations with cord blood metabolic profile  
Maternal antenatal variables (including early pregnancy BMI, GWG and GDM) were 
assessed in relation to the cord blood metabolic profile. To assess for potential 
relationships, multivariable linear regression was undertaken, where components of the 
cord blood metabolic profile were treated as the outcome and maternal antenatal variables 
as the exposure. Adjustment was made for offspring sex, gestational age at delivery and 
randomisation to the UPBEAT intervention.  
 
4.2.6.4 Cord blood metabolic profile and offspring anthropometry 
To assess the association between the cord blood metabolic profile (exposure) and 
subsequent offspring anthropometry (outcome) at birth, multivariable linear regression was 
used. Cord blood metabolic variables significantly associated with neonatal body 
composition were also assessed for potential relationships with infant anthropometry at 6 
months of age, including early life growth velocities using multivariate linear and logistic 
regression, where appropriate.  
 
Adjustment was made for confounders, selected a-priori based on clinical knowledge with 
the aid of direct acyclic graphs as summarised in, Table 4.1, Figure 4.1, Figure 4.2. 
Selected confounders included age at anthropometric measurement (continuous), offspring 
sex (binary; 0-Male, 1-Female) where appropriate and randomisation to the UPBEAT 
intervention (Model 1). Further adjustment was made for maternal parity (binary; 0-
Nultiparous, 1-Multiparous), ethnicity (categorical; reference white ethnicity), current 
smoker in early pregnancy (binary; 0-Non/ex-smoker, 1-Current smoker in early 
pregnancy), GDM (binary; 0-No GDM, 1-GDM), GWG (continuous), within a second 
model (Model 2). For potential associations of metabolic profile at birth and infant 
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anthropometry at 6 months of age, further adjustment was made for mode of feeding 
(categorical; reference exclusive breastfeeding ≥4 months of age).  
 
All linear regression models were further assessed for data points exhibiting high leverage 
by using Cook’s Distance (defined as Di>4/n) (Altman and Krzywinski, 2016), 
heteroscedasticity and linearity. Correction for multiple testing was undertaken using FDR 
utilising the Benjamin & Hochberg procedure. Presented significance levels were corrected 
for multiple testing (statistical significance p<0.05) (Benjamini and Hochberg, 1995).  
 
4.2.6.5 Sensitivity analyses 
Sensitivity analysis were undertaken by assessing demographic characteristics for those 
included within the analyses versus the mother-offspring pairs excluded. It is well 
documented that preterm neonates have a significantly different metabolic profile at birth, 
and subsequent growth, therefore a further sensitivity analysis was performed excluding 
offspring born <34 weeks’ gestation (Tea et al., 2012). A third sensitivity analysis was 
undertaken, as treatment for GDM has been shown to alter fetal adipokines (Landon et al., 
2009); to address this potential effect mothers diagnosed with GDM were excluded from 
the analysis. As mode of delivery has been shown to influence the cord blood metabolic 
profile (Godfrey et al., 1996b), a fourth sensitivity analysis was undertaken with statistical 







Variables  Reason 
Maternal   
UPBEAT Intervention  The intervention was associated with a reduction in maternal GWG, 
measures of adiposity and improvements in maternal antenatal diet and 
physical activity (Poston et al., 2015). In the offspring, the intervention 
was associated with a reduction in cord insulin and a measure of 
central adiposity at 6 months of age.  
BMI  Increasing maternal BMI is associated with raised cord lipid, 
inflammation markers and markers associated with insulin resistance 
as well as a determinants of neonatal body composition (Lemas et al., 
2015; Sharp et al., 2015). 
Parity Increasing maternal parity is associated with increasing neonatal 
adiposity as shown in a rural Indian population (Joshi et al., 2005) and 
a prospective birth cohort in the Netherlands (Gaillard et al., 2014a)  
Ethnicity Maternal ethnicity is differentially associated with neonatal adiposity 
e.g. offspring born to black ethnic groups have reduced birthweight in 
comparison to those from white ethnic groups (Okosun et al., 2000; 
Lin et al., 2015).  
Socioeconomic status Socioeconomic deprivation is associated with reduced educational 
attainment and poor maternal lifestyle behaviours, known determinants 
of neonatal adiposity (Ranjit et al., 2015).  
Smoker in early 
pregnancy  
Smoking in pregnancy is associated with intrauterine growth restriction 
associated and with an adverse metabolic profile measured in the cord 
blood (Rolle-Kampczyk et al., 2016).  
GWG  Multiple observational studies have demonstrated a linear association 
between GWG and neonatal adiposity (Fraser et al., 2010). A linear 
relationship with maternal GWG, cord adipokines and markers insulin 
resistance has been previously demonstrated in offspring born to 
heterogeneous BMI (Solis-Paredes et al., 2016).  
GDM  The relationship between maternal glycaemia and neonatal adiposity 
has recently proven causal. Pathway analysis have identified maternal 
glucose to be key in determining neonatal anthropometry mediated by 
fetal metabolic profile at birth (Lawlor et al., 2014).  
Neonate   
Sex Offspring sex has shown to have a differential influence on cord 
biomarkers of inflammation and adipokines. Females offspring have 
significantly more adipose tissue in comparison to male offspring 
(Power and Schulkin, 2008).  
Gestation at delivery  Preterm delivery is associated with reduced neonatal birthweight, 
length and measures of adiposity. The metabolic profile at birth in 
preterm neonates significantly differs from offspring born at term 
(Moco et al., 2013).   
Infant   
Mode of early life 
feeding  
Breastfeeding has been demonstrated to be protective against 
childhood obesity in early life in comparison to offspring formula fed 
(Owen et al., 2005).  
Table 4.1: A-priori reasoning for selection of maternal, neonatal and infant confounders for 




Figure 4.1: Direct acyclic graph to demonstrate the inter-relationships between variables 




Figure 4.2: Direct acyclic graph to demonstrate inter-relationships between variables 
potentially confounding the relationship between cord blood metabolic profile and infant 
anthropometry at 6 months of age. 
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4.3  Results  
4.3.1 Demography  
Of the 608 cord samples, available from neonates born to women randomised to the 
UPBEAT trial; 343 mother-offspring pairs were included within this analyses (Figure 4.3). 
Median maternal BMI was 35.6 kg/m2 (IQR 33.0, 38.9), 71.7% were of a white ethnic 
group and 87.8% were in the highest quintiles of socioeconomic deprivation. Median 
neonatal birthweight was 3.5 kg (IQR 3.21, 3.82 kg) and 26.0% of offspring demonstrated 
significant catch up growth between assessment at birth and 6 month follow-up visit as 
defined by the WHO (WHO, 2006). Further maternal, neonatal and infant demographics 
and anthropometric characteristics are provided in Table 4.2. To assess for the potential of 
selection bias, comparisons were made between mother-offspring pairs included and 
excluded from the analysis. The incidence of Black ethnicity, neonatal birthweight and 
subscapular SFT were different between the two groups (Table 4.3). There was no 
difference in the incidence of GDM, total GWG or infant anthropometric measures 
between the two groups (Table 4.3).  
 
Summary statistics of cord blood metabolic profile including candidate biomarkers and 
metabolomic analyses are shown in Table 4.4. Following principal component analysis, 4 
distinct clusters of metabolites were identified which were; “Phosphatidylcholines”, “Non-
esterified fatty acids”, “Long-chain Acylcarnitines and TCA metabolites” and “Amino 
acids”, illustrated in Figure 4.4-Figure 4.7. 
 
4.3.2 Effect of the UPBEAT intervention  
Mother’s included in this analysis were older, more likely to be nulliparous and less likely 
to be of Black ethnic origin compared to those without a cord blood sample (Table 4.5). 
Following correction for multiple testing, there were no significant differences in the cord 
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blood metabolic profile including clusters derived from principal component analysis, 
between intervention and control arms (Figure 4.8).   
 
4.3.3 Relationship between maternal antenatal exposures and cord blood metabolic 
profile 
Diagnosis of maternal GDM was associated with reduced cord blood adiponectin and 
increased isocitric acid and LPC 18.1 concentrations following correction for multiple 
testing by using a FDR (Figure 4.9). Both maternal early pregnancy BMI and total GWG 
were not associated with any components of the cord blood metabolic profile (Figure 4.10 
& Figure 4.11). Maternal fasting glucose collected at the time of the OGTT was positively 
associated with higher cord insulin, C-peptide, LPC 18.1, 18.2 and 20.4, alpha aminoadipic 
acid and citric acid following correction for multiple testing. Maternal fasting glucose was 
also associated with lower cord adiponectin and NEFA 26.0 (Figure 4.12). Associations 
between maternal glucose at 1 and 2 hour post OGTT with the cord blood metabolic profile 
are illustrated in Figure 4.13 and Figure 4.14.  
 
4.3.4 Associations between cord blood metabolic profile and neonatal anthropometry  
There was a positive linear relationship between cord C-peptide, insulin, IGF-1, leptin and 
neonatal birthweight z-scores, SSFT, subscapular SFT, triceps SFT (with the exception of 
insulin, and C-peptide), mid upper arm and abdominal circumference (Table 4.6, Figure 
4.15). Clusters of NEFAs as assessed in the metabolome, and cord blood triglycerides, 
were inversely associated with neonatal birthweight z-scores, SSFT, subscapular SFT, 
triceps SFT and mid upper arm circumference at birth (Table 4.6, Figure 4.15). HDL, 
adiponectin and clusters of phosphatidylcholines were linearly associated with birthweight 
z-score only. LPC 16.1 and 18.0 were positively associated with neonatal birth weight, 
SSFT, subscapular and triceps SFTs following correction for multiple testing (Figure 4.16 
and Figure 4.17). Cord blood cholesterol was not associated with any measure of neonatal 
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anthropometry (Figure 4.15). IL-6 and TNF-α were negatively associated with neonatal 
birthweight z-scores. There were no associations between cord clusters of acylcarnitines, 
amino acids and IGF-II with any measure of neonatal anthropometry (Table 4.6, Figure 
4.15 to Figure 4.17). 
 
4.3.5 Associations between cord blood metabolic profile and infant anthropometry at 6 
months of age 
Of those cord blood, biochemical variables significantly associated with neonatal body 
composition, clusters of phosphatidylcholines and adiponectin were linearly associated 
with infant weight and length z-scores at 6 months of age (Table 4.7). In particular, LPC 
16.1 and 18.1 were linearly associated with infant weight z-scores at 6 months of age 
(Figure 4.16 & Figure 4.17). Cord IGF-I was linearly associated with infant weight, BMI 
and mid upper arm circumference z-scores (Table 4.7; Figure 4.16, Figure 4.17). Cord 
leptin and triglycerides were negatively associated with infant mid-upper arm 
circumference z-scores following adjustment for maternal and infant confounding (Table 
4.7; Figure 4.16, Figure 4.17). There were no associations between cord insulin, glucose, 
C-peptide and IL-6 with infant anthropometry at 6 months of age (Table 4.7; Figure 4.16, 
Figure 4.17).  
 
For every unit increase in clusters of phosphatidylcholines, the odds of catch up growth at 6 
months of age increased by 1.35 (1.04 to 1.75), whereas leptin decreased by 0.33 (0.17 to 
0.52) (Table 4.8). IGF-1 and leptin were positively associated with increased odds of catch 




4.3.6 Sensitivity analyses 
The associations between cord blood metabolic profile and neonatal or infant body 
composition remained unchanged following exclusion of offspring born <34 weeks’ 
gestation (N=36) (Figure 4.18,Figure 4.19), those participants exposed to GDM (N=111) 
(Figure 4.20, Figure 4.21) and following further adjustment for mode of delivery (Figure 
































Figure 4.3: Flow diagram of mother-offspring pairs included within this analysis  
  
1555 women recruited to the 
UPBEAT randomised controlled 
trial 
1522 liveborn neonates 
607 neonates with available cord 
blood sample   
255 excluded as no neonatal detailed 
anthropometry  
352 neonates with detailed 
anthropometric measurements taken 
at birth  
 
915 excluded as no cord blood 
sample available for analyses  
343 (22.5%) neonates included in 
analysis with complete data  
 
8 excluded as missing maternal 
covariate data 
209 (13.7%) infants at 6 months of 





N= Mean (SD)/ Median (IQR)/ 
N (%) 
Maternal  
Age (years) 343 31.0 (27.0, 35.0) 





Black 63 (18.4)  
Asian  19 (5.5) 
Other  15 (4.4) 
Multiparous 343 165 (48.1) 
Smoker in early pregnancy 343 19 (5.5) 
Socioeconomic deprivation  343 295 (87.8) 
Gestational weight gain (kg) 343 7.78 (4.07) 
Gestational diabetes  343 111 (32.4) 
Neonate 




Operative vaginal  44 (12.8) 
Emergency C-section   78 (22.7) 
Elective C-section 83 (24.2) 
Gestation at delivery (weeks) 343 39.9 (38.7, 40.9) 
Birthweight (kg) 343  3.6 (3.2, 3.8) 
Birthweight z scores  343 0.21 (0.76) 
Skinfold thickness-subscapular (mm) 343 5.78 (1.42) 
Skinfold thickness triceps (mm) 343 5.34 (1.45) 
Sum of skinfold thicknesses (mm) 343 11.12 (2.59) 
Midarm circumference (cm)  343 11.58 (0.97) 
Abdominal circumference (cm) 343 32.63 (2.05) 
Infant  
Weight for age z-score  247 0.29 (1.01) 
Length for age z-score 238 0.44 (1.85) 
BMI for age z-score  238 0.10 (1.84) 
Arm circumference z-score  246 1.25 (1.47) 
Triceps skinfold thickness z-score 242 0.29 (1.51) 
Subscapular skinfold thickness z-score 209 0.30 (1.45) 
Catch up growth*  246 64 (26.0) 
Catch down growth**  246 60 (24.4) 
Table 4.2: Maternal, neonatal and infant demographic, anthropometry and clinical 
characteristics of mother-offspring pairs included within this analyses (n=343). 
Abbreviations BMI-Body Mass Index. *Catch up growth defined as a ≥ 0.67 SDs increase in weight-z-scores 
from birth to 6 months of age. **Catch down growth defined as a ≥0.67 SDS decrease in weight-z-scores from 


































Table 4.3: Differences in maternal and neonatal demographic, clinical and anthropometric 
characteristics between mother-neonatal pairs included and excluded within the analysis.  
Abbreviations; BMI- Body Mass Index.  
 










Median (IQR)/ N 
(%) 
Maternal 
Age (years) 31.0 (27.0, 35.0) 30.0 (26.0, 35.0) 0.109 
BMI (Kg/ m2) 35.6 (33.0, 38.9) 34.9 (32.7, 38.5) 0.150 
Ethnicity  
Asian  19 (5.5) 76 (6.3) 0.616 
Black  63 (18.4) 338 (27.9) 0.001 
Other  15 (4.4) 70 (5.8) 0.315 
White  246 (71.7) 727 (60.0) <0.001 
Multiparous 165 (48.1) 715 (59.0) 0.001 
Smoker in early pregnancy  19 (5.5) 89 (7.3) 0.249 
Socioeconomic 
deprivation  
295 (86.5) 1085 (89.9) 0.102 
Gestational weight gain 
(kg) 
7.48 (4.07) 7.51 (4.74) 0.891 




Emergency      
C-section  
78 (22.7) 171 (14.5) 0.159 
Operative 
vaginal  
44 (12.8) 134 (11.4) <0.001 
Elective           
C-section  
83 (24.2) 212 (18.0) 0.010 
Vaginal  138 (40.2) 660 (56.1) <0.001 
Gestation at delivery 
(weeks) 
39.9 (38.7, 40.9) 39.9 (38.7, 40.9) <0.001 







5.78 (1.42) 5.39 (1.43) 0.004 
Skinfold thickness triceps 
(mm) 
5.34 (1.45) 5.24 (1.61) 0.494 
Sum of skinfold 
thicknesses (mm) 
11.12 (2.59) 10.51 (2.70) 0.018 
Midarm circumference 
(cm) 
11.58 (0.97) 11.34 (1.24) 0.009 
Abdominal circumference 
(cm) 
32.63 (2.05) 32.28 (2.08) 0.061 
Infant at 6 months  
Weight for age z-score  0.29 (1.01) 0.24 (1.15) 0.564 
Length for age z-score  0.44 (1.85) 0.59 (1.84) 0.317 
BMI for age z-score  0.10 (1.84) -0.09 (1.80) 0.208 
Arm circumference z-score  1.25 (1.47) 1.04 (1.76) 0.109 
Triceps SFT z-score  0.29 (1.51) 0.09 (1.48 0.098 
Subscapular SFT z-score  0.30 (1.45) 0.17 (1.32) 0.304 
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Cord blood biochemical profile  N Concentrations 
(Median/ IQR) 
Candidate cord blood biomarkers    
C-peptide (ng/ml) 574 1.3 (0.9,1.7)  
Insulin (U/ml) 576  6.4 (3.8,10.1) 
Glucose (mmol/l) 576 3.4 (2.4,4.2)   
Triglycerides (mmol/l) 516 0.3 (0.3,0.5)  
Cholesterol (mmol/l) 546  1.4 (1.1,1.7)  
HDL (mmol/l) 577 41.0 (29.0,62.0)   
IGF I (ng/ml) 577 45.0 (32.0,58.0)  
IGF II (ng/ml) 577  496.0 (441.0,558.0)  
Leptin (ng/ml) 577 14.5 (8.0,24.0)  
Adiponectin (ng/ml) 577 31.5 (23.3,39.5) 
IL-6 (pg/ml) 577  4.0 (2.0,8.9)  
TNF-alpha (pg/ml) 577 139.0 (87.0,197.0) 
Metabolites (µmol/l l) 
lyso.PC.a.C14.0 364 1.4 (1.1,1.8) 
lyso.PC.a.C16.0 607 50.6 (39.8,61.4) 
lyso.PC.a.C16.1 526 4.3 (3.1,5.4) 
lyso.PC.a.C18.0 607 9.0 (6.8,11.1) 
lyso.PC.a.C18.1 526 10.4 (8.1,13.6) 
lyso.PC.a.C18.2 607 11.9 (8.7,15.6) 
lyso.PC.a.C18.3 360 0.3 (0.2,0.4) 
lyso.PC.a.C20.3 526 3.0 (2.2,4.0) 
lyso.PC.a.C20.4 607 13.7 (10.3,18.7) 
lyso.PC.a.C20.5 324 0.3 (0.2,0.4) 
lyso.PC.a.C22.5 400 0.4 (0.3,0.7) 
lyso.PC.a.C22.6 607 2.3 (1.6,3.1) 
lyso.PC.e.C18.0 321 0.6 (0.4,0.8) 
PC.aa.C30.0 522 2.8 (2.1,3.6) 
PC.aa.C30.2 313 0.4 (0.3,0.6) 
PC.aa.C32.0 526 16.3 (13.1,21.0) 
PC.aa.C32.1 525 13.7 (10.4,18.4) 
PC.aa.C32.2 342 0.7 (0.4,1.1) 
PC.aa.C34.1 607 126.7 (99.5,161.3) 
PC.aa.C34.2 607 70.9 (55.8,87.8) 
PC.aa.C34.3 442 3.3 (2.6,4.1) 
PC.aa.C34.4 440 0.5 (0.4,0.6) 
PC.aa.C36.0 520 1.8 (1.2,2.5) 
PC.aa.C36.1 525 22.0 (17.9,27.5) 
PC.aa.C36.2 445 42.4 (33.8,52.1) 
PC.aa.C36.3 607 57.1 (46.7,71.1) 
PC.aa.C36.4 607 123.6 (98.3,152.8) 
PC.aa.C36.5 445 3.9 (3.0,5.0) 
PC.aa.C38.0 523 1.2 (1.0,1.7) 
PC.aa.C38.3 525 35.3 (28.1,42.9) 
PC.aa.C38.4 526 96.7 (76.6,119.9) 
PC.aa.C38.5 445 20.9 (16.5,26.3) 
PC.aa.C38.6 526 58.6 (44.7,75.9) 
PC.aa.C40.4 441 3.2 (2.5,4.0) 
PC.aa.C40.5 524 6.4 (4.4,8.4) 
PC.aa.C40.6 526 27.0 (20.0,36.9) 
PC.aa.C42.0 520 0.5 (0.3,0.7) 
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PC.aa.C43.6 318 0.8 (0.6,1.1) 
PC.aa.C44.12 441 0.5 (0.4,0.6) 
PC.ae.C32.0 525 2.5 (2.0,3.2) 
PC.ae.C32.1 525 2.9 (2.3,3.7) 
PC.ae.C32.2 443 0.8 (0.5,1.1) 
PC.ae.C34.0 403 1.3 (1.0,1.7) 
PC.ae.C34.1 483 4.5 (3.7,5.8) 
PC.ae.C34.2 523 2.8 (2.1,3.5) 
PC.ae.C34.3 524 1.0 (0.7,1.2) 
PC.ae.C36.1 523 2.7 (2.2,3.3) 
PC.ae.C36.2 521 2.4 (1.9,2.9) 
PC.ae.C36.3 445 1.6 (1.2,2.1) 
PC.ae.C36.4 606 7.0 (5.4,8.6) 
PC.ae.C36.5 526 5.5 (4.2,7.0) 
PC.ae.C38.0 482 1.1 (0.8,1.4) 
PC.ae.C38.3 442 2.4 (1.8,3.0) 
PC.ae.C38.4 526 7.4 (5.8,9.0) 
PC.ae.C38.5 445 6.0 (4.8,7.5) 
PC.ae.C38.6 443 2.8 (2.1,3.5) 
PC.ae.C40.0 484 6.4 (4.9,7.9) 
PC.ae.C40.1 403 1.0 (0.5,1.4) 
PC.ae.C40.4 521 1.7 (1.3,2.2) 
PC.ae.C40.5 604 1.7 (1.3,2.3) 
PC.ae.C40.6 524 2.2 (1.7,2.8) 
PC.ae.C42.2 322 0.3 (0.2,0.4) 
PC.ae.C42.5 402 1.0 (0.8,1.4) 
PC.ae.C42.6 440 0.6 (0.4,0.9) 
SM.a.C32.1 525 2.7 (2.1,3.5) 
SM.a.C33.1 439 1.8 (1.4,2.3) 
SM.a.C34.0 443 3.4 (2.7,4.2) 
SM.a.C34.1 607 60.8 (47.2,80.5) 
SM.a.C34.2 525 9.7 (7.6,12.3) 
SM.a.C35.1 364 1.5 (1.2,2.0) 
SM.a.C36.1 526 18.3 (14.3,22.4) 
SM.a.C36.2 606 12.1 (8.9,15.4) 
SM.a.C38.1 324 15.6 (11.9,31.6) 
SM.a.C38.2 523 14.2 (11.7,17.6) 
SM.a.C39.1 477 1.3 (1.0,1.7) 
SM.a.C40.2 483 18.5 (14.0,26.5) 
SM.a.C40.4 520 2.0 (1.4,2.9) 
SM.a.C41.1 364 3.9 (3.1,4.8) 
SM.a.C41.2 445 2.7 (2.1,3.4) 
SM.a.C42.1 425 23.9 (19.3,28.7) 
SM.a.C42.2 605 31.7 (25.8,38.7) 
SM.a.C42.3 605 19.1 (15.5,24.4) 
SM.a.C42.6 359 3.6 (2.6,4.7) 
SM.a.C43.1 520 1.1 (0.8,1.4) 
SM.a.C44.1 305 0.6 (0.1,1.8) 
SM.a.C41.0 401 0.7 (0.4,1.7) 
SM.a.C47.5 481 0.0 (0.0,0.0) 
SM.a.C47.6 314 0.0 (0.0,0.0) 
NEFA 10.0 526 0.9 (0.5,1.3) 
NEFA 12.0 605 1.9 (1.2,2.8) 
NEFA 14.1 524 1.1 (0.5,1.7) 
Table 4.4 continued 
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NEFA 15.1 371 0.0 (0.0,0.0) 
NEFA 16.0 607 61.8 (42.9,85.4) 
NEFA 16.1 607 4.2 (2.7,6.9) 
NEFA 17.0 607 2.0 (1.5,2.5) 
NEFA 17.1 526 0.5 (0.4,0.8) 
NEFA 18.1 607 51.3 (35.2,73.4) 
NEFA 18.2 524 16.4 (10.8,25.8) 
NEFA 18.3 583 1.1 (0.7,1.9) 
NEFA 20.0 481 0.4 (0.3,0.5) 
NEFA 20.1 604 0.6 (0.4,0.9) 
NEFA 20.2 526 0.7 (0.5,0.9) 
NEFA 20.3 607 1.5 (1.1,2.2) 
NEFA 20.4 606 2.3 (1.6,3.6) 
NEFA 22.0 526 0.2 (0.1,0.2) 
NEFA 22.1 597 0.1 (0.1,0.2) 
NEFA 22.2 596 0.1 (0.1,0.1) 
NEFA 22.6 521 3.2 (2.2,4.6) 
NEFA 24.1 598 0.4 (0.3,0.6) 
NEFA 19.0 441 0.4 (0.3,0.5) 
NEFA 19.1 523 0.3 (0.2,0.4) 
NEFA 20.5 451 0.1 (0.0,0.2) 
NEFA 22.3 402 0.3 (0.2,0.4) 
NEFA 22.4 599 0.7 (0.5,1.0) 
NEFA 22.5 599 0.6 (0.4,0.9) 
NEFA 24.0 517 0.2 (0.1,0.2) 
NEFA 24.2 323 0.1 (0.1,0.2) 
NEFA 24.4 601 0.2 (0.2,0.3) 
NEFA 24.5 524 0.2 (0.1,0.2) 
NEFA 24.6 402 0.0 (0.0,0.1) 
NEFA 26.0 356 0.0 (0.0,0.1) 
NEFA 26.1 479 0.1 (0.1,0.1) 
NEFA 26.2 517 0.1 (0.1,0.1) 
NEFA 26.3 440 0.1 (0.1,0.1) 
NEFA 26.4 519 0.2 (0.1,0.2) 
NEFA  26.6 359 0.1 (0.1,0.1) 
Carn 525 17.3 (14.3,21.6) 
Carn.a.C10.0 525 0.1 (0.1,0.1) 
Carn.a.C10.1 525 0.1 (0.1,0.2) 
Carn.a.C12.0 524 0.1 (0.0,0.1) 
Carn.a.C12.1 442 0.1 (0.1,0.2) 
Carn.a.C14.0 606 0.1 (0.0,0.1) 
Carn.a.C14.1 525 0.1 (0.1,0.1) 
Carn.a.C15.0 401 0.0 (0.0,0.0) 
Carn.a.C16.0 602 0.1 (0.1,0.2) 
Carn.a.C16.1 605 0.1 (0.1,0.1) 
Carn.a.C18.0 442 0.0 (0.0,0.0) 
Carn.a.C18.1 604 0.1 (0.1,0.2) 
Carn.a.C18.2 357 0.1 (0.1,0.3) 
Carn.a.C2.0 525 5.1 (3.9,7.0) 
Carn.a.C20.0 397 0.0 (0.0,0.0) 
Carn.a.C20.4 304 0.0 (0.0,0.0) 
Carn.a.C3.0 605 0.4 (0.3,0.6) 
Carn.a.C3.0.DC 444 0.3 (0.2,0.9) 
Carn.a.C4.0 605 0.2 (0.1,0.2) 
Table 4.4 continued 
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Carn.a.C4.0.DC 442 0.0 (0.0,0.0) 
Carn.a.C5.0 606 0.1 (0.1,0.2) 
Carn.a.C6.0 606 0.1 (0.1,0.1) 
Carn.a.C8.0 444 0.1 (0.1,0.1) 
Carn.a.C8.1 526 0.1 (0.1,0.1) 
Carn.a.C9.0 441 0.0 (0.0,0.0) 
Pyruvic.acid 605 15.5 (11.2,22.5) 
Lactic.acid 605 27.7 (20.1,41.2) 
Fumaric.acid 605 47.3 (36.2,64.4) 
X3.Methyl.2.oxobutanoic.acid 606 240.5 (115.0,466.0) 
Succinic.acid 606 5600.0 
(3210.0,10200.0) 
Methyl.Malonic.acid 605 1.6 (1.2,2.3) 
Taurine 605 6.5 (4.9,9.5) 
X3.Methyl.2.oxovalveric.acid 603 0.3 (0.3,0.4) 
X4.Methyl.2.oxovalveric.acid 605 121.0 (86.8,173.0) 
Malic.acid 604 7.1 (5.4,10.7) 
Alpha Ketoglutaric acid 605 4.3 (3.0,6.2) 
Alpha Aminoadipic acid 604 0.7 (0.5,0.9) 
Isocitric acid 604 21.2 (17.4,25.5) 
Citric acid 604 114.0 (96.5,133.0) 
Beta Hydroxybutyric acid 524 138.0 (63.5,240.0) 
Alanine 605 454.0 (367.0,555.0) 
Arginine 606 36.0 (21.5,52.1) 
Asparagine 605 41.5 (33.2,52.6) 
Aspartic acid 605 13.8 (9.0,22.1) 
Citrulline 606 13.8 (10.7,17.3) 
Glutamine 605 400.0 (322.0,497.0) 
Glutamic acid 601 106.0 (78.1,149.0) 
Glycine 604 276.5 (231.0,327.0) 
Histidine 603 154.0 (125.0,188.0) 
Isoleucine 602 61.3 (50.0,77.1) 
Leucine 606 107.5 (92.3,128.0) 
Lysine 606 230.0 (193.0,288.0) 
Methionine 606 28.3 (23.4,35.4) 
Ornithine 511 108.0 (85.0,132.0) 
Phenylalanine 606 82.8 (70.3,96.7) 
Proline 485 186.0 (156.0,243.0) 
Tryptophan 605 49.2 (40.3,59.9) 
Serine 484 98.0 (79.5,123.0) 
Threonine 562 202.5 (162.0,253.0) 
Tyrosine 606 58.8 (49.3,73.2) 
Valine 606 204.0 (176.0,250.0) 
Cysteine 483 14.0 (11.4,17.2) 
 
Table 4.4: Summary statistics of the cord blood metabolic profile including candidate 
biomarkers and metabolome from obese pregnant women included in the UPBEAT trial 
(n=607) 
Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin 
growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; LPCE- lysophosphatidylethanolamine; 
PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- 
sphingomyelins; TNFalpha- Tumor necrosis factor; X30B- x3methyl2oxobutanoicacid; X30V- 




Figure 4.4: Graphical representation of phosphatidylcholine cluster derived from principal component analysis of the cord blood metabolomic profile from obese 










































































































































































































































































































































































































































































































































Figure 4.5: Graphical representation of non-esterified fatty acid cluster derived from principal component analysis of the cord blood metabolomic profile from 







































































































































































































































































































































































































































































































































































































































































































Figure 4.6: Graphical representation of long chain acylcarnitines and tricarboxylic acid cycle cluster derived from principal component analysis of the cord blood 




































































































































































































































































































































































































































































































































































































































































































Figure 4.7: Graphical representation of amino acids metabolite cluster derived from principal component analysis of the cord blood metabolomic profile from obese 








































































































































































































































































































































































































































































































































































































































































































Table 4.5: Baseline differences in maternal demographic characteristics at trial entry of those 
included versus those excluded in the analyses to assess the effect of the UPBEAT intervention 











Maternal age   30.97 (5.39) 30.17 (5.58) 0.81 (0.25 to 1.36) 0.005 
Multiparity  318 (52.4%) 562 (59.3%) 0.75 (0.61 to 0.93) 0.007 
BMI (kg/m2)  36.52 (4.93)  36.15 (4.66) 0.37 (-0.12 to 0.86) 0.138 
Socioeconomic 
deprivation  
341 (80.0%) N=822; 666 
(80.6%) 
0.96 (0.72 to 1.29) 0.806 
White ethnicity 433 (71.6) 524 (57.3) 1.25 (1.16 to 1.35) <0.001 
Black ethnicity  116 (19.1%) 272 (29.8%) 0.56 (0.43 to 0.71) <0.001 
Asian ethnicity 29 (4.8%) 62/ (6.8%) 0.69 (0.44 to 1.08) 0.107 
Another 
ethnicity  
28 (4.6%) 56 (6.1%) 0.74 (0.46 to 1.18) 0.205 
Smoker in early 
pregnancy 




Figure 4.8: Effect of the UPBEAT intervention on the cord blood metabolic profile in obese pregnant women illustrated as a volcano plot (n=607).  
Parameter effect estimates of the UPBEAT intervention and significance level following adjustment for false discovery rate using Benjamin & Hochberg procedure. Statistical significance 
p≤0.00026. Adjustment was made for maternal age, pre-pregnancy BMI, parity and ethnicity; minimisation variables used in the randomisation procedure. Abbreviations; CARN-Carnitines; 
HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; LPCE- lysophosphatidylethanolamine; PC-
phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis factor; X30B- x3methyl2oxobutanoicacid; 
X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX: Y, where X is the length of the carbon chain, Y is the number of double bonds, OH in the formula means the 
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Figure 4.9: Volcano plot demonstrating the association of maternal gestational diabetes with cord blood metabolic profile in obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance 
p≤0.00074. Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX: Y, where X is the length of the carbon chain, Y is the number of 
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Figure 4.10: Volcano plot demonstrating the association of maternal pre-pregnancy BMI with cord blood metabolic profile in obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance 
p≤0.00025. Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of 
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Figure 4.11: Volcano plot demonstrating the association of maternal gestational weight gain with cord blood metabolic profile in obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery Statistical significance 
p≤0.00025. Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of 
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Figure 4.12: Volcano plot demonstrating the association of maternal fasting glucose at the time of the oral glucose tolerance test with cord blood metabolic profile in 
obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance 
p≤0.0027. Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of 
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Figure 4.13: Volcano plot demonstrating the association of maternal glucose at 1 hour at the time of the oral glucose tolerance test with cord blood metabolic profile 
in obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance 
p≤0.005. Abbreviations; CARN-Carnitines;  HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of 
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Figure 4.14: Volcano plot demonstrating the association of maternal glucose at 2 hours at the time of the oral glucose tolerance test with cord blood metabolic 
profile in obese pregnant women (n=343).  
Parameter estimates are graphically represented for each biochemical variable in relation to maternal clinical characteristics following correction for a false discovery rate (Benjamin & 
Hochberg procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance 
p≤0.0025. Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; 
LPCE- lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis 
factor; X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of 
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 Birthweight z-scores 
(SDS)  
SSFT (mm) Subscapular SFT 
(mm) 
Triceps SFT (mm) MUAC (cm) Abdominal 
circumference (cm) 
Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) 
PCA-
Phosphatidylcholines 
0.04 (0.02 to 0.07) ** -0.11 (-0.25 to 0.03) -0.06 (-0.12 to 0.01) -0.05 (-0.15 to 0.04) 0.03 (-0.02 to 0.07) 0.01 (-0.10 to 0.11) 
PCA- NEFA -0.04 (-0.08 to 0.00) * -0.28 (-0.49 to -0.08) * -0.11 (-0.21 to 0.00) * -0.18 (-0.32 to -0.03) 
* 
0.02 (-0.05 to 0.10) -0.01 (-0.17 to 0.15) 
PCA- Long chain 
acylcarnitine’s and TCA 
metabolites 
0.00 (-0.04 to 0.04) -0.05 (-0.27 to 0.17) -0.02 (-0.13 to 0.09) -0.03 (-0.18 to 0.12) -0.01 (-0.08 to 0.07) 0.01 (-0.15 to 0.17) 
PCA-Amino acids  0.05 (0.00 to 0.11) -0.05 (-0.36 to 0.25) 0.06 (-0.09 to 0.20) -0.11 (-0.32 to 0.10) 0.06 (-0.04 to 0.16) 0.19 (-0.03 to 0.40) 
Peptide (log2) ng/ml 0.27 (0.14 to 0.39) ** 0.86 (0.22 to 1.50) * 0.52 (0.17 to 0.87) * 0.34 (-0.02 to 0.69) 0.25 (0.00 to 0.49) * 0.73 (0.22 to 1.25) * 
Insulin (log2) U/ml 0.16 (0.09 to 0.23) ** 0.47 (0.12 to 0.82) * 0.31 (0.11 to 0.50) * 0.17 (-0.03 to 0.37) 0.16 (0.02 to 0.29) * 0.38 (0.10 to 0.67) * 
Glucose (log2) mmol/l -1.80 (-3.59 to 0.00) * -2.94 (-12.96 to 7.08) -3.68 (-9.32 to 1.96) 0.48 (-4.94 to 5.90) -2.13 (-6.01 to 1.75) -6.19 (-14.48 to 2.09) 
Triglycerides mmol/l -0.47 (-0.74 to -0.20) ** -1.65 (-3.18 to -0.11) * -0.95 (-1.82 to -0.08)* -0.73 (-1.56 to 0.10) -0.90 (-1.48 to -0.33) * -1.05 (-2.32 to 0.22) 
Cholesterol mmol/l 0.13 (-0.06 to 0.32) -0.75 (-1.68 to 0.17) -0.45 (-0.97 to 0.07) -0.31 (-0.81 to 0.19) -0.11 (-0.48 to 0.25) 0.40 (-0.38 to 1.17) 
HDL mmol/l 0.22 (0.06 to 0.38) * -0.11 (-0.89 to 0.67) -0.25 (-0.68 to 0.17) 0.16 (-0.28 to 0.60) 0.02 (-0.27 to 0.32) 0.38 (-0.25 to 1.01) 
IGFI (log2) ng/ml 1.13 (0.97 to 1.29) ** 1.80 (0.89 to 2.72) ** 1.08 (0.58 to 1.59) ** 0.72 (0.20 to 1.24) * 1.19 (0.87 to 1.51) ** 2.41 (1.70 to 3.12) ** 
IGFII (log2) ng/ml 0.31 (-0.02 to 0.65) 1.57 (-0.15 to 3.29) 0.68 (-0.27 to 1.63) 0.89 (-0.08 to 1.85) 0.29 (-0.37 to 0.96) 0.54 (-0.86 to 1.93) 
Leptin (log2) ng/ml 0.38 (0.30 to 0.46) ** 1.59 (1.21 to 1.97) ** 0.83 (0.62 to 1.04) ** 0.76 (0.54 to 0.98)** 0.50 (0.35 to 0.66) ** 0.80 (0.47 to 1.13) ** 
Adiponectin (log2) up/ml 0.40 (0.12 to 0.68) 0.64 (-0.79 to 2.08) 0.48 (-0.31 to 1.27) 0.07 (-0.73 to 0.87) 0.84 (0.31 to 1.37) * 1.16 (0.00 to 2.31)* 
IL6 (log2) pg/ml -0.04 (-0.07 to 0.00)* 0.06 (-0.11 to 0.23) -0.02 (-0.11 to 0.08) 0.08 (-0.02 to 0.17) -0.04 (-0.11 to 0.03) -0.14 (-0.28 to 0.00)* 
TNF alpha (log2) pg/ml -0.58 (-1.12 to -0.03)* -1.44 (-4.21 to 1.32) -0.72 (-2.25 to 0.80) -0.86 (-2.41 to 0.69) -0.84 (-1.87 to 0.19) -0.61 (-2.82 to 1.60) 
Table 4.6: Associations of the cord blood metabolic profile with neonatal anthropometry in obese pregnant women (n=343) 
Regression coefficients with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, smoker in early pregnancy, gestational diabetes, gestational weight 
gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention. Abbreviations; AA-Amino acids; AcylCar-Acylcarnitines; HDL- High density lipoprotein; IGFI- Insulin 
growth factor I; IGFII- Insulin growth factor II; IL6-Interleukin 6; MUAC-Mid upper arm circumference; NEFA- Non-esterified fatty acids; PC-phosphatidylcholines; PCA-Principal 




















Figure 4.15: Associations of the cord blood metabolic profile with neonatal anthropometry in obese pregnant women (n=343) 
Regression coefficients graphically presented with corresponding 95% confidence intervals. Model 1: Adjustment made for offspring sex, gestation at delivery and randomisation to the 
UPBEAT intervention. Model 2: Adjustment made for maternal parity, ethnicity, and smoker in early pregnancy, gestational diabetes, gestational weight gain, offspring sex, gestation at 
delivery, randomisation to UPBEAT Intervention. Abbreviations; AA-Amino acids cluster; AcylCar-Acylcarnitines cluster; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IGFII- 
Insulin growth factor II; IL6-Interleukin 6; MUAC-Mid upper arm circumference; NEFA- Non-esterified fatty acids cluster; PC-phosphatidylcholines cluster; SDS- Standard deviation scores; 
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Figure 4.16: Heat map demonstrating associations between cord blood metabolites with anthropometric measurements in neonates (n=343) and infants (n=209); 
data from obese pregnant women in the UPBEAT study. 
Regression coefficients plots with adjustment made for maternal parity, ethnicity, smoker in early pregnancy, gestational diabetes, gestational weight gain, offspring sex, gestation at delivery, 
randomisation to UPBEAT Intervention. Additional adjustment is made for early mode of infant feeding for infant anthropometry data at 6 months of age. Abbreviations; AC- Abdominal 
circumference; BMI-Body mass index; BW- Neonatal birthweight z-scores (SDs); CARN-Carnitines; LPC- lysophosphatidylcholines; LPCE- lysophosphatidylethanolamine; MUAC- Mid upper 
arm circumference (cm); PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines SM- sphingomyelins; SSF- Sum of skinfold thicknesses (mm); Tri 
SFT- Triceps skinfold thickness (mm); Sub SFT- Subscapular skinfold thickness (mm); X30B- 3methyl2oxobutanoicacid; X30V- 3methyl2oxovalvericacid; X40B- x4methyl2oxovalvericacid. 
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Figure 4.17: Heat map demonstrating associations between cord blood metabolites with anthropometric measurements in neonates (n=343) and infants (n=209); 
data from obese pregnant women in the UPBEAT study.  
Regression coefficients plots with adjustment made for maternal parity, ethnicity, smoker in early pregnancy, gestational diabetes, gestational weight gain, offspring sex, gestation at 
delivery, randomisation to UPBEAT Intervention. Additional adjustment is made for early mode of infant feeding for infant anthropometry data at 6 months of age. Abbreviations; AC-
abdominal circumference BW- Neonatal birthweight z-scores (SDs); CARN-Carnitines; LPC- lysophosphatidylcholines; LPCE- lysophosphatidylethanolamine; MUAC- Mid upper arm 
circumference (cm); PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines SM- sphingomyelins; SSF- Sum of skinfold thicknesses (mm); TCA- 
tricarboxylic acid; Tri SFT- Triceps skinfold thickness (mm); Sub SFT- Subscapular skinfold thickness (mm); X30B- 3methyl2oxobutanoicacid; X30V- 3methyl2oxovalvericacid; X40B- 
x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of double bonds, OH in the formula means the 
molecule contains a hydroxyl-group.  













Table 4.7: Associations between candidate biomarkers and metabolite clusters from cord blood samples with infant anthropometry at 6 months; data from the 
UPBEAT study (n=209).   
Regression coefficients with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, smoker in early pregnancy, gestational diabetes, gestational weight 
gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention and mode of early life feeding. Abbreviations; HDL- High density lipoprotein; IGFI- Insulin growth factor I; 
IL6-Interleukin 6; MUAC-Mid upper arm circumference; NEFA-non-esterified fatty acids; PCA-principal component analysis; SDS- Standard deviation scores; SFT- skinfold thickness; 













Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) Coef (95% CI) 
PCA-Phosphatidylcholines 0.05 (0.00 to 0.10)* 0.07 (0.01 to 0.13)* 0.01 (-0.04 to 0.07) 0.04 (0.00 to 0.08) 0.05 (-0.02 to 0.13) -0.03 (-0.11 to 0.05) 
PCA-NEFA -0.03 (-0.09 to 0.04) -0.02 (-0.10 to 0.06) -0.02 (-0.09 to 0.05) -0.05 (-0.10 to 0.01) -0.04 (-0.15 to 0.08) 0.01 (-0.11 to 0.14) 
Cpeptide (log2) ng/ml 0.00 (-0.023 to 0.23) -0.18 (-0.59 to 0.24) 0.14 (-0.30 to 0.58) 0.08 (-0.32 to 0.49) 0.32 (-0.03 to 0.67) 0.21 (-0.13 to 0.56) 
Insulin (log2) U/ml 0.07 (-0.05 to 0.20) -0.10 (-0.33 to 0.13) 0.19 (-0.06 to 0.43) 0.06 (-0.16 to 0.28) -0.01 (-0.20 to 0.19) 0.02 (-0.18 to 0.22) 
Glucose (log2) mmol/l -0.80 (-4.29 to 2.69) 0.28 (-6.16 to 6.71) -1.64 (-8.38 to 5.10) 1.19 (-4.95 to 7.32) 1.35 (-4.13 to 6.82) -0.49 (-6.13 to 5.15) 
Triglycerides mmol/l -0.30 (-0.83 to 0.24) 0.37 (-0.64 to 1.38) -0.89 (-1.95 to 0.18) -1.05 (-2.01 to -0.08)* -0.39 (-1.22 to 0.44) -0.34 (-1.20 to 0.53) 
HDL mmol/l 0.18 (-0.10 to 0.47) 0.20 (-0.32 to 0.72) 0.07 (-0.48 to 0.61) 0.35 (-0.15 to 0.85) 0.26 (-0.18 to 0.69) 0.20 (-0.23 to 0.63) 
IGFI (log2) ng/ml 0.45 (0.11 to 0.79)* -0.12 (-0.75 to 0.51) 0.87 (0.22 to 1.53) 0.64 (0.04 to 1.24)* -0.04 (-0.59 to 0.50) 0.07 (-0.46 to 0.61) 
Leptin (log2) ng/ml -0.05 (-0.21 to 0.10) 0.09 (-0.19 to 0.37) -0.21 (-0.50 to 0.08) -0.27 (-0.53 to 0.00)* 0.00 (-0.23 to 0.24) 0.12 (-0.11 to 0.35) 
Adiponectin (log2) ug/ml 0.82 (0.30 to 1.33)** 0.98 (0.05 to 1.92)* 0.18 (-0.81 to 1.17) 0.34 (-0.56 to 1.24) 0.72 (-0.07 to 1.52) 1.00 (0.20 to 1.80)* 
IL6 (log2) pg/ml -0.03 (-0.09 to 0.04) 0.06 (-0.05 to 0.18) -0.09 (-0.21 to 0.03) -0.09 (-0.19 to 0.02) -0.05 (-0.14 to 0.04) -0.09 (-0.18 to 0.00) 




 Catch up growth (n=246)^ Catch down growth (n=246)^^ 
Odds ratio (95% CI) Odds ratio (95% CI) 
PCA-Phosphatidylcholines 1.35 (1.04 to 1.75)* 1.03 (0.86 to 1.22) 
PCA-NEFAs 1.34 (0.93 to 1.93) 1.07 (0.82 to 1.39) 
C-peptide (log2) ng/ml 0.50 (0.24 to 1.05) 1.22 (0.58 to 2.58) 
Insulin (log2) U/ml 0.72 (0.48 to 1.06) 1.10 (0.74 to 1.65) 
Glucose (log2) mmol/l 0.04 (0.00 to 55.03) 0.00 (0.00 to 14.21) 
Triglycerides mmol/l 1.48 (0.29 to 7.62) 0.54 (0.10 to 3.06) 
HDL mmol/l 2.21 (0.93 to 5.26) 1.59 (0.67 to 3.76) 
IGFI (log2) ng/ml 0.40 (0.14 to 1.16) 5.00 (1.62 to 15.21)* 
Leptin (log2) ng/ml 0.30 (0.17 to 0.52)** 2.26 (1.37 to 3.75)** 
Adiponectin (log2) ug/ml 0.20 (0.04 to 1.06) 1.32 (0.27 to 6.89) 
IL6 (log2) pg/ml 0.94 (0.78 to 1.13) 0.95 (0.79 to 1.14) 
TNF alpha (log2) pg/ml 1.44 (0.06 to 35.12) 0.20 (0.01 to 5.10) 
 
Table 4.8: Associations between candidate biomarkers and metabolite clusters from cord blood samples and early infant growth velocities; data from the UPBEAT 
study (n=246).   
Odds ratio with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, and smoker in early pregnancy, gestational diabetes, gestational weight gain, 
offspring sex, gestation at delivery, randomisation to UPBEAT Intervention and mode of early life feeding. Abbreviations; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IL6-
Interleukin 6; MUAC-Mid upper arm circumference; NEFA-non-esterified fatty acids; PCA- Principal component analysis; SDS- Standard deviation scores; SFT- skinfold thickness; TNFalpha- 
Tumour Necrosis Factor alpha.  *p<0.05; ** p<0.001. ^ Catch up growth defined as an increase ≥0.67SDs in weight-z-scores from birth to 6 months of age using the WHO reference 
population (WHO and de Onis, 2006). ^^ Catch down growth defined as a decrease ≤0.67SDs in weight-z-scores from birth to 6 months of age using the WHO reference population (WHO and 

















Figure 4.18: Sensitivity analyses following exclusion of offspring born <34 weeks’ gestation demonstrating no differences in the associations between cord blood 
metabolic profile and neonatal anthropometry (excluded n=36).  
Regression coefficients graphically presented with corresponding 95% confidence intervals. Adjustment made for maternal parity, ethnicity, and smoker in early pregnancy, gestational 
diabetes, gestational weight gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention. Abbreviations; AA-amino acids cluster; Acylcar- Long chain acylcarnitines and 
TCA metabolites cluster; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IGFII- Insulin growth factor II; IL6-Interleukin 6; NEFA-Non-esterified fatty acid cluster; PC-
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Figure 4.19: Sensitivity analyses following exclusion of offspring born <34 weeks’ gestation demonstrating no differences in the associations between cord blood 
metabolic profile and infant anthropometry at 6 months of age (excluded n=36).  
Regression coefficients with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, smoker in early pregnancy, gestational diabetes, gestational weight 
gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention and mode of early life feeding. Abbreviations; HDL- High density lipoprotein; IGFI- Insulin growth factor I; 




































































































Figure 4.20: Sensitivity analyses of associations between cord blood metabolic profile and neonatal anthropometry, following exclusion of neonates exposed to 
gestational diabetes in-utero excluded n=111).   
Regression coefficients graphically presented with corresponding 95% confidence intervals. Adjustment made for maternal parity, ethnicity, and smoker in early pregnancy, gestational 
diabetes, gestational weight gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention. Abbreviations; AA-amino acids cluster; Acylcar- Long chain acylcarnitines and 
TCA metabolite clusters; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IGFII- Insulin growth factor II; IL6-Interleukin 6; NEFA-Non-esterified fatty acid cluster; PC-
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Figure 4.21: Sensitivity analyses of associations between cord blood metabolic profile and infant anthropometry, following exclusion of infants at 6 months exposed 
to gestational diabetes in-utero (excluded n=111).   
Regression coefficients with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, smoker in early pregnancy, gestational weight gain, offspring sex, 
gestation at delivery, randomisation to UPBEAT Intervention and mode of early life feeding. Abbreviations; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IL6-Interleukin 6; 





















































































































Figure 4.22: Sensitivity analyses of associations between cord blood metabolic profile and neonatal anthropometry, following further adjustment for mode of 
delivery. 
Regression coefficients graphically presented with corresponding 95% confidence intervals. Adjustment made for maternal parity, ethnicity, and smoker in early pregnancy, gestational 
diabetes, gestational weight gain, offspring sex, gestation at delivery, randomisation to UPBEAT Intervention and mode of delivery. Abbreviations; AA-amino acids cluster; Acylcar- Long chain 
acylcarnitines and TCA metabolites cluster; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IGFII- Insulin growth factor II; IL6-Interleukin 6; MUAC-Mid upper arm 
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Figure 4.23: Sensitivity analyses of associations between cord blood metabolic profile and infant anthropometry, following adjustment for mode of delivery.  
Regression coefficients with corresponding 95% confidence intervals presented are adjusted for maternal parity, ethnicity, smoker in early pregnancy, gestational weight gain, offspring sex, 
gestation at delivery, randomisation to UPBEAT Intervention, mode of early life feeding and mode of delivery. Abbreviations; HDL- High density lipoprotein; IGFI- Insulin growth factor I; IL6-


























































































4.4.1 Summary of overall findings 
 There was no effect of the UPBEAT lifestyle intervention on the cord blood 
metabolic profile. 
 A novel relationship between cord lysophosphatidylcholines with neonatal and 
infant anthropometry was identified which was positively associated with maternal 
fasting glucose measured in the late second trimester.  
 A positive association was observed between cord blood IGF-1 with neonatal 
measures of growth and body composition, infant weight and mid upper arm 
circumference z-scores at 6 months. 
 An inverse association was identified between cord inflammatory cytokines and 
measures of infant anthropometry at 6 months.  
 There was no relationship between cord triglycerides or NEFAs with measures of 
neonatal or infant anthropometry at 6 months of age.  
 
This study reports a comprehensive cord blood metabolic profile, including candidate 
biochemical markers and metabolome, in offspring born to obese mothers. By 
demonstrating associations with fasting glucose, it has been shown that in-utero exposure 
to maternal dysglycaemia within obese pregnancies, has the potential to modify the cord 
blood metabolic profile at birth. Although there was no effect of the UPBEAT antenatal 
lifestyle intervention on the cord blood metabolic profile, when treating the data as a 
cohort, associations were observed between the cord blood metabolic profile and offspring 
growth in early life. The novel associations between cord lysophosphatidylcholines, 
neonatal adiposity together with the relation with maternal hyperglycaemia may provide 





4.4.2 Cord blood lysophosphatidylcholines 
Clusters of phosphatidylcholines and lysophosphatidylcholines were found to be positively 
associated with early growth velocities and weight z-scores, providing possible mechanistic 
insight of the mechanisms contributing to early postnatal growth in offspring born to obese 
women. The finding that clusters of cord lysophosphatidylcholines, primarily LPC 16.1 and 
LPC 18.1 were not only associated with neonatal weight-z-scores, but also infant growth 
and catch up growth within the first 6 months of age provides novel evidence, suggesting a 
role in the early life growth velocities. Of relevance, associations with cord 
lysophosphatidylcholines and birthweight were recently reported in a birth cohort from 
Germany (Taveras et al., 2004). In this study lysophosphatidylcholines were associated 
with neonatal adiposity as well as birthweight; suggesting a role in body fat accretion. The 
observations that lysophosphatidylcholines were associated with infant weight at 6 months 
could suggest a persistent effect on growth which may have implications for later life 
obesity. It may be of relevance to these observations that the infant growth trajectory in the 
first 6 months has been shown to be predictive of adolescence and early adulthood obesity 
(Ong and Loos, 2006; Taveras et al., 2009; Breij et al., 2014) and that The European 
Childhood Obesity Programme has shown that lysophosphatidylcholines 14.0 correlate 
with rapid growth in infancy and subsequent obesity at 6 years of age (Rzehak et al., 2014). 
Together these findings would suggest a possible role for lysophosphatidylcholines in the 
early life ‘programming’ of obesity risk (Catalano and Ehrenberg, 2006; Leddy et al., 
2008).  
 
Lysophosphatidylcholines are derived from phosphatidylcholines following removal of 
fatty acids, facilitated predominately by lecithin cholesterol acyltransferase (Jonas, 2000), 
but also by endothelial lipase or phospholipases. Lysophosphatidylcholines are bound to 
albumin in human plasma (Belgacem et al., 2007). Further interrogation of the dataset 




IGF-1 with cord lysophosphatidylcholines (Appendix Figure 1-2) supporting the suggestion 
of an interaction between fetal glucose homeostasis and these molecules (Haggarty, 2010). 
This observation is in part supported by one small case-control study (n=46), that identified 
an inverse relationship between maternal gestational diabetes and placental uptake of 
lysophosphatidylcholines 22:6, in women of heterogeneous BMI (Prieto-Sanchez et al., 
2016). A role in fetal metabolism for lysophosphatidylcholines has also been suggested in 
the non-pregnant state with the development of visceral fat obesity, unrelated to genetic 
origin but associated with nutritional status (Agras et al., 1987; Pietiläinen et al., 2007; Lee 
et al., 2015).  
 
A study from the USA, Project Viva cohort, demonstrated that associations between cord 
blood metabolites from a  metabolome, particularly those related to one-carbon metabolism 
may contribute to rapid postnatal weight gain in offspring born to women of heterogeneous 
BMI (Isganaitis et al., 2015). Taken together, studies of the cord blood metabolic profile 
suggest that obesity risk may be determined at birth (Giles et al., 2015). Antenatal 
interventions directed towards optimising adverse fetal exposures may contribute to 
curbing the incidence of childhood obesity.  
 
4.4.3 Cord blood insulin growth factor I, adiponectin, leptin and offspring growth 
The positive associations between cord blood IGF-1 with neonatal measures of growth and 
body composition together with infant weight and mid upper arm circumference z-scores at 
6 months also suggests a persistent influence of in-utero exposures on early growth. In 
early postnatal life, IGF-1 mediates the effect of growth hormone on early growth (Soubry 
et al., 2013). Whilst the relationship between the cord blood metabolic profile and 
differential growth in early infancy suggests a potential persistent effect on growth at 6 
months of age, mechanisms must remain conjectural and causal inference should be made 




to epigenetic modification in-utero (Baker et al., 1993; Kao et al., 1994; Fu et al., 2009) 
with animal studies shedding some light on this, providing evidence of an interaction with 
maternal glycaemia status. For example, Zinkhan et al, demonstrated that in-utero exposure 
to maternal glycaemia in rats led to decreased hepatic H3Me3K36 and mRNA variants of 
the IGF-1 gene in the offspring (Zinkhan et al., 2012). Others have implicated a role of 
these variants to a predisposition to later obesity and insulin resistance (Selak et al., 2003; 
Fu et al., 2009). Whether epigenetic modification may also influence lipid metabolism 
including that of lysophosphatidylcholines, remains conjectural.  
 
The linear associations with cord adiponectin and measures of weight, length and 
subscapular z-scores at 6 months are in keeping with recent evidence from a prospective 
cohort study from Germany, in children born to women of heterogeneous BMI (n=141); 
suggesting a potential long term influence in children at 5 years of age (Meyer et al., 2017). 
Cord blood leptin was associated with measures of neonatal growth and body composition 
and increased odds of catch up growth from birth to 6 months of age, suggesting a potential 
mediatory role of early infancy growth. Cord blood leptin has been implicated as a proxy 
for neonatal fat mass as it is synthesised by the adipocyte Ob gene and is proportional to 
adipose tissue mass (Zimmet et al., 1996; Lawlor et al., 2014). This study has demonstrated 
an inverse relationship with cord leptin and catch up growth independent of birthweight 
which may be explainable by a state of leptin resistance in early infancy, as observed in 
previous studies. Studies have demonstrated an inverse relationship with cord blood leptin 
and catch up growth independent of birthweight, which may be explainable by a state of 





4.4.4 Relationship between maternal gestational diabetes and cord blood metabolic 
profile 
The associations between maternal gestational diabetes, specifically fasting glucose, at the 
time of the oral glucose tolerance test with the cord blood metabolic profile, adds to the 
previously documented relationships including observations from the HAPO study, 
documenting  linear associations of maternal glycaemic profile with cord blood C-peptide 
and adiponectin (Metzger et al., 2008; Lowe et al., 2010).   
 
The linear associations between cord blood anabolic hormones including cord blood C-
peptide, insulin and IGF-1 with measures of growth and body composition at birth, agree 
with previous studies in offspring born to women of heterogeneous BMI (Wang et al., 
1991; Christou et al., 2001; Delvaux et al., 2003; Carlsen et al., 2015) and concur with the 
knowledge that insulin and IGF-1 are the most important regulators of fetal growth in the 
2nd and 3rd trimester (Christou et al., 2001; Catalano et al., 2009). IGF-1 has been shown 
consistently to be raised in cord blood of offspring born to obese women, predominately as 
a consequence of maternal dysglycaemia (Metzger et al., 2009; Harmon et al., 2011; 
Lawlor et al., 2014) .  
 
4.4.5 Cord blood lipids and inflammatory mediators and offspring anthropometry 
Triglycerides and non-esterified fatty acids in maternal circulation have been widely 
implicated as determinants of fetal growth in obese and diabetic women (Catalano et al., 
2009). However, in this study, an inverse relationship between clusters of non-esterified 
fatty acids and triglycerides with neonatal growth and adiposity was observed, which has 
also been reported by others (Jones et al., 1999; Rodie et al., 2004; Kelishadi et al., 2007; 
Cekmez et al., 2009). This association with low rather than high birth weight may reflect 




2007). Importantly, this study questions the role of triglycerides in the determination of 
neonatal adiposity.  
 
Despite the suggestion that inflammatory mediators (interleukin-6 and tumour necrosis 
factor-α) may contribute to the development of neonatal adiposity in-utero, through 
regulation of central pathways of satiety and appetite, this study reported an inverse 
association with neonatal body composition. There is no obvious explanation for this 
finding (Yessoufou and Moutairou, 2011; Cesar and Pisani, 2016). 
 
4.4.6 Strengths and Limitations  
Strengths of this study include an extensive assessment of the cord blood metabolic profile 
at birth, detailed neonatal and infant anthropometric data collection and prospective 
collection of maternal early pregnancy BMI, total gestational weight gain and measures of 
maternal insulin resistance. Using data reduction techniques for the cord blood 
metabolome, metabolite clusters of biological importance associated with measures of 
neonatal and infant anthropometry were identified.  
 
Limitations include the collection of mixed cord blood (umbilical artery and vein), which 
weakens conclusions regarding fetal or maternal origin of the metabolites in previously 
published reports as well as this study (Taveras et al., 2004; Isganaitis et al., 2015). Whilst 
treatment of GDM has the potential to influence cord insulin, C-peptide and IGF-1 
concentrations, this was not adjusted for within this analysis (Landon et al., 2015). 
However, a sensitivity analysis, removing women with GDM, did not modify the observed 
relationships. Duration of labour has been previously shown to influence cord blood 
metabolic profile, but this data was not available, however mode of delivery did not modify 
the observed associations (Hashimoto et al., 2013; Logan et al., 2016a). It must be 




incomplete profile of the late pregnancy in-utero fetal exposures as unmeasured 
micronutrients, essential fatty acids and steroid hormones may also contribute to neonatal 
and early life growth and body composition.  
 
4.4.7 Conclusion  
This study, of more than 300 infants describes for the first time a comprehensive cord 
blood metabolic profile in offspring born to obese women. Known associations of 
metabolic variables with infant adiposity were confirmed and questions raised regarding 
previous associations derived from smaller cohorts. Importantly this study has highlighted 
novel associations with lipid sub-species and early postnatal growth, and provides 
supporting evidence that IGF-1 at birth may be a determinant of later growth trajectories. 
Despite the lack of difference in metabolites in control and intervention arms, this thesis 
has reported a difference in infant adiposity in 6 month old children (Patel et al., 2017). 
Current investigation of the maternal metabolome and neonatal epigenome may shed light 
on the causative mechanisms and further insight into growth trajectories. Ongoing studies 
of the cord epigenome may provide further mechanistic insight into potential pathways. 
Replication in other cohorts including the use of Mendelian randomisation methods are 
required to determine causality. Ongoing follow-up of the UPBEAT offspring will address 





Chapter 5 Infant adiposity following a randomised controlled trial 
of a behavioural intervention in obese pregnancy. 
 
5.1 Background  
The high prevalence of childhood obesity is a major health concern, with 27.3% of children 
estimated to be overweight or obese in the USA (Cunningham et al., 2014). A combination 
of antenatal and postnatal exposures including environmental factors have been implicated 
in the development of childhood obesity (Nelson et al., 2010; Young et al., 2012), which 
has been shown to track into adulthood (Cunningham et al., 2014). Observational studies 
suggest that manipulation of maternal metabolism through diet and/or physical activity in 
the antenatal period has the potential to reduce childhood obesity (Okubo et al., 2014) 
which has been unequivocally achieved in pregnant obese experimental animals and their 
offspring (Patel et al., 2015). These observations have led to a consensus that obesity is in 
part ‘programmed’ in-utero, in keeping with the ‘developmental programming’ hypothesis 
(Patel et al., 2015). As mentioned in Chapter 1: Introduction; well-designed RCTs in 
pregnant women and their offspring are required to infer causality through minimising 
selection bias and confounding (Richmond et al., 2014; Patel et al., 2015).  
 
The UPBEAT of a dietary and physical activity intervention in 1555 obese pregnant 
women, where women were randomised to standard antenatal care or standard antenatal 
care with an intense behavioural intervention that focussed on improving insulin sensitivity 
through reducing dietary glycemic load and saturated fat intake (Poston et al., 2015) 
(Further details provided in Chapter 2:Methods). Although the intervention did not reduce 
GDM or LGA delivery (maternal and neonatal primary outcomes), there were significant 
improvements in maternal antenatal diet and body composition (Poston et al., 2015), all of 





To examine the hypothesis that the lifestyle intervention might reduce the influence of 
maternal obesity on offspring adiposity, our principal aim was to assess whether the 
UPBEAT intervention was associated with a reduction in measures of infant adiposity at 6 
months of age, a pre-defined hypothesis within the trial protocol (Briley et al., 2014). 
Assessment was made to identify whether the pregnancy intervention had lasting influence 
on maternal diet and physical activity, and on known early-life determinants of infant 





5.2 Research design and methods  
5.2.1 Study design and setting  
Between July 2010 and May 2015, a planned follow up at 6 months postpartum was 
undertaken of mothers and their offspring who had participated in the UPBEAT RCT in 
eight inner-city NHS Trust Hospitals in the UK. Further details of the UPBEAT study 
design and participating centres are provided in Chapter 2: Methods.  
 
5.2.2 Study population and consent 
1555 women were recruited to the UPBEAT trial (≥16 years of age; pre-pregnancy BMI 
≥30 kg/m2). Further details of the UPBEAT’s exclusion and inclusion criteria are provided 
in Chapter 2: Methods. If a participant had withdrawn from the trial but was willing to take 
part (n=2), written consent was obtained at the 6 month visit. Infants were excluded if aged 
<4 months or >8 months of age at this visit. Comparison of demographic details at trial 
entry was made between women who declined to participate and those who took part. 
 
5.2.3 Outcomes 
5.2.3.1 Infant anthropometry 
The principal outcome of interest was infant adiposity assessed by measurement of infant 
SFT (triceps and subscapular, measured in triplicate by trained research staff using infant 
skinfold callipers). Subsidiary infant outcomes of infant adiposity included SSFT, 
estimated total body fat; weight, abdominal and upper mid-arm circumferences (Slaughter 
et al., 1988). For these measures, where reference WHO population data were available, z-
scores were calculated (WHO and de Onis, 2006), including adjustment for infant age and 
sex. Occiptofrontal circumference, and crown-rump length and crown-heel length obtained 
with a calibrated infantometer were also measured. Further details regarding measurement 





Duration of breastfeeding, weaning history, measures of appetite, infant sleeping patterns, 
physical activity, healthcare resource use and childcare (Briley et al., 2014) were pre-
specified outcomes. These were evaluated using the Infant Feeding and Growth 
Questionnaire (Robinson et al., 2007), the Baby Eating and Behaviour Questionnaire 
(Llewellyn et al., 2011), the BISQ (Brief Infant Sleep Questionnaire) (Sadeh, 2004), the 
Infant Behaviour Questionnaire (for infant temperament)(Gartstein and Rothbart, 2003) 
and questionnaires ascertaining infant health, medical resource use and early care and 
education, respectively. Further details of questionnaires and respective data management 
procedures are provided in Chapter 2: Methods.  
 
5.2.3.2 Maternal dietary and physical activity analysis 
As discussed in Chapter 2: Methods, maternal diet at 6 months postpartum was assessed 
using the same semi-quantitative FFQ and analysed as previously reported for the mothers 
during their pregnancy (Poston et al., 2015). Data was analysed only in questionnaires 
which were fully completed for both maternal diet and physical activity. Those with 
incomplete/missing dietary data were excluded (65.8%). There was no missing physical 
activity data. The main outcomes of interest were maternal dietary glycaemic load, 
saturated fat intake and energy intake. Other outcomes included glycaemic index, protein 
and fibre intake. Physical activity was assessed, as it had been in pregnancy, using the 
IPAQ and summarised as METs of energy expenditure (IPAQ, 2005). Further details 
regarding data management procedures for both maternal dietary and physical activity 





5.2.4 Statistical analysis 
A complete-case analysis was undertaken for all participating mothers and infants. 
Treatment effects for continuous outcomes were expressed as differences in means 
obtained from multivariable linear regression, and binary endpoints as risk ratios with 95% 
confidence obtained using binomial regression. For both, adjustment was made for 
minimisation variables (maternal BMI at trial enrolment, parity and ethnicity), infant sex 
and age at follow up. The number of intervention contact sessions during pregnancy were 
evaluated in relation to measures of infant adiposity.  
 
Although loss to follow-up was similar in both trial arms, assessment was made for the 
possibility that loss to follow-up resulted in selection bias using three complementary 
methods. All sets of analyses were pre-planned sensitivity analyses. Using Little’s chi-
squared covariate dependent missing (CDM) test to explore evidence of the data being 
MNAR (i.e. the possibility that those who were lost to follow-up the effect of the 
intervention on outcome differed from those who did attend the follow up) for both 
offspring and maternal outcomes was undertaken (Catalano and Hauguel-De Mouzon, 
2011).  
 
Second, for the primary offspring outcomes only (subscapular and triceps SFT), several 
simulation datasets were generated, over a range of scenarios regarding missing data in 
both arms of the study that were informed by predictors of loss to follow-up (maternal BMI 
at trial enrolment, parity and ethnicity) (White et al., 2011). The scenarios selected aimed 
to cover a range of plausible situations that could result in bias under the assumption of 
data being MAR. The analysis was undertaken using the STATA command ‘rctmiss’ for 
the primary outcome of the study (Patro-Gołąb et al., 2016b). For the purpose of this 
sensitivity analysis δ was assumed as .5, .75, 1, 1.5, 2. Thirdly, for the primary infant 




data for infant adiposity to investigate whether loss to follow up may have resulted in type 
2 statistical error. Data was imputed to create 50 datasets using 10 burn-in iterations for 
live-born infants using maternal and infant variables throughout pregnancy and early 
postpartum period.  
 
Pre-defined interaction analyses using Wald tests were performed for duration of exclusive 
breast feeding (< 3 months vs. ≥3 months) and neonatal sex. Statistical significance for 
interaction was determined as p≤0.05. As the intervention was associated with 
modifications in maternal diet, assessment of the effect of maternal dietary glycaemic load, 
saturated fat and energy intake at 27-28+6 weeks’ gestation and GWG on any differences 
observed in infant skinfold thicknesses using the method of average causal mediation 
analysis were undertaken (Hicks and Tingley, 2011). Similarly, assessment was made for 
any differences observed in maternal diet at 6 months postpartum on any observed 




5.3 Results  
5.3.1 Demography 
Of the 1555 participants randomised to UPBEAT at 15-18+6 week’s gestation between July 
2010 and May 2015 and with a live born infant, 1522 were approached between 4-8 
months postpartum to attend a 6-month follow up. Of these 1522, 720 (47.3%) infants and 
707 (46.5%) mothers took part in this study (Figure 5.1). Thirteen mothers were excluded 
as they were pregnant at time of study, and 22 infants were excluded because the follow up 
appointment was held ≤4 months or ≥8 months of age (Figure 5.1). In comparison to those 
who did not take part, mothers who attended the 6 month visit were on average 1.3 years 
older, more likely to be Caucasian, nulliparous, to have had GDM in the index pregnancy 
(28.2% vs. 23.3%; p=0.041), and were less likely to be current smokers (Table 5.1). There 
were no differences in maternal early pregnancy BMI and SSFT between women who 
participated in the 6 month follow-up visit compared to those who did not. Women in the 
intervention arm demonstrated reduced GWG as previously reported (Poston et al., 2015). 
The infants who attended the 6 month appointment had a greater gestational age at delivery 
(by 2 days), were 67g heavier, and more likely to have been breastfed at birth than those 
that did not attend the follow up visit (Table 5.2). 
 
There was no difference between mean maternal BMI between the intervention and 
standard care groups at trial entry (36.17 vs. 36.31 kg/m2, respectively) or at 6 months 
postpartum (36.26 vs. 36.45 kg/m2, respectively). The incidence of maternal smoking at 15-
18+6 weeks’ gestation was higher in the standard antenatal care arm in comparison to the 
intervention arm (5.6% vs. 2.0%) (Table 5.3). There were no differences in all other 





5.3.2 Infant anthropometry 
Three hundred and fifty six infants in the standard antenatal care arm and 342 infants in the 
intervention arm (mean age 5.82 months) had anthropometric measurements collected at 6 
months of age. There was no statistical difference in triceps SFT in the intervention vs. the 
standard care arm (difference -0.14 SD, 95% CI -0.38 to 0.10), p=0.246), but subscapular 
SFT z-score was -0.26 SD (-0.49 to -0.02; p=0.03) lower in the intervention arm (Table 
5.4). Infants in the intervention arm had a 5% lower subscapular SFT (-0.38mm; -0.70 to    
-0.06; p=0.02), compared to infants in the standard antenatal care arm (Table 5.4). The 
infant SSFT was 0.63mm lower in the intervention arm, but did not reach statistical 
significance (p=0.06) in comparison to the standard antenatal care arm (Table 5.4). There 
were no differences in BMI z-score and abdominal circumference (Table 5.4) or in other 
anthropometric measures between the two arms (Table 5.4).  
 
5.3.2.1 Sensitivity analyses 
Maternal smoking status at trial entry, did not influence the difference in subscapular SFT 
between the two arms (Table 5.5), as with the use of multiple imputation (Table 5.6). There 
was no evidence for trial outcomes being missing anything more than completely at 
random (p = 0.856). Undertaking sensitivity analyses for deviation from the missing at 
random assumption, significant differences in infant subscapular SFT (mm) were found 
within a range of -0.35 to -0.38mm dependent on the assumption of missingness taken 
(Table 5.7). Similar results to the complete-case analysis were also observed for infant 
triceps skinfold thickness (Table 5.8). 
  
5.3.3 Infant early life feeding, appetite, satiety and general health at 6 months  
There was no difference in infant feeding between the two trial arms, nor appetite, satiety 




(SD 65.3) days and total number of hours spent sleeping were similar between arms (Table 
5.9). There was an increase in infant inpatient nights in the intervention arm, attributable to 
1 infant requiring long-term hospital admission due a ventricular septal defect repair (Table 
5.9). No differences in infant use of medications or in the cause of hospital inpatient 
admissions, expect for gastrointestinal related disorders, which were lower in the 
intervention arm were observed (Table 5.10). There was no association between the 
number of antenatal contact sessions with the health trainer and measures of infant 
anthropometry (Table 5.11). 
 
5.3.4 Pre-defined interaction tests 
No interactions were observed between randomisation allocation and infant sex (Table 
5.12), but there was a significant interaction of breast feeding (< 3mths/ ≥3mths) with the 
intervention; triceps skin fold thickness was lower in infants of mothers in the intervention 
arm who breastfed ≥3 months vs those in the standard care arm -0.90mm (-1.59 to -0.21); 
p=0.01; Wald interaction test; p=0.02) (Figure 5.2). Similar patterns of differences of effect 
by breastfeeding for SSFT, estimated total body fat and arm circumference did not achieve 
statistical significance (p-values for interactions all ≥ 0.05) (Table 5.13).  
  
5.3.5 Maternal diet and physical activity at 6 months postpartum 
In those women who provided complete dietary data glycaemic index, glycaemic load, 
saturated fat and total energy intake were reduced in the mothers in the intervention arm in 
comparison to standard care, as well as a significant reduction in total fat and protein 
intakes (Table 5.14, Figure 5.3). When the under-reporters (calorie intake) were included in 
sensitivity analyses, there were no differences in effect size estimates of dietary variables. 
Furthermore, there was no difference in maternal characteristics (including maternal age, 




under-reporting calorie intake. There was no effect of the intervention of maternal physical 
activity (Table 5.14).  
 
5.3.6 Mediation analysis  
Causal analysis suggested a partial indirect effect of the intervention associated with 
reduction in maternal early GWG (between 15-18+6 and 27-28+6 weeks’ gestation) 
(p=0.015), late GWG (between 27-28+6 and 34-36 weeks’ gestation) (p=0.009), total GWG 
(p=0.014) and maternal dietary saturated fat intake at 27-28+6 week’s gestation (p=0.016) in 
relation to infant subscapular skinfold thickness at age 6 months (Figure 5.4). In contrast, 
there was no suggested effect of postnatal maternal diet on the observed differences in 
infant subscapular skinfold measurements (Figure 5.5). As there was no effect of the 
intervention on maternal physical activity, there was no rationale for exploring a causal 















Table 5.1: Maternal demographics of those who consented to 6 months follow up in the UPBEAT trial versus those who did not by randomisation allocation 
(included n=720 versus excluded n=799).  
*Difference calculated for maternal offspring followed up (intervention vs. control) & those not followed up (intervention vs. control) at 6-months postpartum. Abbreviations; GDM-Gestational 
diabetes, IMD-Index of multiple deprivation; PET-Preeclampsia.  
Maternal Followed up Not followed up Follow up vs. no 
follow-up  
p-value  Intervention Control 
Mean difference/ 
OR (95%CI) * 
Intervention Control 
Mean difference/ 
OR (95% CI) * 
Maternal age 
(years) 






























Asian N=355 14 (3.9) N=365 11 (3) 1.31 (0.60 to 
2.84) 
N=407 29 (7.1) N=392 37 (9.4) 0.75 (0.47 to 
1.20) 
<0.001 
Black 65 (18.3) 76 (20.8) 0.88 (0.65 to 
1.18) 
128 (31.4) 118 (30.1) 1.01 (0.85 to 
1.29) 
<0.001 
White 21 (5.9) 22 (6.0) 0.98 (0.55 to 
1.75) 
23 (5.7) 18 (4.6) 1.23 (0.67 to 
2.24) 
<0.001 
Other  255 (71.8) 256 (70.1) 1.02 (0.93 to 
1.12) 
227 (55.8) 219 (55.9) 1.00 (0.88 to 
1.13) 
0.47 
Multiparous  N=355 176 (49.6) N=365 178 (48.8) 1.02 (0.88 to 
1.18) 





 N=355 8 (2.3) N=365 20 (5.5) 0.41 (0.18 to 
0.92) 
N=407 39 (9.6) N=392 38 (9.7) 0.99 (0.65 to 
1.51) 
<0.001 
IMD quintiles 1  N=354 16 (4.5) N=364 19 (5.2) - N=403 13 (3.2) N=392 15 (3.8) - 0.16 
2 30 (8.5) 19 (5.2) 1.87 (0.78 to 
4.52) 
26 (6.5) 25 (6.4) 1.20 (0.48 to 
3.02) 
3 37 (10.5) 40 (11.0) 1.10 (0.49 to 
2.45) 
50 (12.4) 44 (11.2) 1.31 (0.56 to 
3.06) 
4 122 (34.5) 140 (38.5) 1.03 (0.51 to 
2.10) 
117 (29.0) 138 (35.2) 0.98 (0.45 to 
2.14) 
5 149 (42.1) 146 (40.1) 1.21 (0.60 to 
2.45) 



















GDM N=349 102 (29.2) N=355 96 (27.0) 1.08 (0.85 to 
1.37) 
N=287 60 (20.9) N=306 77 (25.2) 0.83 (0.62 to 
1.12) 
0.04 
PET N=352 11 (3.1) N=362 11 (3.0) 1.03 (0.45 to 
2.34) 
N=392 16 (4.1) N=382 16 (4.2) 0.97 (0.49 to 
1.92) 
0.28 
Total gestational weight gain 
from pre-pregnancy weight 
N=333 6.88 (4.70) N=341 7.82 (4.42) -0.93 (-1.62 to -
0.24) 







Table 5.2: Infant characteristics of those who consented to 6 months in the UPBEAT trial follow-up versus those who did not (included n=720 versus excluded 
n=799).  
Abbreviations; LGA-Large for gestational age, NICU-Neonatal intensive care unit, SGA-Small for gestational age
 Follow up at 6 months No follow up Mean Difference/ Odds 
ratio (95% Confidence 
Intervals) 
p-value 
 Mean (SD)/N (%)  Mean (SD)/N (%) 
Birth 
characteristics 
Gestation at birth (weeks) N=720 39.64 (1.95) N=799 39.37 (2.54) 0.26 (0.04 to 0.49) 0.02 
Admission to NICU N=720  56 (7.8) N=799 66 (8.3) 0.94 (0.67 to 1.32) 0.73 
Breastfeeding at birth  N=717 445 (62.1) N=776 416 (53.6) 1.16 (1.06 to 1.26) <0.001 
Anthropometry Birthweight (grams) N=720 3457.62 (565.18) N=799 3390.11 (647.71) 67.51 (6.46 to 128.56) 0.03 
Birthweight >4kg N=720 102 (14.2) N=799 108 (13.5) 1.05 (0.82 to 1.35) 0.71 
LGA >90th  N=720 60 (8.3) N=799 73 (9.1) 0.91 (0.66 to 1.26) 0.58 
SGA <10th  N=720 84 (11.7) N=799 92 (11.5) 1.01 (0.77 to 1.34) 0.93 
Subscapular skinfold thickness (mm) N=354 10.87 (2.64) N=148 11.06 (2.64) -0.20 (-0.33 to 0.23) 0.73 
Triceps skinfold thickness (mm) N=363 5.26 (1.53) N=154 5.41 (1.46) -0.15 (-0.43 to 0.13) 0.29 
Sum of skinfold thickness (mm) N=354 10.87 (2.64) N=148 11.06 (2.64) -0.20 (-0.70 to 0.31) 0.73 
Abdominal circumference (cm) N=386 11.45 (1.10) N=182 11.54 (1.10) -0.09 (-0.28 to 0.10) 0.36 




 Intervention (n=342) Control (n= 356) 
 Mean (SD)/N (%)  Mean (SD)/N (%) 
Maternal demographics 
Pre-pregnancy       
Maternal age 
(years) 
 N=342 31.30 (5.04) N=356 31.00 (5.58) 
Maternal ethnicity Asian N=342 14 (4.1) N=356 11 (3.1) 
Black 62 (18.1) 72 (20.2) 
Other 19 (5.6) 22 (6.2) 
White  247 (72.2) 251 (70.5) 
Multiparous N=342 169 (49.4) N=356 174 (48.9) 





N=341 15 (4.4) N=355 19 (5.4) 
2 29 (8.5) 19 (5.4) 
3 35 (10.3) 38 (10.7) 
4 119 (34.9) 136 (38.3) 
5 (most 
deprived) 
143 (41.9) 143 (40.3) 
Family history GDM N=333 10 (3.0) N=344 11 (3.2) 
PET N=333 40 (12.0) N=344 33 (9.6) 
T2DM N=341 86 (25.2) N=356 70 (19.7) 
15-18+6 weeks’ gestation  









N=340 117.90 (11.15) N=352 119.32 (11.00) 
Sum of skin 
folds (mm)ⱡ  
N=337 124.34 (28.46) N=354 122.18 (25.06) 
Maternal Antenatal and postpartum history  
Gestational diabetes** N=336 97 (28.9) N=346 93 (26.9) 
Pre-eclampsia∞  N=340 11 (3.2) N=353 11 (3.1) 
Total gestational weight gain from 
pre-pregnancy weight¶ 
N=320 6.92 (4.65) N=332 7.83 (4.41) 
Maternal 6 month postpartum 
BMI (kg/m2) 
N=345 36.26 (5.14) N=355 36.45 (5.41) 
Change in maternal weight from 
15-18 weeks to 6 months 
postpartum (kg) 
N=344 -0.37 (7.41) N=355 0.36 (6.71) 
Infant demographics  
Infant age at 6 months follow up 
(months) 
N=342 5.80 (0.65) N=356 5.85 (0.72) 
Gestation at birth (weeks) N=342 39.73 (1.54) N=356 39.55 (2.29) 
Birthweight (grams) N=342 3479.23 (529.40) N=356 3436.55 (604.09) 
Large for Gestational Age >90th 
(customised)†  
N=342 30 (8.8) N=356 27 (7.6) 
Neonatal 
feeding history 
at 72 hrs 
Artificial 
feeding 
N=341 63 (18.5) N=354 78 (22.0) 
Breast feeding N=341 213 (62.5) N=354 216 (61.0) 
Partially 
breastfeeding 
N=341 65 (19.1) N=354 60 (17.0) 
Table 5.3: Maternal and infant demographics by randomisation allocation at 6 months’ 
postpartum visit (n=698). 
^ Maternal current smoking at 15-18 weeks’ gestation significantly different between intervention and control 
groups(p=0.02). *IMD quintiles are calculated for the region of residence, by fifths of the population. UK 
wide-scores were developed by reconciling Scottish data to English norms. ** Gestational diabetes diagnosis 
by International Association of Diabetes in Pregnancy Study Group criteria at 27+0 to 28+6 weeks’ gestation.  
ⱡ Sum of skinfold thicknesses calculated by the addition of biceps, triceps, suprailiac and subscapular skinfold 




diastolic blood pressure ≥90 mm Hg, or both, on at least two occasions 4 hours apart, with proteinuria ≥300 
mg/ 24 hours. ¶Gestational weight gain calculated using estimated weight before pregnancy per the Institute of 
Medicine Weight Management in Pregnancy Guidelines. † Customised birthweight centile calculated adjusting 
















Table 5.4: Infant anthropometry by UPBEAT randomisation allocation at 6 months’ postpartum visit (n=698). 
*Treatment effect adjusted for minimisation variables of randomisation (maternal BMI, ethnicity and parity), infant age at 6 month follow up and infant sex. **Z-scores calculated using WHO 
Anthro; version 3.2.2. † Total body fat estimation calculated using sex-specific equations utilising 2 infant skinfold thicknesses (Slaughter et al., 1988).  
 
  
 Intervention  Control  Mean Diff/ Risk 
Ratio* (95% CI) 
p-value 
Mean (SD) Mean (SD) 
Subscapular skinfold thickness z-scores** N=267 0.08 (1.37) N=280 0.36 (1.37) -0.26 (-0.49 to -0.02) 0.03 
Subscapular skinfold thickness (mm) N=267 7.55 (1.86) N=281 7.95 (2.03) -0.38 (-0.70 to -0.06) 0.02 
Triceps skinfold thickness z-scores** N=296 0.10 (1.56) N=298 0.24 (1.43) -0.14 (-0.38 to 0.10) 0.25 
Triceps skinfold thickness (mm) N=307 9.69 (2.76) N=320 9.87 (2.69) -0.22 (-0.64 to 0.20) 0.31 
Sum of skinfolds (mm) N=267 17.08 (3.93) N=280  17.71 (3.97) -0.63 (-1.30 to 0.04) 0.06 
BMI for age z-scores**  N=317 -0.07 (1.86) N=320 0.04 (1.78) -0.12 (-0.40 to 0.16) 0.39 
Abdominal circumference (cm) N=329 43.74 (4.73) N=347 43.72 (6.27) 0.07 (-0.78 to 0.92) 0.87 
Total body fat estimation (%) † N=267 19.40 (5.00) N=280 20.20 (5.07) -0.80 (-1.65 to 0.04) 0.06 
Weight (kg) N=332 7.93 (1.07) N=345 8.03 (1.08) -0.09 (-0.24 to 0.06) 0.25 
Weight for age z-scores** N=321 0.20 (1.08) N=322 0.29 (1.12) -0.09 (-0.26 to 0.08) 0.29 
Length (cm) N=321 67.41 (8.58) N=338 66.37 (12.37) 1.21 (-0.40 to 2.81) 0.14 
Length z-scores**  N=309 0.53 (1.79) N=313 0.55 (1.89) -0.02 (-0.30 to 0.27) 0.92 
Weight for length z-score ** N=314 -0.08 (1.79) N=324 0.08 (1.63) -0.18 (-0.45 to 0.09) 0.18 
Mid Upper Arm circumference (cm) N=329 15.30 (1.49) N=347 15.39 (2.08) -0.10 (-0.39 to 0.19) 0.51 
Crown rump length (cm) N=186 45.16 (2.89) N=195  45.14 (3.06) 0.04 (-0.57 to 0.65) 0.90 

















Table 5.5: Sensitivity analysis for infant outcomes adjusting for maternal smoking to determine the influence of the UPBEAT intervention on infant anthropometry 
at 6 month of age (n=698). 
*Treatment effect adjusted for minimisation variables of randomisation (maternal BMI, ethnicity and parity), infant age at 6 month follow up and infant sex and maternal smoking status at 15-
18+6 weeks’ gestation **Z-scores calculated using WHO Anthro; version 3.2.2 (de Onis and Blössner, 2003) .‡ Infant total body fat estimation calculated using sex-specific equations with two 
skin fold measurements as published by Slaughter et al (1988)(Slaughter et al., 1988).  
 Intervention  Control  Mean Diff/ Risk Ratio* 
(95% CI) 
p-value 
Mean (SD)/N (%) Mean (SD)/N (%) 
Subscapular (mm) N=267 7.55 (1.86) N=281 7.95 (2.03) -0.39 (-0.71 to -0.07) 0.02 
Triceps (mm) N=307 9.69 (2.76) N=320 9.87 (2.69) -0.21 (-0.64 to 0.21) 0.33 
Sum of skinfolds (mm) N=267 17.08 (3.93) N=280  17.71 (3.97) -0.63 (-1.30 to 0.03) 0.06 
Total body fat 
estimation (%) ‡ 
N=267 19.40 (5.00) N=280 20.20 (5.07) -0.81 (-1.66 to 0.03) 0.06 
Weight (kg) N=332 7.93 (1.07) N=345 8.03 (1.08) -0.10 (-0.25 to 0.06) 0.22 
Height (cm) N=321 67.41 (8.58) N=338 66.37 (12.37) 1.31 (-0.33 to 2.96) 0.12 
Weight z-scores** N=321 0.20 (1.08) N=322 0.28 (1.13) -0.10 (-0.27 TO 0.08) 0.25 
BMI z-scores** N=321 -0.09 (1.87) N=313 0.01 (1.78) -0.14 (-0.42 to 0.15) 0.35 
Weight for length z-
scores**  
N=314 -0.08 (1.79) N=324 0.08 (1.63) -0.20 (-0.46 to 0.07) 0.15 
Abdominal 
circumference (cm) 
N=329 43.74 (4.73) N=347 43.72 (6.27) 0.01 (-0.82 to 0.85) 0.98 
Arm circumference (cm) N=329 15.30 (1.49) N=347 15.39 (2.08) -0.10 (-0.39 to 0.19) 0.50 
Crown length (cm) N=186 45.16 (2.89) N=195  45.14 (3.06) 0.04 (-0.57 to 0.65) 0.91 
Occiptofrontal 
circumference (cm) 















Table 5.6: Multiple imputation to increase precision of treatment estimates of the effect of the UPBEAT intervention on infant anthropometry at 6 months. 
Multiple imputation methodology; Data was imputed to create 50 datasets using 10 burn-in iterations for live-born infants using maternal trial entry BMI, age, ethnicity, parity, early pregnancy 
smoking status, randomisation allocation, measures of maternal anthropometry including GWG, maternal diet at 27-28+6 weeks’ and 6 months postpartum (glycaemic load, glycaemic index, 
saturated fat, carbohydrate, protein, energy intake), maternal physical activity at 27-28+6 weeks’ and 6 months post-partum (MET), gestation at delivery, infant sex, age at follow-up, mode and 
duration of early feeding, sleep, child health, duration of hospital admissions. Analyses were performed by intention to treat. *Treatment effects were estimated on pooled datasets using risk 
ratio (binary outcomes) and mean difference (continuous outcomes) adjusted for minimisation variables (Maternal BMI, parity and ethnicity) infant sex and age at follow-up visit. 
Abbreviations: MI- Multiple imputation   
 
  Observations  Missing data  % missing data Effect size using MI*  P-value 
Subscapular skinfold thickness 
(mm) 
548 972 63.95 -0.29(-0.63 to -0.06) 0.04 
Triceps skinfold thickness 
(mm) 
627 893 58.75 -0.10 (-0.52 to 0.32) 0.61 





64.01 -0.63 (-1.31 to 0.06) 0.06 
Total body fat estimation (%) 547 973 64.01 -0.79 (-1.66 to 0.72) 0.07 
Weight (kg) 677 843 55.46 -0.08 (-0.20 to 0.04) 0.18 
Height (cm) 659 861 56.64 0.83 (-0.45 to 2.12) 0.19 
Weight z-scores  643 877 57.70 -0.09 (-0.27 to 0.09) 0.31 
Length z-scores  622 898 59.08 -0.16 (-0.45 to 0.42) 0.93 
BMI z-scores  622 898 59.08 -0.11 (-0.49 to 0.28) 0.55 
Weight for length z-scores  638 882 58.03 -0.13 (-0.46 to 0.20) 0.40 
Abdominal circumference (cm) 676 844 55.53 -0.01 (-0.87 to 0.85) 0.98 
Mid-arm circumference (cm) 676 844 55.53 -0.01 (-0.41 to 0.39) 0.95 
Crown-rump length (cm) 381 1139 74.93 0.08 (-0.92 to 1.09) 0.84 
Occiptofrontal circumference 
(cm)  









Table 5.7: Sensitivity analysis for departure from missing at random assumption for the effect 






Table 5.8: Sensitivity analysis for departure from missing at random assumption for the effect 
of the UPBEAT intervention on infant triceps skinfold thickness at 6 months of age. 
δ Difference  Standard error 
0.5 -0.38 0.16 
0.75 -0.38 0.16 
1 -0.37 0.16 
1.5 -0.36 0.17 
2 -0.35 0.17 
δ Difference  Standard error 
0.5 -0.16 0.21 
0.75 -0.15 0.22 
1 -0.15 0.22 
1.5 -0.14 0.22 




Table 5.9: Postnatal characteristics previously implicated with infant adiposity, by UPBEAT randomisation allocation at 6 months follow-up visit (n=698). 
Treatment effect adjusted for minimisation variables of randomisation (maternal BMI, ethnicity and parity), infant age at 6 month follow up and infant sex.** Appetite and satiety assessed by 
the Baby Eating Behaviour Questionnaire (Llewellyn et al., 2011). 
 Intervention Control  Diff/ Risk ratio* p-value 
Mean (SD)/N (%) Mean (SD)/N (%) 
Infant feeding at 6 months 
Breast milk only N=336 9 (2.7) N=347  10 (2.9) 1.01 (0.42 to 2.43) 0.98 
Mixed feeding N=336 55 (16.4) N=347 62 (17.9) 0.97 (0.70 to 1.33) 0.83 
Breast milk &solids N=336 57 (17.0) N=347 61 (17.6) 0.98 (0.71 to 1.36) 0.92 
Formula & solids N=336 193 (57.4) N=347 193 (55.6) 1.05 (0.93 to 1.19) 0.40 
Formula only  N=336 22 (6.5) N=347 21 (6.1) 1.09 (0.62 to 1.95) 0.76 
Days exclusively breast fed N=260 80.57 (65.11) N=243 85.04 (65.60) -4.81 (-16.18 to 6.57) 0.41 
Appetite and satiety ** 
Enjoyment of food N=293 18.54 (2.23) N=314 18.40 (2.45) 0.15 (-0.22 to 0.52) 0.43 
Food responsiveness N=342 11.94 (4.95) N=350 12.34 (4.87) -0.39 (-1.12 to 0.33) 0.29 
General appetite  N=342 3.56 (1.31) N=350 3.65 (1.18) -0.08 (-0.27 to 0.10) 0.38 
Slowness in eating  N=342 10.08 (2.62) N=350 10.26 (2.55) -0.18 (-0.56 to 0.20) 0.35 
Satiety responsiveness N=341 6.49 (2.63) N=350 6.46 (2.48) 0.02 (-0.36 to 0.40) 0.91 
Childcare 
Childcare centre N=260 19 (7.3) N=274 18 (6.6) 1.05 (0.56 to 1.95) 0.88 
Family Member N=260 237 (91.2) N=274 244 (89.1) 1.03 (0.98 to 1.09) 0.29 
Nanny N=260 5 (1.9) N=274 6 (2.2) 0.90 (0.27 to 2.94) 0.86 
Other N=260 4 (1.5) N=274 9 (3.3) 0.44 (0.14 to 1.42) 0.17 
Sleep 
Total infant sleep (hours) N=340 14.57 (11.17) N=353 13.54 (9.68) 1.04 (-0.52 to 2.60) 0.19 
Child health  













Table 5.10: Cause of infant hospital admissions and medication use by randomisation allocation in offspring born to obese women. 
* Difference/ risk ratio adjusted for maternal pre-pregnancy BMI, parity, ethnicity and infant sex and age at follow up.  
 Intervention Control Risk ratio* P-value 
N (%) N (%) 
Reason for hospital admission  
Gastrointestinal  N=35 2(5.7) N=33 9 (27.3) 0.21 (0.05 to 0.92) 0.04 
Viral or bacterial infection N=35 15 (42.9) N=33 10 (30.3) 1.44 (0.77 to 2.71) 0.26 
Weight loss N=35 3 (8.6) N=33 2 (6.1) 1.47 (0.26 to 8.23) 0.66 
Congenital anomaly N=35 3 (8.6) N=33 2 (6.1) 1.51 (0.27 to 8.53) 0.64 
Respiratory N=35 7 (20.0) N=33 4 (12.1) 1.87 (0.61 to 5.73) 0.27 
Hypoglycaemia N=35 0 (0.0) N=33 1 (3.0) - - 
Other N=35 5 (14.3) N=33 5 (15.2) - 1.00 
Reasons for use of medications 
Infection  N=491 96 (19.6)) N=488 76 (15.6) 1.20 (0.91 to 1.57) 0.19 
Other N=491 147 (29.9) N=488 154 (31.6) 0.96 (0.80 to 1.16) 0.69 
Pain  N=491 174 (35.4) N=488 182 (37.3) 0.96 (0.82 to 1.14) 0.67 





Table 5.11: Infant anthropometry according to number of maternal health trainer sessions 
within the intervention arm of the UPBEAT randomised controlled trial (n=342).  
*Difference/ risk ration adjusted for maternal pre-pregnancy BMI, parity, ethnicity and infant sex and age at 
follow up. ‡ Infant total body fat estimation calculated using sex-specific equations with two skin fold 
measurements as published by Slaughter et a l(Slaughter et al., 1988). **Z-scores calculated using WHO 
Anthro; version 3.2.2 (de Onis and Blössner, 2003) 
 
  







N=184 7.46 (1.94) 0.09 (-0.40 to 
0.58) 
0.72 
Triceps (mm) N=98 9.12 
(2.63) 
N=209 9.95 (2.78) -0.64 (-1.31 to 
0.03) 
0.06 






-0.22 (-1.32 to 
0.89) 
0.70 














































Table 5.12: Pre-defined interaction tests for infant anthropometry by offspring sex stratified 
by UPBEAT randomisation allocation (n=698). 
*Treatment effect adjusted maternal pre-pregnancy BMI, parity, ethnicity and infant sex and age at follow up. 
Differences and risk ratios are calculated by randomisation allocation. ** Z-scores calculated using WHO 
Anthro; version 3.2.2 (de Onis and Blössner, 2003). ‡ Infant total body fat estimation calculated using sex-
specific equations with two skin fold measurements as published by Slaughter et al (Slaughter et al., 1988). 
 





p-value Diff/Risk Ratio* p-value 
Subscapular (mm) -0.50 (-0.97 to -
0.02) 
0.04 -0.23 (-0.65 to 
0.20) 
0.29 0.42 
Triceps (mm) -0.19 (-0.80 to 
0.42) 
0.53 -0.26 (-0.86 to 
0.34) 
0.39 0.87 
Sum of skinfolds 
(mm) 
-0.83 (-1.83 to 
0.17) 
0.10 -0.41 (-1.30 to 
0.48) 
0.37 0.55 
Total body fat 
estimation (%) ‡ 
-1.09 (-2.41 to 
0.22) 
0.10 -0.49 (-1.56 to 
0.58) 
0.37 0.14 
Infant weight (kg) -0.13 (-0.34 to 
0.08) 





-0.14 (-0.36 to 
0.08) 






-0.06 (-0.52 to 
0.40) 






0.30 (-0.89 to 
1.49) 























Figure 5.2: Relationship between duration of exclusive breastfeeding and anthropometry 
measured at 6 months postpartum in infants from the UPBEAT trial (n=698). 
Effect estimates/ mean differences plotted with 95% confidence intervals. For triceps skinfold thickness 
(n=627), sum of skinfold thickness (n=547), total body fat (n=547) and upper mid-arm circumference (n=676). 
*Significant Wald test for interaction p<0.05 
  
-1.5 -1 0 1-0.5 0.5-2
Triceps Skinfold Thickness (mm)
*
-3 -2 -1 0 1-4 2
Total Body Fat (%)
-3 -2 -1 0 1
Sum Of Skinfold Thickness (mm)
-1 0-0.5 0.5 1
Upper Mid-Arm Circumference (cm)





Table 5.13: Pre-defined interaction tests by infant breastfeeding (defined as >3 months or <3 
months) stratified by randomisation to the UPBEAT intervention (n=698). 
*Treatment effect adjusted for maternal pre-pregnancy BMI, parity, ethnicity and infant sex and age at follow 
up. Presented differences and risk ratio are calculated by treatment allocation. ** Z-scores calculated using 
WHO Anthro; version 3.2.2 (de Onis and Blössner, 2003). ‡ Infant total body fat estimation calculated using 
sex-specific equations with two skin fold measurements as published by Slaughter et al (Slaughter et al., 1988).  
 <3months breastfeeding ≥ 3 months breastfeeding Wald test for 
interaction Diff/ Risk Ratio* p-value Diff/ Risk Ratio* p-
value 
Subscapular (mm) -0.27 (-0.66 to 
0.12) 
0.18 -0.54 (-1.10 to 
0.02) 
0.06 0.44 
Triceps (mm) 0.148 (-0.36 to 
0.71) 
0.52 -0.90 (-1.59 to -
0.21) 
0.01 0.02 
Sum of skinfolds 
(mm) 
-0.18 (-1.02 to 
0.67) 
0.68 -1.42 (-2.52 to -
0.32) 
0.01 0.09 
Total body fat 
estimation (%) ‡ 
-0.23 (-1.30 to 
0.85) 
0.68 -1.81 (-3.20 to -
0.42) 
0.01 0.09 
Infant weight (kg) -0.05 (-0.24 to 
0.14) 





-0.04 (-0.24 to 
0.17) 






0.05 (-0.85 to 
0.96) 






0.11 (-0.24 to 
0.45) 



















Table 5.14: Maternal dietary and physical activity data by randomisation allocation at 6 months postpartum (n=698). 
Abbreviations: CI- Confidence Intervals; %E- %Energy; g/day- grams per day; kcal/day- kilocalories per day; MET- Metabolic equivalent of task; MVPA- Moderate and Vigorous physical 
activity. *Treatment effect adjusted for maternal trial entry BMI, parity and ethnicity. ** Maternal diet- Women with a reported energy ≤4.5 Mj/day or ≥20Mj/day at 15+0 -18+6 weeks’ gestation 
were excluded from the analyses of diet. Dietary intervention estimates were calculated using multiple regression and adjusted for minimisation variables. ^ Physical activity estimates were 
calculated using bootstrapped (1000 replications), median regression adjusting for minimisation variables. † MET is defined as the energy expenditure ratio of activity to rest; 1 MET is 
approximately equal to an individual’s resting energy expenditure. 
 
  Intervention Standard care Treatment effect* P-value 
Mean Difference (95% CI) 
 Mean (SD)/ N (%)  Mean (SD)/ N (%) 
Maternal diet**       
Glycaemic Load per 
day 
N=116 98.94 (32.80) N=126 134.69 (62.68) -35.34 (-48.00 to -22.67) <0.001 
Saturated fat (%E) N=116 11.89 (2.61) N=126 13.75 (2.85) -1.93 (-2.64 to -1.22) <0.001 
Total energy 
(kcal/day) 
N=116 1473.84 (596.60) N=126 1831.21 (727.65) -354.52 (-505.95 to -203.10) <0.001 
Glycaemic Index (0-
100) 
N=116 53.06 (4.06) N=126 57.04 (3.74) -3.94 (-4.93 to -2.94) <0.001 
Carbohydrate (%E) N=116 47.69 (6.71) N=126 48.03 (6.22) -0.18 (-1.84 to 1.49) 0.84 
Total fat (%E) N=116 29.70 (4.94) N=126 32.26 (4.75) -2.65 (-3.91 to -1.38) <0.001 
Protein (%E) N=116 22.57 (4.42) N=126 19.82 (3.94) 2.70 (1.63 to 3.77) <0.001 
Fibre (g/day) N=116 12.12 (4.36) N=126 12.27 (6.81) -0.12 (-1.57 to 1.33) 0.87 
Maternal physical 
activity^ 
 Median (IQR)  Median (IQR) Median regression (95% CI)  
MET (min/week) † N=349 2190 (1053, 4158) N=358 2012 (990, 4088) 93.95 (-264.81 to 452.72) 0.61 
MVPA (min/week) N=349 120 (0, 360) N=358 120 (0, 360) 10.43 (-39.31 to 60.18) 0.68 


















Figure 5.3: Maternal glycaemic load, saturated fat and energy intake at 6 months postpartum 
by randomisation allocation in obese women enrolled in the UPBEAT randomised controlled 
trial (n=242). 
Abbreviations: %E- Percentage energy; kcal/day- kilocalorie per day.Arithmetic mean with standard error 
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 b 95% CI  p-value  
Maternal anthropometry 
Early GWG* -0.41 -0.73 to -0.09 0.02 
Late GWG* * -0.45 -0.78 to -0.12 0.01 
Total GWG  -0.44 -0.78 to -0.11 0.01 
Maternal diet  
Glycaemic load at 27-28+6 
weeks’ 
-0.31 -0.65 to 0.04 0.08 
Saturated fat at 27-28+6 
weeks’ (%E) 
-0.38 -0.72 to -0.04 0.03 
Energy intake at 27-28+6 
weeks’ (kcal) 
-0.34 -0.68 to -0.01 0.05 
Figure 5.4: Casual mediation analysis assessing the influence of change in maternal dietary 
intake and gestational weight gain at 27-28 weeks' mediated on the observed difference in 
infant subscapular skinfold thickness in offspring born to obese pregnant women.  
* Early GWG defined as maternal weight objectively measured at 27-28+6 weeks’ gestation subtracted from 
weight at trial entry (15-18+6 weeks’ gestation). **Late GWG defined as maternal weight objectively measured 
at 34-36 weeks’ gestation subtracted from maternal weight at 27-28+6 weeks’. Casual mediation analysis was 
performed for late gestational weight gain, independent of early GWG. Abbreviations; GL- Glycaemic load, 






 Effect  b 95% CI  p-value  
Maternal Glycaemic load at 6 months *  
 Direct effect  -0.59 -1.29 to 0.11 0.100 
 Indirect effect  0.00 -2.80 to 0.00 0.570 
 Total effect  -0.59 -1.29 to 0.11 0.100 
Maternal Saturated fat at 6 months *  
 Direct effect  -0.42 -1.11 to 0.27 0.230 
 Indirect effect  - - - 
 Total effect  -0.42 -1.11 to 0.27 0.230 
Maternal energy intake at 6 months *  
 Direct effect  -0.62 -1.30 to 0.05 0.076 
 Indirect effect  0.015 -0.005 to 0.007 0.623 
 Total effect  -0.62 -1.30 to 0.06 0.076 
Figure 5.5: Casual mediation analysis assessing the effect of change in maternal diet at 6 
months postpartum mediated on infant subscapular skinfold thickness in offspring born to 
obese pregnant women.   
*Casual mediation analyses undertaken for maternal 6-month postpartum dietary intake independent of 





5.4.1 Overall findings 
This study has addressed the effect of a pregnancy lifestyle behavioural intervention in 
obese women on offspring adiposity, maternal diet and physical activity at 6 months 
postpartum. This study, for the first time has found that a dietary and physical activity 
intervention in pregnant women with obesity was associated with a reduction in a measure 
of offspring adiposity, and that changes in maternal diet during pregnancy persisted into the 
postnatal period. Further analyses suggested that the effect of the intervention on offspring 
adiposity was independently mediated by the observed reduction in maternal gestational 
weight gain, dietary fat and energy intake in pregnancy and therefore an expectation that 
lifestyle interventions have the potential to reduce offspring adiposity. Subscapular skinfold 
thickness, in comparison to the other anthropometric measurements assessed, is recognised 
as an accurate index of central adiposity, with a generally lower measurement error than 
triceps skinfold thickness (Godfrey et al., 1996b; Silventoinen et al., 2009). In children and 
adults, subscapular skinfold thickness has been related to impaired glucose metabolism, 
and in adolescents to increased serum cholesterol concentrations (Srinivasan et al., 2003; 
Santos et al., 2016). It is plausible, therefore that the maternal dietary and weight changes 
resulting from the intervention may influence infant body composition towards a healthier 
metabolic profile (Srinivasan et al., 2003; Craig et al., 2008; Renault et al., 2015).  
 
5.4.2 The effect of the UPBEAT intervention on infant adiposity at 6 months of age 
Although the magnitude of difference in this measure of adiposity (subscapular skinfold 
thickness) between intervention and controls arms was modest (5%), it reflected a 0.26 
reduction in z-score, which incorporated adjustment for infant sex and age. Indications 
from mother-child cohorts, including the USA Project Viva study, suggest that even 
modest differences in body composition at age 6 months may be amplified as the child 




Bogalusa Heart Study observed that greater offspring childhood subscapular skinfold 
thickness related to parental type 2 diabetes was associated with a subsequent adverse 
metabolic profile in early adulthood (Srinivasan et al., 2003). Any persistent influence of 
the intervention on childhood obesity will only be revealed as the children are older, but an 
abundance of evidence suggests that increased adiposity tracks from infancy, through 
childhood to adulthood (Cunningham et al., 2014). 
 
We are aware of only two relevant similar studies. The first, the Lifestyle in Pregnancy 
study (LIP) (Vinter et al., 2011), assessed body composition in older infants (2.8 years) of 
obese mothers (n=157) who had been randomised to an antenatal lifestyle intervention with 
the primary aim of reducing gestational weight gain. No change in infant total fat mass, as 
assessed by dual energy x-ray absorptiometry scan, was observed (Tanvig et al., 2014). 
However, it was not reported whether this intervention modified specific components of 
maternal antenatal diet or body composition, although a reduction in median gestational 
weight gain was observed. Secondly, a recent randomised controlled trial of a low 
glycaemic diet, but in women of heterogeneous BMI, found no difference in infant body 
composition at 6 months of age between intervention and control arms, despite a reduction 
in neonatal thigh circumference (Donnelly et al., 2015; Horan et al., 2016). The difference 
between these studies and UPBEAT may relate to the greater intensity of the UPBEAT 
intervention, involving 8 contact sessions with health trainers, at weekly intervals (Poston 
et al., 2015). 
 
5.4.3 Maternal postpartum diet composition and physical activity 
There remains a paucity of data regarding the long-term efficacy of lifestyle interventions 
in obese pregnant women (Patel et al., 2015). This study has shown that dietary advice 
focussing on a reduction of maternal insulin resistance, as a component of a complex 




health as well as familial nutritional environment (Owen et al., 2005; Robinson et al., 
2007; Ranjit et al., 2015). Although this study found significant differences in maternal 
nutritional composition, no differences were observed between groups in maternal BMI or 
measures of adiposity at 6 months postpartum. A sustained effect of any maternal dietary 
intervention on maternal dietary intake postpartum has to our knowledge not been reported 
previously. In contrast, in the LIMIT trial, follow up of 50.5% of participants, reported no 
difference in maternal dietary composition at 4 months postpartum, also by self-report 
(Dodd et al., 2014a). The lower magnitude of intervention effects on maternal dietary 
variables compared with UPBEAT may explain these differences. 
 
Using the method of causal mediation analysis, this study found evidence that the lower 
dietary saturated fat and energy intake at 28 weeks’ gestation induced by the UPBEAT 
intervention, rather than the change in glycaemic load, was associated with the reduction in 
infant subscapular skinfold thickness at 6 months of age. The reduction in gestational 
weight gain irrespective of timing and total gestational weight gain were also directly 
associated with the observed difference. These observations would concur with several 
reports describing associations between maternal gestational weight gain or diet and 
offspring adiposity (Oken et al., 2007; Okubo et al., 2014). Antenatal interventions shown 
to improve maternal diet and subsequently reduce gestational weight gain may therefore be 
pragmatic and effective measures to reduce early infant adiposity. 
 
5.4.4 Maternal breastfeeding and infant adiposity 
The observation that exclusive breastfeeding for more than 3 months may interact with the 
maternal intervention to reduce offspring triceps skinfold thickness provides some evidence 
that breast feeding may compound the benefits of the maternal intervention, although 
caution should be exercised in over-interpretation as the study was not powered to test 




elucidated; whilst we previously reported no differences in fasting lipids, C-peptide and 
insulin at 28 weeks’ gestation between randomisation arms (Poston et al., 2015), ongoing 
biochemical and metabolomic analyses in maternal and cord blood may provide insight 
into mechanistic pathways.  
 
5.4.5 Strengths and Limitations  
A limitation of this study was the follow up of only 47.3% of those infants eligible from the 
original randomised controlled trial (Poston et al., 2015), but this was similar to the rate of 
follow up of recently published randomised controlled trials in pregnant women (Tanvig et 
al., 2014; Landon et al., 2015; Horan et al., 2016). Due to the stringent inclusion of only 
complete dietary questionnaires, maternal dietary data was calculated only for 34.2% of the 
mothers. The dietary data was collected by self-report but compared favourably to a more 
rigorous method (triple pass 24hr recall) as assessed in the pilot trial (Poston et al., 2013). 
Strengths of the study include the prospective collection of in-depth data addressing 
familial and individual determinants of infant adiposity, and of maternal in-utero 
exposures. The richness of data in the UPBEAT study can be considered both a strength 
and limitation. Whilst providing comprehensive information relevant to developmental 
origins of early infant obesity, and assessment of mediation effects, limits are imposed on 
interpretation of secondary analyses in the context of multiple testing. 
 
5.4.6 Conclusion  
In conclusion, this study provides evidence of the potential for targeted intervention in 
obese women to improve health for the mother and her offspring. Pregnancy, as 
demonstrated in this study, appears to be a pragmatic ‘teachable’ moment for initiating 
long-term healthier dietary behaviours in the mother and reducing a physiologically 




Chapter 6  Role of early feeding on infant anthropometry  
6.1 Introduction  
The development of childhood obesity is multifactorial. A combination of exposure to an 
adverse in-utero environment as well as sub-optimal postnatal feeding and rapid growth 
trajectories are likely to play a contributory role, as discussed in Chapter 1 (Patel et al., 
2015). This chapter focusses on two facets of early life feeding; firstly, relationships 
between breast feeding and infant growth and body composition at six months, and 
secondly, the relationship between infant eating behaviours and anthropometric outcomes 
in children whose mothers participated in the UPBEAT study.  
 
Rapid infant weight gain within the first year of life has been associated with an increased 
risk of later obesity and raised systolic blood pressure in mid-childhood (Baird et al., 2005; 
Druet et al., 2012; Weng et al., 2012; Ong et al., 2015; Perng et al., 2016). Recent evidence 
supports the notion that the trajectory of growth associated with the development of later 
obesity is established in early infancy in offspring born to mothers of heterogeneous BMI 
(Stuart and Panico, 2016). Observational studies have implicated a role of early infancy 
nutritional status with the development of childhood obesity, thereby providing convincing 
evidence that early life mode and/or intensity of feeding may be a potential target, 
amenable to intervention, for the prevention of childhood obesity. One mechanism by 
which mode of infant feeding could lead to obesity in later life is through modification of 
early infant growth velocities, differentiation of adipocyte precursors and satiety and 
appetite regulation (Patel et al., 2015).  
 
Previous population studies have demonstrated that breastfeeding may be protective against 
later obesity; however these studies have been based on measures of offspring weight 




potential to disentangle the associations of early growth and mode of feeding with different 
components of body composition. The mechanisms remain speculative but could relate to 
reduced early growth trajectories or to other biological pathways, for example, persistent 
modification of the central appetite and satiety mechanisms (Bartok and Ventura, 2009; 
Berry et al., 2013).  
 
At present, the WHO recommends exclusive breastfeeding for the first 6 months of life 
with subsequent introduction of solids. Despite the known benefits of breastfeeding, obese 
women are less likely to breastfeed exclusively and more likely to introduce solids < 4 
months in comparison to lean women (Li et al., 2003). Since, specific influences of obese 
maternal feeding practices in relation to early infancy body composition remain unknown, 
this study sought to address the relationship between mode of early life feeding, age at 
weaning on measures of adiposity and growth in infants at 6 months of age.  
 
Few studies have addressed the relationship between offspring feeding behaviours and 
adiposity in early infancy (Agras et al., 1987; Taveras et al., 2004; Llewellyn et al., 2010). 
In one of these, utilising the validated Baby Eating Behaviour Questionnaire, 4 obesogenic 
appetite traits were identified and associated with weight gain from birth to 2 years 
(Llewellyn et al., 2011; Quah et al., 2015). This was prompted by previous experimental 
studies in animals suggesting a relationship between maternal obesity and offspring 
hyperphagia as described in Chapter 1: Introduction (Patel et al., 2015); this relationship 
mediated through fetal leptin known to influence neurodevelopment of the energy control 
centres of the hypothalamus (Ross and Desai, 2014). However, in human pregnancy cord 
leptin concentrations have been associated with approximately 10-15% of the variation in 
offspring weight, suggesting a more important influence of postnatal environmental factors 





The primary aim of this study was to assess the role of early life feeding practices, 
including mode of feeding and age at introduction of solids, and measures of body 
composition and growth in infants at 6 months, born to obese women. Since mechanisms 
controlling appetite and satiety are considered to develop in early infancy, relationships 
between mode of feeding and appetite and satiety were also studied. A third aim, was to 
investigate the relationship between measures of infant appetite and satiety with infant 





6.2 Research design and methods  
6.2.1  Study design  
The study design was a cohort analyses using complete cases from the UPBEAT dataset.  
 
6.2.2 Study population  
Details of the UPBEAT study population including trial inclusion and exclusion criteria are 
provided in Chapter 2: Methods.  
 
Mother and infant pairs were included within this analysis if they had attended the follow-
up visit at 6 months of age, completed a feeding and growth questionnaire and if detailed 
infant anthropometric data were available at 6 months of age. Infants were excluded if 
suffering from significant ill-health at 6 months, or born ≤34 weeks’ gestation. As preterm 
infants (born ≤ 34 weeks’ gestation) have significantly different growth trajectories in early 
infancy, and in appetite and satiety measures compared to infants born at term, they were 
excluded from the analysis (Llewellyn et al., 2010; Gong et al., 2013).   
 
6.2.3 Outcomes  
The primary outcome for this study was measures of infant adiposity as assessed by 
subscapular and triceps SFT z-scores derived using the WHO reference population (WHO, 
2006). Secondary outcomes included weight, length, BMI and mid-upper arm 
circumference z-scores, SSFT (mm), estimated body fat (%) derived from sex specific 
equations and infant weight and length gain velocity (Slaughter et al., 1988; WHO, 2006). 
Further assessment was made for overweight and obesity in early infancy, catch up and 
catch down growth as per WHO definitions. Associated definitions and methodology for 





Infant weight gain velocity in the first 6 months were calculated as; 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 (𝑔/𝑚𝑜𝑛𝑡ℎ) =
𝐼𝑛𝑓𝑎𝑛𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑎𝑡 6 𝑚𝑜𝑛𝑡ℎ𝑠 − 𝐵𝑖𝑟𝑡ℎ𝑤𝑒𝑖𝑔ℎ𝑡
𝐸𝑥𝑎𝑐𝑡 𝑎𝑔𝑒 𝑎𝑡 6 𝑚𝑜𝑛𝑡ℎ 𝑓𝑜𝑙𝑙𝑜𝑤 − 𝑢𝑝 (𝑚𝑜𝑛𝑡ℎ𝑠)
 
Infant length velocity within the first 6 months were calculated as; 
𝐿𝑒𝑛𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 (𝑐𝑚/ 𝑚𝑜𝑛𝑡ℎ) =
𝐼𝑛𝑓𝑎𝑛𝑡 𝑙𝑒𝑛𝑔ℎ𝑡 𝑎𝑡 6 𝑚𝑜𝑛𝑡ℎ𝑠 − 𝐿𝑒𝑛𝑔ℎ𝑡 𝑎𝑡 𝑏𝑖𝑟𝑡ℎ
𝐸𝑥𝑎𝑐𝑡 𝑎𝑔𝑒 𝑎𝑡 6 𝑚𝑜𝑛𝑡ℎ 𝑓𝑜𝑙𝑙𝑜𝑤 − 𝑢𝑝 (𝑚𝑜𝑛𝑡ℎ𝑠)
 
 
6.2.4 Exposures  
6.2.4.1 Early feeding and growth questionnaire  
Data regarding mode and duration of early feeding were collected using a validated feeding 
and growth questionnaire addressing mode, duration of early feeding and weaning history. 
Information was obtained on whether infants received anything other than breast milk 
during this period including water, sugar-sweetened beverages and food and mineral 
supplements. Questionnaires were administered by trained midwives at the 6 months 
postpartum study visit. Definitions of early life feeding exposures were derived based on 
previous studies (Huh et al., 2011),  and are summarised in Table 6.1.  
 Exposure  Definition  
Exclusive breastfeeding  Exclusive breastfeeding ≥ 4 months (122 days) of age where infants 
did not receive anything else with the exception of water 
Formula feeding  Last episode of breastfeeding ≤2 months (61 days) of age where 
data was also provided on the age of introduction of formula feeding 
and type of formula milk provided 
Mixed feeding  Last episode of breastfeeding >2 months and ≤4 months of age In 
scenarios where predominately breastfed infants received 
supplements of sugar sweetened beverages, this was classed as 
mixed feeding.  
Table 6.1: Definitions of early mode of feeding exposure used in investigating the role of early 
infant feeding on body composition at 6 months of age. 
 
6.2.4.2 Introduction of solid foods  
This was defined as the age of introduction to any type of solid foods. Recent evidence has 




to women of heterogeneous BMI, despite WHO guidance (Chivers et al., 2010; Huh et al., 
2011; Barrera et al., 2016). In accordance with previously published data, the average 
weaning age was categorised as “introduction to solids ≤4 months”, “introduction to solids 
between 4-5 months” and “introduction of solids ≥6 months” 
 
6.2.4.3 Infant appetite and satiety questionnaire   
The validated Baby Eating Behaviour Questionnaire was used to assess infant appetite and 
satiety at 6 months of age (Llewellyn et al., 2011). This 18-item questionnaire provides a 
standardised measure to characterise infant appetite characteristics, previously associated 
with excessive weight gain in children (Llewellyn et al., 2011). Mothers were required to 
score their baby’s feeding style during a ‘typical daytime feed’ and responses varied from 
never (1) to always (5). The questionnaire was adapted from the Children’s Eating 
Behaviour Questionnaire which identified five distinctive appetite traits; enjoyment of 
food, food responsiveness, slowness in eating, satiety responsiveness and general appetite 
(Llewellyn et al., 2011). Questionnaires were analysed in accordance with previously 
published guidance (Llewellyn et al., 2011; Mallan et al., 2014).  
 
6.2.5 Confounder selection   
Potential confounders and covariates were identified a-priori based on relevant clinical 
information and literature as summarised in Table 6.2. Direct acyclic graphs were drawn 
including all potential confounders to visualise potential inter-relationships as shown in 
Figure 6.1. To estimate the effect of early mode of feeding on infant anthropometry, 
adjustment was made for offspring sex, age at 6 month follow up visit and randomisation to 
the UPBEAT intervention (Model 1). Further adjustment was made for early pregnancy 
maternal BMI, ethnicity, socioeconomic deprivation, incidence of GDM and neonatal size 
at birth (Model 2). To assess the influence of infant appetite and satiety on measures of 




concentration and mode of infant feeding (Model 3). Cord blood leptin concentrations have 
been previously inversely associated with offspring satiety response and adiposity in early 
infancy (Christou et al., 2001; Bouret, 2010; Boeke et al., 2013). Mode of feeding has 
shown to be independently associated with growth and adiposity deposition in early life 
(Owen et al., 2005).  
 
Methods relating to collection of potential confounders and cord blood leptin sample 
collection and analyses are provided in Chapter 2: Methods. 
 
6.2.6 Statistical analysis  
A complete case analysis was undertaken. Observations with missing outcome, exposure, 
and confounder data were excluded from the analysis. Baseline maternal and infant 
characteristics were summarised by mode of early feeding (exclusive breastfeeding, 
formula and mixed feeding). Continuous maternal and infant characteristics were 
summarised by mean (SD) or median (IQR), where appropriate. Binary and categorical 
variables were summarised by count and percentages. Assessment was undertaken to 
identify if the distribution of infant anthropometry differed by offspring sex. Comparisons 
were made between the different modalities of early feeding and measures of infant body 
composition and anthropometry at 6 months by chi-squared t-test, anova or a Kruskal-
Wallis-h-test where appropriate.  
 
To investigate the association between mode of early infant feeding and measures of infant 
anthropometry, multivariate linear or logistic regression was used as appropriate, with 
adjustment for potential confounders. To test for potential interactions, Wald test was used 
to assess whether the relationship between mode of early feeding and infant anthropometry 
was modified by the timing of introduction of solids. Statistical significance for the 





Measures of infant appetite and satiety were summarised using median and IQR. To assess 
the relationship between mode of early feeding with infant appetite and satiety at 6 months 
of age, linear regression analysis was undertaken (Llewellyn et al., 2010), with exclusive 
breastfeeding set as the reference category. To assess the influence of measures of appetite 
and satiety with infant anthropometry, linear or logistic regression was undertaken as 
appropriate with adjustment for potential confounders (Model 2 & Model 3).  
 
6.2.6.1 Missing data and sensitivity analysis  
To assess for the potential selection bias within this analysis, comparisons were made 
between mother-offspring pairs included and excluded within this study. A further analysis 
was undertaken by excluding infants born ≥34 weeks and <37 weeks, in addition to those 
born <34 weeks. 
 
From the 698 infants with detailed anthropometric data at 6 months, 47.1% had missing 
exposure and confounder data, therefore assessment was made for the possibility that 
missing data resulted in potential selection bias using three complementary methods. 
Firstly the Little Chi-squared dependent test was undertaken to explore the potential of the 
data being missing not at random for missing exposure and confounder data in relation to 
infant outcomes at 6 months (Catalano and Hauguel-De Mouzon, 2011). A second 
assessment was made, to identify predictors of missingness to determine whether the 
mechanism of missingness was MCAR or MAR. Thirdly for the primary aim of this study; 
to assess the mode of feeding on infant growth and body composition, multivariate chain 
equations was used to impute the missing exposure and confounder data for infants with 
detailed anthropometric measures at 6 months of age (n=698). Assessment was undertaken 
to determine known predictors of missingness and data was subsequently imputed to create 




Table 6.2: Description and reasoning behind potential confounders and covariates associated 
with mode of early feeding and infant anthropometry at 6 months of age. 
All confounders and their interrelationships were illustrated using direct acyclic graphs and minimal sufficient 
adjustment was undertaken.
Confounder  Definition  Reasoning  
Maternal 
Maternal age Continuous Increasing maternal age has been associated with 
increasing duration of exclusive breastfeeding (Jones 
et al., 2011) and reduced abdominal adiposity in 
infants aged between 19-44 years (Savage et al., 
2013). 
Maternal BMI  Continuous  Increasing maternal BMI is an independent risk factor 
for early introduction of solid food to infants of lean 
women (Castillo et al., 2016). Maternal BMI is an 
independent risk factor for increasing infant adiposity 
(Lawlor et al., 2012; Sharp et al., 2015).  
Parity  Binary; 0-Nultip 
(reference), 1-Multip  
Multiparity is associated with increased incidence of 
breastfeeding and independently associated with 
higher infant adiposity (Gaillard et al., 2014a; 










Population level data has identified associations 
between sociodemographic level and breastfeeding 
(Oakley et al., 2013). As discussed in Chapter 1: 
Introduction, socioeconomic deprivation is associated 
with an increased risk of childhood obesity (Falconer 





2-Asian, 3-Other  
Maternal ethnicity is strongly associated with infant 
adiposity. Maternal ethnicity influences the immediate 
familial environment including feeding practices 




Binary; 0 <12 years 
full time education, 
1->12 years of full 
time education 
(reference) 
Reduced educational attainment has been associated 
with a dose-response relationship with duration of 
breastfeeding (Lamerz et al., 2005).  
 
Maternal GDM  Binary; 0- No 
gestational diabetes 
(reference), 1- 
Gestational diabetes  
Maternal GDM is associated with infant body 
composition (Metzger et al., 2009) and demonstrated 
to influence mode of feeding (Gunderson, 2007). 
Total GWG  Continuous 
measured in Kg 
Observational studies have demonstrated an 
independent association between maternal total GWG 
and offspring adiposity (Karachaliou et al., 2015).  
Offspring    
Size at birth  Birthweight/ 
birthweight z-scores  
Size at birth and faster postnatal growth are associated 
with earlier introduction of solids(Bergmann et al., 
2003) . Increased birthweight is associated with larger 
appetites, greater enjoyment of food and increased 
responsiveness to food cues in comparison to low 
birthweight infants (Llewellyn et al., 2010; Llewellyn 




measured in days.  
Increasing infant age has been associated has 
consistently been associated with increasing 
anthropometric measurements (Carberry et al., 2010).  
Infant sex  Binary variable; 0-
Female, 1-Male  
Adipose tissue is deposited differentially in males and 
females. Sex differences in glycaemic sensitivity are 






Figure 6.1: Direct acyclic graphs illustrating the interrelationship between potential confounders with early mode of feeding and infant anthropometry at 6 months 
of age.  
The UPBEAT intervention, age at follow-up and infant sex were covariates (blue) within the statistical models. Abbreviations GDM- Gestational diabetes; GWG- Gestational weight gain. 




6.3 Results  
6.3.1 Demographic characteristics 
Of the 1522 live-born neonates, 353 infants were included within this analysis (Figure 6.2). 
Infants were excluded for the analysis due to missing early life feeding data (16.6%) and 
confounder data (32.6%) (Figure 6.2). Infants without anthropometric measurements 
differed from those with; further details are provided in Chapter 5: Infant adiposity 
following a randomised controlled trial of a behavioural intervention in obese pregnancy. 
Of the included infants, 46.7% were exclusively breastfed ≥ 4 months, 45.6% were formula 
fed and 7.6% were fed a mixture of breast and formula feed. Within this cohort, 46.6% 
infants were introduced solids <4.6 months of age (Table 6.3). Mothers exclusively 
breastfeeding were significantly more likely to be older, Caucasian, have a higher BMI, 
and increased incidence of GDM (Table 6.3). There was no evidence to suggest that the 
distribution of infant anthropometry differed by offspring sex, therefore reported results 
were not stratified by infant sex (Figure 6.3).  
 
6.3.2 Association of early mode of feeding and infant anthropometry at 6 months 
Univariate analysis comparing mode of early life feeding and infant body composition are 
summarised in Table 6.4. Following adjustment for maternal and infant confounding, 
formula feeding was associated with significantly higher weight z-scores and rate of weight 
gain at 6 months of age in comparison to infants exclusively breastfed (Table 6.5). Formula 
feeding was also associated with increased odds of catch up growth within the first 6 
months of age (Table 6.5).  Infants fed a mixture of breast and formula feed had 
significantly lower arm z-scores at 6 months of age (Table 6.5).  Other measures of infant 
anthropometry did not differ by mode of early life feeding (Table 6.5) following 





6.3.3 Timing of introduction of solids, mode of early feeding and infant anthropometry at 
6 months.  
There were no significant differences between mode of early feeding, age at introduction of 
solids and infant anthropometry at 6 months of age, in offspring born to obese women. 
(Table 6.6, Figure 6.4, Figure 6.5). 
 
6.3.4 Infant appetite and satiety, mode of early feeding and infant anthropometry at 6 
months 
Formula feeding in early life was associated with reduced enjoyment of food in comparison 
to children who were breastfed (Table 6.7). Food responsiveness, general appetite, 
slowness in eating and satiety responsiveness did not differ between other modes of feeding 
(Table 6.7). 
  
Measures of general appetite as assessed by the Baby Eating Behaviour Questionnaire were 
found to be associated with infant subscapular SFT, SSFT, total body fat (%), weight z-
scores and catch up growth following adjustment for maternal and offspring confounders 
(Model 2) (Figure 6.6, Figure 6.7). Following adjustment for cord leptin concentrations and 
mode of feeding, the associations appeared more apparent (Model 3) (Figure 6.6, Figure 
6.7). Reduced satiety responsiveness in contrast was associated with reduced measures 
SSFT and total body fat, however did not remain significant following adjustment for cord 
leptin concentrations and mode of early feeding (Model 3) (Figure 6.8, Figure 6.9). There 
were no associations with measures of enjoyment of food, food responsiveness and 
slowness of eating with infant growth and adiposity at 6 months of age, in offspring born to 





6.3.5 Sensitivity analysis and missing data 
Assessment was made for selection bias and it was found that mothers of infants included 
within the main analysis were significantly older, were more likely to be nulliparous and 
more likely to be Caucasian, in comparison to those excluded from the analysis (Table 6.9). 
There was no difference in the incidence of GDM or total GWG between those included 
and excluded within the analysis. Infants included did not differ by gestational age at 
delivery, birthweight or measures of neonatal adiposity including neonatal SSFT or 
neonatal arm circumference in comparison to those excluded (Table 6.9). However, 
neonates included had a marginally reduced, but significant, abdominal circumference than 
those excluded from the analysis at birth (Table 6.9). Exclusion of infants born <37 weeks’ 
gestation, demonstrated no significant differences in the observed associations (Table 
6.10). 
 
Using Little’s Covariate dependent missing test, there was no evidence of the data being 
‘missing not at random’ (Prob > Chi-square =0.967). Patterns of missing data (including 
missing exposure and covariate data) were explored. Centre, maternal age, number of years 
in full time education and gestation at delivery were identified to be significant predictors 
of missingness, suggesting that the pattern of missing data within this analyses was likely 
to be MAR (Table 6.11). Maternal early pregnancy BMI, socioeconomic deprivation, total 
GWG or incidence of GDM were not identified as significant predictors of missingness 
(Table 6.11). Using multiple imputation by chained equations as a sensitivity analyses, 


























Figure 6.2: Flow diagram of mother-infant pairs included within this analysis.  
 
  
1522 live-born neonates 
Refused follow-up at 6 months 
postpartum (n=100) 
Did not respond to follow up (n=701) 
Infant death (n=1) 
 
698 neonates with detailed anthropometric 
measurements at 6months of age.   
Excluded (n=345):  
Delivery <34 weeks (n=1) 
Missing exposure data (n=116) 
Missing covariate/ confounder data (n=228) 
353 infants included within 





Figure 6.3: Distributional assessment of infant anthropometric measurements at 6 months of 
age by stratified by offspring sex.  
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(IQR)/ N (%) 
Maternal  
Age (years) 32.03 (4.72) 30.92 (5.45) 29.56 (5.55) 0.002 
Multiparous 80 (48.48) 68 (40.48) 15 (53.57) 0.220 
BMI (kg/m2) 35.87 (4.96) 37.30 (5.22) 35.06 (5.41) 0.01 
Ethnicity 
White  101 (61.21) 131 (81.37) 19 (70.37) <0.001 
Black  40 (24.24) 15 (9.32) 7 (25.93) 0.001 
Asian  7 (4.24) 4 (2.48) 0 (0.00) 0.412 
Other  17 (10.30) 11 (6.83) 1 (3.70) 0.352 
Current smoker in 
early pregnancy 
3 (1.82) 5 (3.11) 0 (0.00) 0.054 
Socioeconomic 
deprivation  
108 (78.36) 94 (77.05) 17 (85.00) 0.726 
Gestational 
diabetes*  
34 (20.61) 62 (38.51) 7 (25.93) 0.002 
Gestational weight 
gain (kg)** 
7.19 (4.39) 7.80 (4.75) 8.29 (4.37) 0.339 
Neonate 
Gestation at delivery 
(weeks) 
40.29 (39.00 to 
41.00) 
39.86 (38.43 to 
41.71) 
39.86 (38.86 to 
41.00) 
0.077 
Birthweight (grams) 3600 (3210 to 
3845) 
3428 (3155 to 
3760) 
3360 (3140 to 
3660) 
0.159 
Neonatal sum of 
skinfold thicknesses 
(mm)^ 
10.77 (2.81) 10.92 (2.91) 9.96 (1.78) 0.429 
Neonatal abdominal 
circumference (cm) 
32.17 (2.31) 32.30 (2.03) 32.02 (2.31) 0.867 
Neonatal arm 
circumference (cm) 
11.46 (0.99) 11.62 (1.00) 11.14 (0.83) 0.158 
(log2) Cord blood 
leptin (ng/ml) 
2.85 (0.70) 2.72 (0.72) 2.78 (0.71) 0.49 
Table 6.3: Maternal and neonatal demographic, clinical and biochemical characteristics 
stratified by mode of early feeding; data from the UPBEAT study (n=353) 
*Gestational diabetes diagnosed using the International Association of Diabetes in Pregnancy Group’s criteria 
at 24-28 weeks’ gestation. **Gestational weight gain defined as total weight gain from calculated pre-
pregnancy weight gain to 34-36 weeks’ gestation. ^Neonatal sum of skinfolds defined as sum of triceps skinfold 












Mean (SD)/ N 
(%) 
Mean (SD)/ N (%) Mean (SD)/N 
(%) 
Triceps skinfold z-scores* 0.05 (1.50) 0.16 (1.38) 0.17 (1.30) 0.79 
Subscapular skinfold z-
scores* 
0.24 (1.45) 0.16 (1.44) 0.30 (1.42) 0.82 
Sum of skinfold thickness 
(mm) 
17.30 (4.08) 17.36 (3.94) 17.50 (4.18) 0.97 
Total body fat estimation 
(%) ^ 
19.75 (5.20) 19.70 (5.06) 19.81 (5.26) 0.99 
Weight z-score* 0.15 (1.06) 0.28 (1.01) 0.18 (1.04) 0.52 
BMI z-scores* -0.13 (1.85) 0.06 (1.53) 0.12 (1.44) 0.68 
Length z-scores* 0.51 (1.82) 0.53 (1.60) 0.18 (1.49) 0.62 
Arm circumference z-
scores * 
1.07 (1.01) 1.14 (1.02) 1.37 (1.06) 0.39 
Weight change (kg/ 
month) 
0.63 (0.14) 0.68 (0.13) 0.67 (0.15) 0.02 
Length change 
(cm/month) 
2.52 (0.64) 2.64 (0.61) 2.61 (0.54) 0.38 
BMI z-scores ≥85th *  16 (10.30) 15 (10.00) 4 (16.60) 0.61 
BMI z-scores ≥ 95th *  5 (3.11) 8 (5.10) 2 (7.69) 0.47 
Catch up growth * 38 (23.60) 56 (35.67) 9 (34.62) 0.06 
Catch down growth*  49 (30.43) 36 (23.08) 5 (19.23) 0.23 
Table 6.4: Univariate analysis of infant body composition at 6 months of age stratified by 
mode of early feeding in offspring born to obese women (n=353) 
*Infant z-scores calculated using the WHO growth standards; Catch up and catch down growth defined using 
the WHO definitions of change in weight >0.67 SDs (WHO, 2006). ^Infant total body fat estimation calculated 





















 Breastfeeding Formula feeding (n=161) Mixed feeding (N=27) 
Mean difference (95% CI) p-value  Mean difference (95% CI) p-value  
Triceps SFT z-scores * Model 1 REF 0.07 (-0.24 to 0.39) 0.64 0.00 (-0.36 to 0.37) 0.98 
Model 2 0.20 (-0.39 to 0.79) 0.51 0.47 (-0.19 to 1.13) 0.16 
Subscapular SFT z-scores* Model 1 REF -0.10 (-0.41 to 0.21) 0.53 0.21 (-0.14 to 0.57) 0.23 
Model 2 0.03 (-0.55 to 0.62) 0.91 0.37 (-0.27 to 1.01) 0.25 
SSFT (mm) Model 1 REF -0.04 (-0.92 to 0.84) 0.93 0.37 (-1.27 to 2.00) 0.66 
Model 2 -0.33 (-0.64 to 1.29) 0.51 1.44 (-0.30 to 3.19) 0.10 
Total body fat estimation (%) ^ Model 1 REF 0.04 (-1.15 to 1.07) 0.94 0.47 (-1.61 to 2.54) 0.66 
Model 2 -0.44 (-0.78 to 1.65) 0.48 1.84 (-0.37 to 4.04) 0.10 
Weight z-scores* Model 1 REF 0.10 (-0.13 to 0.33) 0.39 0.05 (-0.38 to 0.47) 0.82 
Model 2 0.26 (0.01 to 0.52) 0.04** 0.21 (-0.25 to 0.67) 0.37 
BMI z-scores* Model 1 REF 0.13 (-0.24 to 0.51) 0.49 0.24 (-0.46 to 0.94) 0.50 
Model 2 0.23 (-0.21 to 0.67) 0.31 0.52 (-0.28 to 1.32) 0.20 
Length z-scores*  Model 1 REF -0.01 (-0.39 to 0.38) 0.97 -0.34 (-1.05 to 0.38) 0.35 
Model 2 -0.26 (-1.9 to 0.71) 0.26 -0.30 (-1.11 to 0.51) 0.46 
Arm circumference z-scores * Model 1 REF 0.04 (-0.18 to 0.27) 0.70 0.31 (-0.11 to 0.72) 0.15 
Model 2 0.10 (-0.16 to 0.36) 0.46 0.52 (0.05 to 1.00) 0.03** 
Rate of weight gain (kg/ month) Model 1 REF 0.03 (-0.00 to 0.05) 0.07 0.02 (-0.03 to 0.08) 0.39 
Model 2 0.04 (0.00 to 0.07) 0.04** 0.03 (-0.03 to 0.09) 0.41 
Rate of length gain (cm/month) Model 1 REF 0.07 (-0.10 to 0.25) 0.40 0.05 (-0.26 to 0.36) 0.76 
Model 2 0.15 (-0.07 to 0.37) 0.18 0.01 (-0.35 to 0.37) 0.96 
BMI z-scores ≥85th *  Model 1 REF 0.99 (0.48 to 2.05) 0.97 1.61 (0.49 to 5.27) 0.43 
Model 2 0.92 (0.35 to 2.40) 0.87 2.28 (0.54 to 9.65) 0.26 
BMI z-scores ≥ 95th * Model 1 REF 1.58 (0.51 to 4.94) 0.43 2.40 (0.44 to 13.05) 0.31 
Model 2 2.45 (0.59 to 10.2) 0.22 2.22 (0.21 to 23.64) 0.51 
Catch up growth * Model 1 REF 1.80 (1.10 to 2.92) 0.02** 1.71 (0.71 to 4.15) 0.24 
Model 2 2.48 (1.31 to 4.71) 0.01** 1.75 (0.59 to 5.25) 0.32 
Catch down growth*  Model 1 REF 0.68 (0.41 to 1.13) 0.14 0.55 (0.19 to 1.54) 0.25 




Table 6.5: Multivariate analyses assessing the role of mode of early feeding on measures of infant anthropometry at 6 months of age, in offspring born to obese 
women (n=353)  
*Infant z-scores calculated using the WHO growth standards (WHO, 2006). Catch up and catch down growth defined using the WHO definitions of change in weight >0.67 SDs; Infant sum of 
skinfold thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured in triplicates. ^Infant total body fat estimation calculated sex-specific, validated 
equations (Slaughter et al., 1988). Model 1- Adjustment made for randomisation to the UPBEAT Intervention, infant sex and infant age at anthropometric measurement. Model 2- Adjustment 
made randomisation to the UPBEAT Intervention, infant sex and infant age at anthropometric measurement as well as maternal early pregnancy BMI, ethnicity, socioeconomic deprivation, 


























Triceps SFT z-scores* -0.82 (1.44) 0.21 (1.51) -0.72 (1.29) 0.10 (1.38) 0.17 (1.42) 0.22 (1.14) 0.08 (1.45) 0.33 (1.17) - 
Subscapular z-scores* 0.10 (1.46) 0.27 (1.43) 0.23 (1.58) -0.05 (1.41) 0.18 (1.43) 0.51 (1.61) 1.00 (1.12) 0.19 (1.43) - 
SSFT (mm) 15.55 (3.72) 17.62 (4.14) 17.06 (3.77) 16.94 (3.70) 17.39 (4.02) 18.13 (4.05) 18.58 (4.86) 17.49 (3.89) - 
Total body fat estimation (%) 17.48 (4.82) 20.17 (5.30) 19.41 (4.60) 19.25 (4.68) 19.71 (5.20) 20.66 (5.19) 21.57 (6.54) 19.68 (4.69) - 
Weight z-scores* 0.03 (0.79) 0.22 (1.08) -0.07 (1.15) 0.23 (1.05) 0.29 (0.98) 0.36 (1.18) -0.11 (1.14) 0.32 (1.03) - 
BMI z-scores* -0.51 (1.07) -0.04 (2.02) -0.28 (1.26) 0.17 (2.00) 0.00 (1.37) -0.36 (1.28) -0.65 (1.11) 0.40 (1.50) - 
Length z-scores* 0.72 (1.40) 0.53 (1.97) 0.22 (1.25) 0.28 (2.15) 0.53 (1.42) 1.11 (1.25) 0.68 (0.86) 0.06 (1.66) - 
Arm circumference z-scores 0.60 (1.06) 1.17 (1.00) 0.95 (1.08) 1.02 (1.03) 1.17 (1.03) 1.21 (0.96) 1.24 (1.08) 1.48 (1.06) - 
Rate of weight change (kg/month) 0.65 (0.15) 0.63 (0.14) 0.63 (0.14) 0.68 (0.13) 0.67 (0.13) 0.69 (0.14) 0.66 (0.11) 0.68 (0.16) - 
Rate of length change (cm/month) 2.90 (0.25) 2.48 (0.69) 2.52 (0.43) 2.62 (0.79) 2.57 (0.65) 2.84 (0.52) 2.81 (0.19) 2.54 (0.62) - 
BMI ≥95th centile*  0 (0.0) 5 (4.2) 0 (0.0) 3 (7.9) 4 (3.9) 1 (6.3) 0 (0.0) 2 (10.5) 0 (0.0) 
BMI ≥85th centile*  0 (0.0) 12 (10.4) 4 (18.2) 2 (5.7) 12 (12.1) 1 (6.7) 0 (0.0) 4 (23.5) 0 (0.0) 
Catch up growth  7 (36.8) 26 (21.7) 5 (22.7) 16 (42.1) 35 (34.0) 5 (31.3) 2 (33.3) 7 (36.8) 0 (0.0) 
Catch down growth  5 (26.3) 37 (30.8) 7 (31.8) 6 (15.7) 28 (27.5) 2 (12.5) 0 (0.0) 4 (21.1) 0 (0.0) 
Table 6.6: Differences in infant anthropometry stratified by mode of early life feeding and age at introduction of solids in offspring born to obese women (n=353).  
*Infant z-scores calculated using the WHO growth standards(WHO, 2006). Catch up and catch down growth defined using the WHO definitions of change in weight >0.67 SDs; Infant sum of 
skinfold thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured in triplicates. ^Infant total body fat estimation calculated sex-specific, validated 
equations (Slaughter et al., 1988). Wald test for 3-way interaction p>0.05 for all infant anthropometric measures at 6 months of age. Adjustment made for randomisation to the UPBEAT 





Figure 6.4: The association between mode of early feeding, timing of introduction of solid foods and infant adiposity at 6 months of age, in offspring born to obese 
women (n=353)  
Wald test for interaction p>0.05. Breastfeeding and introduction of solids ≥4.6 months was treated the reference category within the analysis. Infant z-scores calculated using the WHO growth 
standards(WHO, 2006); definitions of change in weight >0.67 SDs; Infant sum of skinfold thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured 
in triplicates. Infant total body fat estimation calculated sex-specific, validated equations (Slaughter et al., 1988). Adjustment made for randomisation to the UPBEAT Intervention, infant sex 
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Figure 6.5: The association between mode of early feeding, timing of introduction of solid foods and measures of infant growth at 6 months of age, in offspring born 
to obese women (n=353).  
Wald test for interaction p>0.05. Breastfeeding and introduction of solids ≥4.6 months was treated the reference category within the analysis. Infant z-scores calculated using the WHO growth 
standards(WHO, 2006); definitions of change in weight >0.67 SDs;  Infant sum of skinfold thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each 
measured in triplicates. Infant total body fat estimation calculated sex-specific, validated equations (Slaughter et al., 1988). Adjustment made for randomisation to the UPBEAT Intervention, 





Table 6.7: Measures of infant appetite and satiety at 6 months of age by mode of early feeding 
in offspring born to obese women (n=353).  
Data obtained from the validated Baby Eating Behaviour Questionnaire (Llewellyn et al., 2011). Adjustment 
made for randomisation to the UPBEAT intervention, infant sex, infant age at anthropometric measurement as 
well as maternal early pregnancy BMI, ethnicity, socioeconomic deprivation, gestational diabetes and infant 





Formula (N=161) Mixed (N=27) 






-0.751 -1.235 -0.267 0.002 -
0.909 
-1.974 0.156 0.094 
Food 
responsiveness 
0.365 -0.745 1.476 0.518 1.583 -4.222 3.588 0.121 
General appetite  -0.180 -0.441 0.081 0.176 0.043 -0.399 0.486 0.847 
Slowness in 
eating  
-0.035 -0.578 0.507 0.898 0.380 -0.618 1.379 0.455 
Satiety 
responsiveness  





Figure 6.6: Associations between measures of general appetite with infant adiposity and anthropometry at 6 months of age, in offspring born to obese women 
(n=353).  
Regression coefficients and 95% confidence intervals plotted. Model 2: adjustment made for randomisation to the UPBEAT intervention, maternal early pregnancy BMI, socioeconomic 
deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex and age at 6 month follow-up visit. Model 3- adjustment made for randomisation to the UPBEAT intervention, 
maternal early pregnancy BMI, socioeconomic deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex, cord blood leptin, age at 6 month follow-up and mode of early 





Figure 6.7: Associations between measures of general appetite with infant obesity and growth at 6 months of age, in offspring born to obese women (n=353).  
Odds ratio and 95% confidence intervals plotted. Model 2: adjustment made for randomisation to the UPBEAT intervention, maternal early pregnancy BMI, and socioeconomic deprivation, and 
ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex and age at 6 month follow-up visit. Model 3- adjustment made for randomisation to the UPBEAT intervention, maternal 
early pregnancy BMI, socioeconomic deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex, cord blood leptin, age at 6 month follow-up and mode of early feeding. 







Figure 6.8: Associations between measures of satiety responsiveness with infant adiposity and anthropometry at 6 months of age, in offspring born to obese women 
(n=353).  
Regression coefficients and 95% confidence intervals plotted. Model 2: adjustment made for randomisation to the UPBEAT intervention, maternal early pregnancy BMI, socioeconomic 
deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex and age at 6 month follow-up visit. Model 3- adjustment made for randomisation to the UPBEAT intervention, 
maternal early pregnancy BMI, socioeconomic deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex, cord blood leptin, age at 6 month follow-up and mode of early 





Figure 6.9: Associations between measures of satiety responsiveness with infant obesity and growth at 6 months of age, in offspring born to obese women (n=353).  
Odds ratio and 95% confidence intervals plotted. Model 2: adjustment made for randomisation to the UPBEAT intervention, maternal early pregnancy BMI, socioeconomic deprivation, 
ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex and age at 6 month follow-up visit. Model 3- adjustment made for randomisation to the UPBEAT intervention, maternal 
early pregnancy BMI, socioeconomic deprivation, ethnicity, diagnosis of gestational diabetes, offspring birthweight, sex, cord blood leptin, age at 6 month follow-up and mode of early feeding. 





 Enjoyment of food  Food responsiveness  Slowness in eating  
Mean difference (95% CI)/  
Odds ratio (95% CI) † 
Mean difference (95% CI)/  
Odds ratio (95% CI) † 
Mean difference (95% CI)/  
Odds ratio (95% CI) † 
Triceps skinfold z-scores * -0.04 (-0.19 to 0.10) 0.02 (-0.03 to 0.07) -0.04 (-0.15 to 0.06) 
Subscapular skinfold thickness z-scores*  -0.05 (-0.19 to 0.09) 0.03 (-0.01 to 0.08) -0.01 (-0.11 to 0.09) 
Sum of skinfold thickness (mm)** -0.10 (-0.48 to -0.28) 0.08 (-0.47 to 0.21) -0.10 (-0.37 to 0.17) 
Total body fat estimation (%) ^ -0.12 (-0.60 to 0.36) 0.10 (-0.05 to 0.26) -0.13 (-0.47 to 0.21) 
Weight z-scores*  -0.07 (-0.18 to 0.03) 0.02 (-0.02 to 0.06) -0.02 (-0.09 to 0.06) 
BMI z-scores * -0.06 (-0.26 to 0.13) -0.08 (-0.07 to 0.06) -0.12 (-0.26 to 0.02) 
Length z-scores*  -0.05 (-0.25 to 0.15) 0.03 (-0.03 to 0.10) 0.08 (-0.05 to 0.22) 
Arm circumference z-scores * -0.06 (-0.16 to 0.04) 0.01 (-0.03 to 0.04) -0.03 (-0.10 to 0.04) 
Weight change (kg/month) -0.01 (-0.02 to 0.00) 0.00 (-0.00 to 0.01) -0.00 (-0.01 to 0.01) 
Length change (cm/month) -0.04 (-0.12 to 0.05) 0.15 (-0.01 to 0.43) 0.04 (-0.01 to 0.10) 
BMI z-scores ≥85th centile  0.86 (0.63 to 1.18) 1.03 (0.88 to 1.20) 0.72 (0.51 to 1.04) 
BMI z-scores ≥95th centile  1.02 (0.51 to 2.06) 0.78 (0.57 to 1.10) 0.57 (0.29 to 1.11) 
Catch up growth** 0.98 (0.76 to 1.26) 1.13 (0.98 to 1.26) 0.88 (0.71 to 1.07) 
Catch down growth**  1.10 (0.78 to 1.55) 0.98 (0.90 to 1.08) 1.01 (0.81 to 1.25) 
Table 6.8: Associations between measures of infant appetite including measures of enjoyment of food, food responsiveness and slowness in eating with infant 
adiposity and anthropometry at 6 months of age, in offspring born to obese women (n=353). 
 
No significant associations were observed between measures of enjoyment of food, food responsiveness and slowness of eating with infant anthropometry at 6 months of age. Data obtained from 
the validated Baby Eating Behaviour Questionnaire (Llewellyn et al., 2011). *Infant z-scores calculated using the WHO growth standards(WHO, 2006); **Catch up and catch down growth 
defined using the WHO definitions of change in weight >0.67 SDs;  Infant sum of skinfold thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured 
in triplicates. ^Infant total body fat estimation calculated sex-specific, validated equations (Slaughter et al., 1988). † Analyses adjusted for randomisation to the UPBEAT intervention, maternal 
early pregnancy BMI, socioeconomic deprivation, ethnicity, and diagnosis of gestational diabetes, offspring birthweight, sex, and cord blood leptin, age at 6 month follow-up and mode of early 





Table 6.9: Comparison of baseline maternal and neonatal demographic, clinical, and 
anthropometric characteristics between those included (n=353) and excluded (n=1167) from 
the analysis.  
*Gestational diabetes diagnosed using the International Association of Diabetes in Pregnancy Group’s criteria 
at 24-28 weeks’ gestation. **Gestational weight gain defined as total weight gain from calculated pre-
pregnancy weight gain to 34-36 weeks’ gestation. ^Neonatal sum of skinfolds defined as sum of triceps skinfold 
thicknesses and subscapular skinfold thicknesses, each measured in triplicates. 
  
 Included  Excluded  P-value  
Mean (SD)/ Median 
(IQR)/ N (%) 
N=353 
Mean (SD)/ Median 
(IQR)/N (%) 
N=1167 
Age (years) 31.33 (5.16) 30.20 (5.58) <0.001 
Multiparous 162 (45.8) 697 (59.8) <0.001 
BMI (kg/m2) 36.45 (5.16) 36.25 (4.65) 0.508 
Ethnicity    
White  251 (70.9) 706 (60.5) <0.001 
Black  63 (17.8) 325 (27.9) <0.001 
Asian  11 (3.1) 80 (6.9) 0.012 
Other  29 (8.2) 55 (4.7) 0.013 
Current smoker in 
early pregnancy 
8 (2.3) 97 (8.3) <0.001 
Socioeconomic 
deprivation  
217 (78.3) 790 (81.0) 0.338 
Gestational diabetes* 103 (29.1) 274 (28.4) 0.794 
Gestational weight 
gain (kg)** 
7.54 (4.55) 7.48 (4.54) 0.838 
Gestation at delivery 
(weeks) 
39.71 (38.71 to 
40.86) 
40.00 (38.86 to 
40.86) 
0.032 
Birthweight (grams) 3500 (3165 to 3806) 3450 (3100 to 3790) 0.126 
Neonatal sum of 
skinfold thicknesses 
(mm)^ 
10.77 (2.78) 11.02 (2.55) 0.320 
Neonatal abdominal 
circumference (cm) 
32.22 (2.18) 32.68 (1.98) 0.016 
Neonatal arm 
circumference (cm) 




Table 6.10: Sensitivity analysis of removal of infants born >34 weeks’ gestation and ≤37 weeks’ 
gestation (n=8 excluded).  
*Infant z-scores calculated using the WHO growth standards (WHO, 2006). **Infant sum of skinfold 
thicknesses calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured in 
triplicates. ^Infant total body fat estimation calculated sex-specific, validated equations (Slaughter et al., 1988). 
†Analyses adjusted for randomisation to the UPBEAT Intervention, infant sex and infant age at anthropometric 
measurement as well as maternal early pregnancy BMI, ethnicity, socioeconomic deprivation, gestational 
diabetes and infant size at birth. 
 
  
 Breastfeeding  Formula feeding  Mixed feeding  
Mean difference/ 




 (95% CI) 
Triceps skinfold z-scores* REF -0.02 (-0.39 to 0.35) 0.47 (-0.19 to 1.14) 
Subscapular skinfold z-scores* REF 0.21 (-0.15 to 0.57) 0.37 (-0.27 to 1.01) 
Sum of skinfold thickness (mm)** REF 0.27 (-0.71 to 1.26) 1.44 (-0.32 to 3.20) 
Weight z-scores* REF 0.27 (0.01 to 0.52) 0.23 (-0.23 to 0.69) 
BMI z-scores* REF 0.21 (-0.24 to 0.66) 0.54 (-0.27 to 1.34) 
Length z-scores* REF 0.29 (-0.17 to 0.74) -0.28 (-1.10 to 0.54) 
Total body fat estimation (%) ^ REF 0.37 (-0.88 to 1.61) 1.83 (-0.39 to 4.05) 
Arm circumference z-scores * REF 0.09 (-0.18 to 0.35) 0.54 (0.6 to 1.01) 
Weight change (kg/ month) REF 0.04 (0.01 to 0.07) 0.03 (-0.03 to 0.09) 
Length change (cm/month) REF 0.16 (-0.06 to 0.38) 0.01 (-0.36 to 0.38) 
Catch up growth  REF 2.40 (1.40 to 4.12) 1.24 (0.46 to 3.31) 






 Missing data  Complete data 
Comparison  
N (%), Mean 
(SD) 








54 (15.9) 53 (14.8) 
Newcastle 49 (14.2) 71 (20.2) 
Glasgow 107 (30.9) 77 (21.9) 
Manchester 13 (3.8) 28 (8.0) 
Bradford 5 (1.4) 7 (2.0) 
Sunderland  8 (2.3) 5 (1.4) 
St Georges’ 9 (2.6) 5 (1.4) 
Maternal demographic characteristics  
Age (years) 30.1 (5.70) 31.6 (5.05) 0.001 
Multiparity 181 (52.3) 162 (46.0) 0.097 
Ethnicity  
White 249 (72.0) 249 (70.7) 
0.72 
Black  71 (20.5) 63 (17.9) 
Asian  14 (4.0) 11 (3.1) 
Other  12 (3.5) 29 (8.2) 
Socioeconomic deprivation  200 (84.4) 217 (78.9) 0.11 
Number of years in full time 
education  
14.5 (2.9) 15.7 (2.7) <0.001 
Maternal anthropometry  







123.8 (27.0) 122.7 (26.6) 0.58 
27-28+6 weeks’ 
gestation  
126.6 (25.1) 124.0 (27.0) 0.19 
34-36 weeks’ 
gestation  
123.4 (26.7) 122.8 (27.0) 0.79 
Total gestational weight gain 
(kg)**  
7.2 (4.6) 7.6 (4.5) 0.24 
Antenatal clinical history  
Diagnosis of GDM* 96 (28.9) 103 (29.3) 0.92 
Pre-eclampsia 12 (3.5) 10 (2.9) 0.63 
Birth outcomes  
Mode of 
delivery 
Vaginal  165 (47.7) 170 (48.3) 
0.32 Instrumental  51 (14.7) 369 (11.1) 
C-section  130 (37.6) 143 (40.6) 
Postpartum haemorrhage (>1l) 47 (13.7) 59 (16.9) 0.24 
Neonatal 
sex 
Male  173 (50.0) 182 (51.7) 0.65 
Female 173 (50.0) 170 (48.3) 
Gestation at delivery (weeks) 39.4 (2.3) 39.9 (1.5) 0.004 
Birthweight (kg) 3.42 (0.61) 3.59 (0.52) 0.09 
Neonatal sum of skinfold 
thicknesses (mm)^ 
10.8 (2.8) 11.0 (2.5) 0.44 




Table 6.11: Predictors of missing exposure (mode of infant feeding) and maternal covariate 
data in infants with detailed anthropometric data at 6 months of age.  
*Gestational diabetes diagnosed using the International Association of Diabetes in Pregnancy Group’s criteria 
at 24-28 weeks’ gestation. **Gestational weight gain defined as total weight gain from calculated pre-
pregnancy weight gain to 34-36 weeks’ gestation. ^Neonatal sum of skinfolds defined as sum of triceps skinfold 





Table 6.12: Sensitivity analyses assessing the role of mode of early feeding on measures of 
infant anthropometry at 6 months of age., in offspring born to obese women (n=353) using 
multiple imputation. 
*Infant z-scores calculated using the WHO growth standards (WHO, 2006);Catch up and catch down growth 
defined using the WHO definitions of change in weight >0.67 SDs;  Infant sum of skinfold thicknesses 
calculated as the addition of subscapular and triceps skinfolds thicknesses, each measured in triplicates. 
^Infant total body fat estimation calculated using sex-specific, validated equations (Slaughter et al., 1988).. 
Multiple imputation methodology; data was imputed to create 50 datasets using 10 burn-in iterations for 
missing mode of feeding (exposure) and covariate data for infants with detailed anthropometry at 6 months of 
age (n=698, 49.2% missing) using centre, maternal age, trial entry BMI, parity, smoking status, randomisation 
allocation, ethnicity, socioeconomic deprivation, diagnosis of gestational diabetes, total gestational weight 
gain, sum of skinfold thicknesses at 15-18+6, 27-28+6 and 34-36 weeks’ gestation,  mode of delivery, gestation 
at delivery, admission to neonatal intensive care, neonatal sex and offspring age at 6 month visit. Multivariate 
regression analyses (adjusted for potential confounders) was performed and effect estimates were estimate on 
pooled datasets using mean difference (continuous outcomes) and odds ratio (binary outcomes). **Adjustment 
made randomisation for the UPBEAT Intervention, infant sex and infant age at anthropometric measurement as 
well as maternal early pregnancy BMI, ethnicity, socioeconomic deprivation, gestational diabetes and infant 





Mixed feeding (7.6%) 
Mean difference/ 
Odds ratio 
(95% CI) ** 
Mean difference/ 
Odds ratio 
(95% CI) ** 
Triceps SFT z-scores*  REF 0.13 (0.18 to 0.43) 0.31 (-0.23 to 0.86) 
Subscapular SFT z-
scores* 
REF 0.03 (-0.23 to 0.34) 0.12 (-0.43 to 0.66) 
SSFT (mm) REF -0.27 (-1.11 to 0.57) 0.42 (-1.05 to 1.89) 
Total body fat estimation 
(%) 
REF -0.34 (-1.40 to 0.72) 0.54 (-1.33 to 2.40) 
Weight z-scores*  REF 0.25 (0.06 to 0.44) ^ 0.11 (-0.25 to 0.46) 
BMI z-scores*  REF -0.00 (-0.34 to 0.33) 0.07 (-0.55 to 0.69) 
Length z-scores*  REF -0.37 (-0.49 to 0.75) -0.04 (-1.36 to 0.38) 
Arm circumference z-
score  
REF 0.21 (-0.11 to 0.52) 0.74 (-0.11 to 1.05) 
Rate of weight gain 
(kg/month) 
REF 0.03 (0.01 to 0.06) ^ 0.01 (-0.04 to 0.06) 
Rate of length gain 
(cm/month) 
REF 0.31 (-0.14 to 0.75) 0.27 (-0.07 to 0.61) 
BMI z-scores ≥85th * REF 1.06 (0.54 to 2.08) 1.89 (0.63 to 5.68) 
BMI z-scores ≥ 95th * REF 1.10 (0.40 to 3.07) 1.62 (0.32 to 8.26) 
Catch up growth  REF 2.06 (1.31 to 3.26) ^ 1.15 (0.49 to 2.70) 





6.4.1 Summary of overall findings 
The increasing incidence of maternal obesity is of public health concern, not only because 
of the immediate adverse health outcomes, but also due to the possible transgenerational 
association with childhood obesity (Poston et al., 2016). As the trajectory of later obesity is 
also thought to be determined in early infancy, targeted interventions within this period 
may have a major influence on curbing the escalating incidence (Giles et al., 2015). 
Although breastfeeding has been demonstrated to be protective against childhood obesity 
(Armstrong and Reilly, 2002; Arenz et al., 2004; Smith, 2012; Robinson et al., 2015b), 
obese mothers have reduced rates of initiation and duration of exclusive breastfeeding (as 
assessed as a continuous measure) (Bever Babendure et al., 2015). 
 
This investigation addressed the influence of mode of early feeding with infant 
anthropometry and demonstrated a protective influence of exclusive breastfeeding on the 
infant. Exclusive breastfeeding ≥4 months was found to be protective against linear 
increases in weight z-scores, velocities of weight gain and catch up growth but not with 
measures of adiposity in comparison to infants’ formula or mixed fed. Measures of general 
appetite in early infancy were associated with measures of adiposity, weight and catch up 
growth independent of cord blood leptin concentrations and mode of early feeding.  
   
6.4.2 Association between breastfeeding and infant anthropometry, body composition at 
6 months of age.  
To our knowledge, this is the first study addressing breastfeeding and infant adiposity in 
obese women. Within this high risk group, this study demonstrated that exclusive 
breastfeeding ≥ 4months  in obese women is associated with reduced measures of infant 




pregnancy BMI and GDM. A protective effect of breastfeeding and later childhood obesity 
was initially proposed by Kramer et al (Kramer et al., 2004). To date, studies have 
demonstrated small improvements in measures of growth in offspring born to women of 
heterogeneous BMI. Determining the true effect of breastfeeding on later childhood 
obesity, is difficult due to the large number of confounders. For example, socioeconomic 
deprivation is known to influence duration of exclusive breastfeeding as well as dietary 
composition in early life (Young et al., 2012). Meta-analyses suggest small reductions in 
childhood obesity (Owen et al., 2005; Yan et al., 2014). A dose response relationship has 
been suggested between duration of exclusive breastfeeding for >1 month and an 
associated 30% risk reduction of obesity in adolescence (Harder et al., 2005). However, the 
majority of studies have assessed older children, than investigated in the present study; 
therefore, direct comparisons in relation to effect estimates with this study are difficult to 
make.  
 
This analysis demonstrated reduced catch-up and weight gain velocities in breastfed infants 
which are comparable to studies in women of heterogeneous BMI and this may benefit in 
relation to later obesity risk. Rapid weight gain and catch up growth in early infancy are 
associated with an increased risk of later childhood obesity (Baird et al., 2005; Ong and 
Loos, 2006). Within the ALSPAC cohort, catch up growth from birth to two years was 
associated with increased visceral fat mass at 5 years of age (Ong et al., 2000). In another 
longitudinal study undertaken in the prospective Dortmund Nutritional and Anthropometric 
Longitudinally Designed (DONALD) cohort, it was observed that in boys alone breastfed 
for <16 weeks, born to overweight women there was significantly greater postnatal growth 
up to 7 years of age in comparison to those breastfed >17 weeks (Buyken et al., 2008). 
Together these studies and the UPBEAT study, suggest that breastfeeding may have the 
potential to offset the ‘programming’ effect of childhood obesity, through modification of 





6.4.3 Role of timing of introduction of solids and infant anthropometry at 6 months 
This study demonstrated limited adherence to current WHO breastfeeding guidelines 
amongst obese women (exclusive breastfeeding in 46.7% and introduction of solids ≥6 
months of age in 12.1% of the included cohort), highlighting the need for targeted 
interventions within the postpartum period for obese women to promote exclusive 
breastfeeding and later introduction of solids.   
 
There was no association between mode of early life feeding, further stratified by timing of 
introduction to solids with infant anthropometry at 6 months of age, born to obese women. 
This finding is supported by a previous observational study demonstrating no association 
between the timing of solid food introduction and later child adiposity at 6 and 12 months 
of age (Huh et al., 2011) in offspring born to women of heterogeneous BMI. However a 
recent systematic review identified that early introduction of solids (≤4 months of age) was 
associated with a small increased risk of developing overweight/ obesity in childhood 
(Daniels et al., 2015). Early introduction of solids is associated with increased energy 
consumption, and also provides vital micronutrients including vitamin D, iron, zinc; 
essential for growth and development (Krebs and Hambidge, 2007). However, a 
prospective cohort study in the USA demonstrated low rates of initiation and duration of 
exclusive breastfeeding, similar to the findings from the presented study, reported formula 
feeding with the introduction of solids before 4 months of age to be associated with a six 
fold increased risk of childhood obesity at 3 years of age (Huh et al., 2011). The results of 
the ongoing follow up of the UPBEAT children at 3-4 years are awaited with interest to 
determine the long-term influence of early-life feeding on measures of body composition.   
 
Although the protective mechanisms of breastfeeding on childhood obesity are yet to be 
delineated, it has been suggested that differences in weight gain velocity between infants’ 




milk. However, despite some previous reports of breast milk composition in women with 
GDM; reports suggest a beneficial influence on early weight velocity (Ailhaud et al., 2006; 
Gunderson, 2007; Nasser et al., 2010).  
 
In contrast, formula milk does not contain bioactive compounds and generally has a higher 
protein content, both of which may be significant risk factors for later obesity (Patro-Gołąb 
et al., 2016b). The Childhood Obesity Project provided causal evidence of a high protein 
formula diet associated with increased growth and weight status at 1 year of age in 
comparison to a low protein diet. However breastfed infants had significantly reduced 
weight and length z-scores than formula fed infants at 24 months despite its protein content 
(Koletzko et al., 2009; Kirchberg et al., 2015). 
 
6.4.4 Infant appetite and satiety at 6 months of age 
Exclusive breastfed infants were more likely to demonstrate ‘enjoyment of food’ compared 
to formula or mixed fed infants. This finding was unexpected given the direction of the 
observed effect sizes on measures of infant anthropometry by mode of early life feeding, at 
6 months of age (Llewellyn et al., 2011). The term ‘enjoyment of food’ has consistently 
been associated with the development of obesity and therefore considered an ‘obesity risk’ 
characteristics (Llewellyn et al., 2011). 
 
Measures of general appetite assessed by the validated Baby Eating Behaviour 
Questionnaire were found to be positively associated with measures of infant adiposity, 
weight z-scores and catch up scores, independent of cord leptin, mode of early feeding, 
maternal and infant confounding. This finding is similar to previous reports suggesting that 
the early postnatal environment other than the mode of feeding, may influence general 
appetite and development of increased adiposity (Reilly et al., 2005; Gorski et al., 2006). 




supplemented milk and beverages which were not assessed within this study. However, the 
associations with satiety responsiveness with measures of infant adiposity and growth were 
unexpected as reduced satiety is thought as an obesogenic trait and is associated with 
increased appetite (Carnell and Wardle, 2009; Syrad et al., 2016). Of interest, a validation 
study of the Baby Eating Behaviour Questionnaire in an Australian cohort of mother-infant 
dyads, Mallan MK et al demonstrated poor performance of satiety responsiveness as 
measured by the Baby Eating Behaviour Questionnaire (α=0.56) in comparison to the other 
derived satiety and appetite measures (Mallan et al., 2014) and this may provide an 
explanation for this unexpected result in this study too.  
 
6.4.5  Strengths and limitations  
The analysis undertaken here differs from previously published reports as our sample of 
mothers and their infants were from a prospective cohort, recruited from inner-city 
populations. As 80% of the population included in this study were in this highest quintile of 
socioeconomic deprivation compromised entirely of obese women, this study was well 
placed to assess the mode of early feeding on infant anthropometric outcomes within this 
high-risk group. Due to the detailed data available, including cord leptin concentrations, 
potential associations linking early nutrition with later obesity risk are suggested, as well as 
the assessment of appetite and satiety in infants at 6 months of age. Limitations include the 
study being undertaken in <30% of the original cohort. However, sensitivity analyses 
including the use of multiple imputation did not result in differences in the observed 
relationships. Identification of selection bias may limit translatability of findings to the 
greater population, however there were no differences in BMI, incidence of gestational 
diabetes or infant characteristics between those included and excluded within the analyses. 
The Baby Eating Behaviour Questionnaire is a parent-reported measure and subjected to 
recall bias. Furthermore, the questionnaire was collected retrospectively, therefore if infants 




solids within this cohort. It may also be difficult for mothers to objectively assess two 
different modes of feeding retrospectively together with potential subjective reporting and 
bias towards breastfeeding (Llewellyn et al., 2011). Replication of findings using the Baby 
Eating Behaviour Questionnaire in infants of 3 months of age may provide further insight 
in appetite and satiety during the predominant milk feeding period. The questionnaire used 
to assess appetite and satiety did not however distinguish between delivery of breastmilk 
via breast or bottle which may confound the interpretation of this data as previous studies 
have suggested that the mode of delivery may influence appetite (Li et al., 2014). The 
analysis was unable to assess the influence of sweetened beverages or milk supplements 
given in the early postnatal life. 
 
6.4.6 Conclusion 
This study has provided evidence that exclusive breastfeeding may modify early life 
childhood growth but not adiposity in infants at 6 months of age, born to obese mothers. 
Future assessment of metabolites within breastmilk, may provide invaluable mechanistic 
insight associated with this observed protective effect on early life growth. A novel, and 
potential important association between appetite and adiposity in 6 month infants not 
previously reported in any study; requires further investigation of the associated 
mechanisms as suggests that appetite may be a modifiable determinant of adiposity. 
Ongoing follow-up of this cohort will provide further understanding of the long-term 






Chapter 7 Discussion 
7.1 Main findings of this thesis  
This thesis sought to define the associations of the in-utero and early life origins of infant 
adiposity at 6 months of age, born to obese mothers, from a multi-ethnic population 
associated with high socioeconomic deprivation. The main findings of this thesis are 
summarised in Figure 7.1.  
 
Figure 7.1: Summary of main findings of the analyses incorporated in this thesis.    
Observed associations are illustrated in this figure where neonatal adiposity & infant anthropometry are the 
outcomes of interest (red text). Potential confounders adjusted for within each analysis have not been depicted.    
Potential causal relationship determined following planned follow-up of the UPBEAT randomised 
controlled trial.  Blue arrow indicates a significant interaction. Abbreviations: GWG- Gestational weight gain; 




Maternal obesity is associated with greater childhood adiposity and adverse body fat 
distribution (Patel et al., 2015; Godfrey et al., 2016; Poston et al., 2016). Obesity in early 
childhood has shown within population studies to be associated with an increased risk of 
later obesity and cardiometabolic disease (Cunningham et al., 2014; Gaillard et al., 2014b; 
Perng et al., 2016). As the trajectory for later obesity is thought to be determined at birth 
and has shown to track through childhood, recognition of effective, targeted interventions 
within this sensitive window of opportunity are required to curb this increasing epidemic 
(Cunningham et al., 2014; Giles et al., 2015).  
 
This thesis sought to identify in-utero and early life origins associated with neonatal and 
infant adiposity using data from the UK Pregnancies Better Eating and Physical Activity 
Trial. Within this cohort of obese women, the work presented has led to the following 
observations;  
 Maternal fasting glucose in late second trimester was found to partially mediate the 
influence of maternal parity and measures of early pregnancy adiposity on neonatal 
adiposity. Maternal birthweight was independently associated with neonatal 
adiposity.  
 Higher maternal glycaemia, specifically fasting glucose assessed at late second 
trimester was linearly associated with cord blood concentrations of 
lysophosphatidylcholines. Cord blood insulin growth factor I and 
lysophosphatidylcholines were identified as potential determinants of infant weight 
at 6 months of age in offspring born to obese women.  
  An antenatal lifestyle (dietary and physical activity) intervention in obese pregnant 
women was found to have the potential to reduce infant adiposity at 6 months of 
age, and this observation was partially mediated through the changes in maternal 




 In comparison to exclusive breastfeeding, formula and mixed feeding (breast and 
formula feeding) was associated with increased weight and velocities of weight 
gain in infants at 6 months of age.  
 
Within this cohort of obese pregnant women, maternal fasting glucose measured in the late 
2nd trimester was shown to be an important mediator of early pregnancy characteristics 
including measures of maternal upper body adiposity and parity. Furthermore, increasing 
maternal glycaemia was found to be a significant maternal exposure associated with the 
cord blood metabolic profile. Population studies have consistently demonstrated 
associations with maternal fasting glucose, neonatal adiposity and subsequent growth 
(Pettitt et al., 1993; Metzger et al., 2009; Aris et al., 2014; Logan et al., 2016b). Using 
Mendelian randomisation methodology, the relationship between maternal fasting glucose 
at 27-28 weeks’ and neonatal adiposity was recently proven causal (Tyrrell et al., 2016). 
The mean BMI from the included studies (n=11 cohort studies included) was 22.8 to 24.8 
kg/m2, therefore this conclusion may have limited relevance to the greater degree of 
maternal dysglycaemia observed in obese pregnancies and the subsequent association with 
neonatal adiposity.  
 
Undertaking mediation analyses as reported in this thesis, facilitated the identification of a 
critical, intermediary role in the relationship between maternal fasting glucose in the late 
2nd trimester (at the time of the OGTT) and neonatal adiposity within a homogeneous obese 
cohort. There are very few relevant studies in the literature, although Lawlor et al, have 
demonstrated previously that maternal fasting glucose concentrations at a similar gestation 
partially mediate the associated risk of Pakistani ethnicity with neonatal fat mass, using 
cord leptin as a proxy measure, but within a heterogeneous BMI population (Lawlor et al., 
2014). Since excessive fetal growth, occurs earlier in pregnancy than at the time of the oral 




also important to understand the earlier pregnancy determinants of neonatal adiposity and 
this thesis has reported a comprehensive assessment of early maternal characteristics 
including biochemical variables, the relationships with neonatal adiposity and the 
associated cord blood metabolic profile. This has provided novel mechanistic insight as 
well as identification of potential targets for future intervention which may be of benefit in 
the prevention of neonatal and infant adiposity, in offspring born to obese women.  
 
By undertaking an exploratory analysis, components of the cord metabolic profile, 
specifically lysophosphatidylcholines and insulin growth factor I were associated with 
neonatal adiposity and weight, together with measures of infant growth at 6 months of age. 
Evidence from longitudinal population studies suggest that the trajectory of later obesity 
may be determined at birth (Tilling et al., 2011; Jones-Smith et al., 2013; Giles et al., 
2015). Although studies assessing the cord blood metabolic profile in relation to infant 
obesity at a later age are limited, one small case-control study has found that metabolite 
derangements in one-carbon metabolism pathways in cord blood were associated with rapid 
weight gain within the first 6 months (Isganaitis et al., 2015). That study as well as the 
report from the UPBEAT cohort presented in this thesis, provide initial evidence that 
metabolite patterns associated with later disease risk are present at birth and may play a 
contributory role in the determination of later growth trajectories (Giles et al., 2015; 
Isganaitis et al., 2015). However, it is not clear if the cord metabolite profile reported here 
was causally associated with disordered maternal metabolic function in this obese cohort, 
or whether the fasting/feeding state in before and during delivery could have a potential 
influence (Isganaitis et al., 2015).  
 
To date, there are no published studies assessing the cord metabolic profile in relation to 
maternal adverse in-utero exposure in obese pregnancies. From the reported UPBEAT 




obese women, including raised lysophosphatidylcholines which, as I have suggested, may 
act as mediator in the association between maternal glycaemia and offspring adiposity at 
birth and at 6 months of age. If these findings are proven causal, interventions targeted at 
improving maternal glycaemic profiles in obese pregnancies may provide a robust 
approach to reducing offspring adiposity.  
 
In view of the growing incidence of maternal obesity (NCD-RisC, 2016; Poston et al., 
2016), several well-powered clinical studies assessing antenatal interventions have been 
undertaken which have demonstrated small improvements in maternal dietary behaviours 
and/ or reductions in gestational weight gain. None of these have been associated with a 
reduction in the incidence of maternal gestational diabetes (Vinter et al., 2011; Walsh et 
al., 2012; Dodd et al., 2014a; Poston et al., 2015), however as reported in this thesis and 
recently published (Patel et al, 2017), the intervention in the UPBEAT trial, which changed 
diet substantially, reduced GWG and maternal adiposity was associated with a reduction in 
a measure of infant adiposity at 6 months of age. Although a small effect size estimate was 
observed; this follow-up of a randomised controlled trial, provides for the first time, causal 
evidence that an intensive behavioural lifestyle intervention has the potential reduce infant 
adiposity within an obese cohort. Antenatal lifestyle interventions have shown to result in 
changes in neonatal thigh circumference born to mothers randomised to a low glycaemic 
diet in pregnancy (Donnelly et al., 2015). However, unlike the UPBEAT studies, previous 
studies assessing lifestyle interventions in pregnancy have found no difference in offspring 
anthropometry in early infancy (Vinter et al., 2011; Horan et al., 2016); which may reflect 
the greater intensity of the UPBEAT intervention  leading to improved diet and reduced 
adiposity in the mother (Poston et al., 2015; Flynn et al., 2016).  
 
By undertaking causal mediation analysis specifically for a randomised controlled trial, 




with the observed difference in infant subscapular skinfold thicknesses. Although the 
intervention had no effect on the cord blood metabolic profile, in an unpublished report the 
UPBEAT intervention has been found to lead to a reduction in maternal lipid metabolites, 
longitudinally assessed at three time points during pregnancy (Lawlor et al, manuscript in 
preparation). Ongoing investigation of the cord epigenome as well as the maternal 
metabolome may identify causative mechanisms associated with the UPBEAT 
intervention.  
 
Early life feeding practices in obese populations are considerably different to that of 
women within a normal BMI range, and this thesis has demonstrated as far as we are aware 
for the first time, the beneficial role of exclusive breastfeeding in obese women on infant 
weight and associated velocities in early life; both known predictors of later childhood 
obesity (Ong et al., 2000; Ong et al., 2006; Ong and Loos, 2006; Kramer et al., 2007). 
Although small effect estimates were observed, these findings are in line with a previous 
report undertaken in offspring born to women of heterogeneous BMI (Owen et al., 2005); 
suggesting that promotion of exclusive breastfeeding in obese women may modify the risk 
of rapid weight gain in early infancy. Evidence has demonstrated that breastfeeding 
interventions delivered effectively can result in significant improvements in breastfeeding 
practices (Rollins et al., 2016). Over the last two decades, the promotion of breastfeeding is 
no longer considered the sole obligation of the mother but a societal responsibility. The 
determinants of breastfeeding include sociocultural trends, influence of healthcare systems, 
employment, family and community environment together with maternal  and infant 
attributes; all potential targets of intervention (Rollins et al., 2016). Methods of 
intervention include mass advertising, amendments and formulation of policies together 





The UPBEAT study was associated with significantly improved maternal dietary 
behaviours at 6 months postpartum, suggesting that women in the postpartum period are 
amenable to dietary advice, which may have a beneficial impact within the preconception 
period for subsequent pregnancies. Systematic reviews and meta-analyses have identified 
that weight reduction in the postpartum period is achievable in overweight and obese 
women (van der Pligt et al., 2013) and have demonstrated that breastfeeding duration was 
associated with maternal weight loss (not reported within this thesis). Interventions which 
focus on the postpartum period are likely to be more feasible that those within the 
preconception period, and our group has embarked on an intervention to promote weight 
loss in women who most at risk of postpartum weight retention (The Swan Study). 
Targeting women preconceptionally is challenging due to identification and recruitment 
(Hanson et al., 2016), and would require adoption of a public health intervention approach. 
Recently the use of ‘healthy eating behaviour conversations’ provides an approach to 
modify lifestyle behaviours within a public health setting (Barker et al., 2016); however 
ongoing work will determine whether this and other similar  approaches provide a 
translatable, effective method to curb the increasing incidence of maternal and subsequent 
offspring obesity epidemic.   
 
With the exception of Chapter 6, the work reported in this thesis is derived from a 
prospective observational study, therefore the Bradford Hill criteria should be considered 
when inferring causality from epidemiological data (Hill, 1965). This criteria was 
established to increase our confidence that an exposure was causally associated with an 
outcome providing a criterion was met, which included strength of association, 
consistency, temporality, biological gradient, plausibility, coherence, experiment and 
analogy(Hill, 1965). Although the Bradford Hill criteria provides guidelines for inferring 
causality, each criterion should be applied and interpreted specifically within a data 
integration framework against new methods of data collection including the use of 




sophisticated epidemiological techniques causal inference is no longer informed by the 
traditional use of epidemiological techniques but rather a combination of research tools and 
collaboration amongst scientific disciplines (Fedak et al., 2015).  
 
7.2 Strengths and limitations  
This study was conducted within a prospective cohort of obese women, recruited from 
inner-city, socioeconomically deprived populations. As socioeconomic deprivation has 
been consistently associated with an increase in all-cause mortality (Smith et al., 1990; 
Smith et al., 1998), characterising maternal in-utero factors associated with offspring 
adiposity in a population with high socio-economic deprivation, could contribute to 
improved health of women and children most at risk of sub-optimal health in later life. 
UPBEAT provides a unique database, including detailed maternal demographic, clinical, 
familial and environmental characteristics, longitudinal anthropometric, dietary and 
physical activity assessment; allowing an in-depth examination of the consequences of 
maternal obesity on offspring adiposity and anthropometry. In addition, follow-up of 
offspring born to obese women including the collection of anthropometric and dietary data, 
allows evaluation of the potential role of early life characteristics with subsequent growth 
together with detailed data on potential confounders. This cohort also provides one of the 
largest biobanks to date from obese women collected at regular intervals during pregnancy, 
providing a unique opportunity to address mechanistic relationships between maternal in-
utero exposures with fetal and infant outcomes. Universal screening of gestational diabetes 
using the International Association of Diabetes in Pregnancy study group’s criteria 
provided a standardized approach in the classification of an important in-utero exposure 
variable within the reported analyses of this thesis.  
 
As with all longitudinal studies, attrition at follow-up was common for both maternal and 




randomised controlled trials (Tanvig et al., 2014; Landon et al., 2015; Horan et al., 2016). 
In addition, the statistical analysis incorporated within this thesis, acknowledged the 
introduction of bias associated with missing data and sensitivity analyses did not 
demonstrate considerable differences in observed effect estimates. The treatment of 
gestational diabetes has been shown to alter the maternal metabolic environment especially 
within the third trimester and this may modify offspring adiposity deposition (Stumvoll  et 
al., 1995; Ratner et al., 2008; Rowan et al., 2011). This study did not have a standardised 
approach for the treatment of gestational diabetes in participants which may have resulted 
in differences within pharmacological intervention between the centres. The study also 
lacked detailed data on initiation and duration of different modalities of treatment for 
gestational diabetes. Within epidemiological research, assessing the influence of different 
treatment modalities on outcomes is challenging, as the modalities of treatment (including 
capillary blood testing, dietary advice, metformin and/or insulin) overlap considerably. To 
consider any potential effect, analyses were adjusted for the incidence of gestational 
diabetes, a proxy variable for the initiation of treatment of gestational diabetes. 
Furthermore, detailed sensitivity analyses were undertaken excluding participants 
diagnosed with gestational diabetes, to assess for potential modification in observed effect 
estimates. Infant and maternal dietary data at 6 months postpartum, were collected with the 
use of validated questionnaires (Bingham et al., 2001; Robinson et al., 2007; Briley et al., 
2014), which may be subjected to recall bias. However, at the time of undertaking this 
study, and to date the use of questionnaires is the accepted and established method of 
collecting dietary data within a population cohort.  
 
7.3 Recommended future work 
Ongoing follow-up of the offspring at 3 years of age, will provide valuable data to assess 
whether the UPBEAT intervention led to long-term, sustained improvements in offspring 




bioelectrical impedance data. Furthermore, combining the cord blood metabolomics data, 
with longitudinal anthropometric data, will provide further understanding of the 
mechanistic pathways implicated with the development of childhood adiposity. As the cord 
metabolomics analyses, identified no effect of the UPBEAT intervention; cord blood 
epigenetic analysis currently being undertaken, may identify potential mediators associated 
with the observed change in infant central fat mass at 6 months of age.   
 
Maternal second trimester fasting glycaemic profile was shown to play a critical role in the 
development of neonatal adiposity and cord blood metabolic profile. Work from this thesis 
could be extended by undertaking continuous glucose monitoring in obese pregnant 
women. This would allow the characterisation of subtle variations in maternal antenatal 
glucose in relation to offspring adiposity throughout the life course. Furthermore, the 
provision of comprehensive glucose data, would allow the characterisation and evaluation 
of different modalities of gestational diabetes treatment with outcomes in early infancy.  
 
As maternal obesity places an increased burden on healthcare resources, universal 
screening and subsequent treatment for all obese women does not provide a cost-effective 
solution for the prevention of adverse offspring outcomes (Farrar et al., 2016b). Early 
detection and treatment of gestational diabetes by metformin in women most at risk, using 
for example, the GDM risk assessment tool recently developed in the UPBEAT cohort 
(White et al., 2016), in combination with a dietary and physical activity intervention, may 
provide a cost-effective solution to modify maternal fasting glycaemic profiles, gestational 
weight gain and lifestyle behaviours to the postpartum period (Poston et al., 2013; Poston 






7.4 Conclusion  
Using data from the UPBEAT cohort, this thesis has demonstrated the following key 
observations.  
 In offspring born to obese pregnant women, maternal fasting glucose in the late 
second trimester partially mediates the influence of maternal parity and measures 
of early pregnancy adiposity on neonatal adiposity.  
 Cord blood insulin growth factor I and lysophosphatidylcholines are potential 
determinants of infant weight at 6 months of age in offspring born to obese women.  
  An antenatal lifestyle (dietary and physical activity) intervention in obese pregnant 
women has the potential to reduce infant adiposity at 6 months of age, partially 
mediated through changes in maternal gestational weight gain and antenatal diet 
associated with the intervention. This finding suggests a causal association between 
improvements in obese maternal diet and physical activity is associated with a 
reduction in infant adiposity. 
 In comparison to exclusive breastfeeding, formula and mixed feeding (breast and 
formula feeding) was associated with increased weight and velocities of weight 
gain in infants of obese mothers at 6 months of age.  
 
If these findings are proven casual, this study will have provided evidence towards the 
development of interventions to improve maternal fasting glucose, which in combination 
with a lifestyle intervention in the antenatal period and promotion of breastfeeding in the 






Appendix Figure 1: Association of cord blood metabolomics profile with cord C-peptide in obese pregnant mothers; data from the UPBEAT study (n=343). 
Parameter estimates are graphically represented for each biochemical variable in relation to cord blood C-peptide allowing correction for a false discovery rate (Benjamin & Hochberg 
procedure) (Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance p≤0.0019. 
Abbreviations; CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; LPCE- 
lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis factor; 
X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of double 
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Appendix Figure 2: Association of cord blood metabolomics profile with cord IGF-1 in obese pregnant mothers; data from the UPBEAT study (n=343). 
Parameter estimates are graphically represented for each biochemical variable in relation to cord blood IGF-1 allowing correction for a false discovery rate (Benjamin & Hochberg procedure) 
(Benjamini and Hochberg, 1995). Adjustment made for randomisation to the UPBEAT intervention, offspring sex and gestation at delivery. Statistical significance p≤0.0019. Abbreviations; 
CARN-Carnitines; HDL-High density lipoprotein; IGFI- Insulin growth factor I; IGF II- Insulin growth factor II; IL6- Interleukin 6; LPC- lysophosphatidylcholines; LPCE- 
lysophosphatidylethanolamine; PC-phosphatidylcholines; PCA- diacylphosphatidylcholines; PCE- acylalkylphosphatidylcholines; SM- sphingomyelins. TNFalpha- Tumor necrosis factor; 
X30B- x3methyl2oxobutanoicacid; X30V-- x4methyl2oxovalvericacid. NEFAs are described using the nomenclature CX:Y, where X is the length of the carbon chain, Y is the number of double 
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